10097139	102	Lammich S	Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.	Proceedings of the National Academy of Sciences of the United States of America	1999	196
12714508	102	Hundhausen C	The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.	Blood	2003	166
12832423	102	Matthews V	Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).	The Journal of biological chemistry	2003	80
15716380	102	Gavert N	L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.	The Journal of cell biology	2005	77
18603587	102	Raucci A	A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).	FASEB journal 	2008	114
19726678	102	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	146
19726682	102	van Tetering G	Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.	The Journal of biological chemistry	2009	81
21246057	102	Zhao Y	Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.	PloS one	2011	54
21349442	102	Bonda DJ	The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.	The Lancet. Neurology	2011	40
23035126	102	Haining EJ	The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.	The Journal of biological chemistry	2012	30
24055016	102	Suh J	ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.	Neuron	2013	33
25150980	102	Shimoda M	Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.	Nature cell biology	2014	24
8358726	142	Kaufmann SH	Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.	Cancer research	1993	272
10728709	142	Gamet-Payrastre L	Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells.	Cancer research	2000	103
11350913	142	Sunwoo JB	Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.	Clinical cancer research 	2001	96
11812763	142	Pacher P	The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.	Diabetes	2002	88
14514658	142	Singh AV	Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.	Carcinogenesis	2004	92
15498778	142	Audebert M	Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining.	The Journal of biological chemistry	2004	189
16306359	142	Obrosova IG	Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.	Diabetes	2005	68
17339367	142	Pledgie-Tracy A	Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.	Molecular cancer therapeutics	2007	70
17505006	142	Albert JM	Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.	Clinical cancer research 	2007	77
17913816	142	Won S	NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis.	Journal of virology	2007	72
18006697	142	Chauhan D	Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.	Blood	2008	60
18188152	142	Oka S	Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs.	The EMBO journal	2008	55
18794155	142	Stan SD	Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.	Cancer research	2008	63
19509164	142	Ikeda H	The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.	Clinical cancer research 	2009	48
19762485	142	Kurtova AV	Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.	Blood	2009	87
19996272	142	Carboni JM	BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR.	Molecular cancer therapeutics	2009	65
20049735	142	Mendes-Pereira AM	Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors.	EMBO molecular medicine	2009	172
20072652	142	Lin L	A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.	Neoplasia	2010	52
20187128	142	Caramés B	Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis.	Arthritis and rheumatism	2010	105
20805366	142	Chauhan D	A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma.	Blood	2010	44
21487248	142	Dedes KJ	Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.	Cell cycle	2011	52
21680843	142	Mao Z	SIRT6 promotes DNA repair under stress by activating PARP1.	Science	2011	170
21706030	142	Johnson N	Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.	Nature medicine	2011	57
21908496	142	Rojo F	Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer.	Annals of oncology 	2012	38
22416035	142	Williamson CT	Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.	EMBO molecular medicine	2012	40
22682224	142	Cantó C	The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.	Cell metabolism	2012	167
22902501	142	Doege CA	Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.	Nature	2012	104
22993403	142	Schiewer MJ	Dual roles of PARP-1 promote cancer growth and progression.	Cancer discovery	2012	62
23319653	142	Robu M	Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair.	Proceedings of the National Academy of Sciences of the United States of America	2013	46
23554447	142	Michels J	Cisplatin resistance associated with PARP hyperactivation.	Cancer research	2013	29
23703322	142	Montero J	p53 regulates a non-apoptotic death induced by ROS.	Cell death and differentiation	2013	31
23744078	142	Young LC	Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.	The Journal of biological chemistry	2013	32
23881923	142	Shen Y	BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.	Clinical cancer research 	2013	54
24077350	142	Cardnell RJ	Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer.	Clinical cancer research 	2013	47
24270264	142	Meloche J	Role for DNA damage signaling in pulmonary arterial hypertension.	Circulation	2014	30
24435446	142	Fiskus W	Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.	Molecular cancer therapeutics	2014	39
25026298	142	Ha K	Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.	Oncotarget	2014	23
25422887	142	Gong Z	LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.	PloS one	2014	22
25533949	142	Sajish M	A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol.	Nature	2015	22
26779812	142	Du Y	Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.	Nature medicine	2016	13
27376578	142	Adriaens C	p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity.	Nature medicine	2016	20
10194466	183	Wallukat G	Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.	The Journal of clinical investigation	1999	152
12511528	183	Kobori H	Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.	Hypertension	2003	96
15718497	183	Jaffe IZ	Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.	Circulation research	2005	78
17494887	183	Kaneshiro Y	Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.	Journal of the American Society of Nephrology 	2007	59
18579813	183	Brooke BS	Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.	The New England journal of medicine	2008	156
19050672	183	Ye J	Emerging role of adipose tissue hypoxia in obesity and insulin resistance.	International journal of obesity	2009	114
19075095	183	Kobori H	Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.	Hypertension	2009	60
19240212	183	San-Cristobal P	Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.	Proceedings of the National Academy of Sciences of the United States of America	2009	90
21576625	183	Wenzel K	Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.	Hypertension	2011	36
22028412	183	Kim JA	Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.	American journal of physiology. Endocrinology and metabolism	2012	34
22922412	183	McCurley A	Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.	Nature medicine	2012	63
24144355	183	Schiffrin EL	Immune mechanisms in hypertension and vascular injury.	Clinical science	2014	39
25421983	183	Li W	Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.	Hypertension	2015	19
26585673	183	Nagpal V	MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.	Circulation	2016	13
10203785	207	Maehama T	PTEN: a tumour suppressor that functions as a phospholipid phosphatase.	Trends in cell biology	1999	123
10910062	207	Sekulić A	A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.	Cancer research	2000	166
11715023	207	Bodine SC	Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.	Nature cell biology	2001	514
12039858	207	Humar R	Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.	FASEB journal 	2002	84
12094235	207	Vivanco I	The phosphatidylinositol 3-Kinase AKT pathway in human cancer.	Nature reviews. Cancer	2002	1352
12374740	207	Frödin M	A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.	The EMBO journal	2002	91
12376533	207	Beffert U	Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.	The Journal of biological chemistry	2002	84
12393915	207	Yan F	Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.	The Journal of biological chemistry	2002	97
12511591	207	West KA	Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.	The Journal of clinical investigation	2003	163
12702506	207	Xu Q	Survival of acute myeloid leukemia cells requires PI3 kinase activation.	Blood	2003	109
12897778	207	Matsunaga T	Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.	Nature medicine	2003	133
14517300	207	Rathmell JC	Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.	Molecular and cellular biology	2003	161
14585353	207	Luo J	Targeting the PI3K-Akt pathway in human cancer: rationale and promise.	Cancer cell	2003	296
14612533	207	Christensen JG	A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.	Cancer research	2003	133
14695208	207	Burtrum D	A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.	Cancer research	2003	101
14713953	207	Miyauchi H	Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway.	The EMBO journal	2004	76
15156201	207	Majumder PK	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.	Nature medicine	2004	274
15172999	207	Elstrom RL	Akt stimulates aerobic glycolysis in cancer cells.	Cancer research	2004	367
15319269	207	Wolfrum S	Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.	Arteriosclerosis, thrombosis, and vascular biology	2004	98
15585641	207	deGraffenried LA	Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.	Clinical cancer research 	2004	77
15723049	207	Ohanna M	Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.	Nature cell biology	2005	101
16027121	207	Hahn-Windgassen A	Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.	The Journal of biological chemistry	2005	156
16103100	207	Graff JR	The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts.	Cancer research	2005	99
16186396	207	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	91
16397263	207	Schittenhelm MM	Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.	Cancer research	2006	92
16428510	207	Qian DZ	Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.	Clinical cancer research 	2006	71
16537497	207	Liu H	Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.	Proceedings of the National Academy of Sciences of the United States of America	2006	64
16622124	207	Yaguchi S	Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.	Journal of the National Cancer Institute	2006	66
16636132	207	Khakoo AY	Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.	The Journal of experimental medicine	2006	181
16715125	207	Wang X	Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.	Oncogene	2006	71
16962653	207	Jacinto E	SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.	Cell	2006	484
17018841	207	Lee MJ	A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.	American journal of physiology. Renal physiology	2007	83
17047067	207	Cao C	Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.	Cancer research	2006	93
17052453	207	Zhang HH	S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt.	Molecular cell	2006	99
17203200	207	Chong ZZ	The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.	International journal of molecular medicine	2007	56
17318262	207	Govindarajan B	Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.	The Journal of clinical investigation	2007	86
17395690	207	Aoki H	Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.	Molecular pharmacology	2007	128
17483336	207	Ao M	Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.	Cancer research	2007	77
17537959	207	Tsokas P	Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway.	The Journal of neuroscience 	2007	65
17560336	207	Vivanco I	Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.	Cancer cell	2007	86
17563753	207	Julien S	Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.	Oncogene	2007	132
17611497	207	Carpten JD	A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.	Nature	2007	373
17616691	207	Liu LZ	AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.	Cancer research	2007	63
17646396	207	Lamouille S	Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.	The Journal of cell biology	2007	159
18281460	207	Hambardzumyan D	PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.	Genes and development	2008	145
18339865	207	Yi T	Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.	Cancer research	2008	51
18344980	207	Lim KH	Tumour maintenance is mediated by eNOS.	Nature	2008	97
18381444	207	Rhodes N	Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity.	Cancer research	2008	82
18504432	207	Bleeker FE	AKT1(E17K) in human solid tumours.	Oncogene	2008	55
18511810	207	Paugh SW	A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.	Blood	2008	80
18519702	207	Park CC	Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.	Cancer research	2008	65
18566586	207	Facchinetti V	The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C.	The EMBO journal	2008	191
18566587	207	Ikenoue T	Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.	The EMBO journal	2008	225
18606717	207	Maira SM	Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity.	Molecular cancer therapeutics	2008	363
18701483	207	Schnell CR	Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging.	Cancer research	2008	60
18794129	207	Wang X	Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.	Cancer research	2008	58
18838554	207	Degtyarev M	Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.	The Journal of cell biology	2008	147
18948577	207	Okawa Y	SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.	Blood	2009	47
19010843	207	Hu-Lowe DD	Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.	Clinical cancer research 	2008	109
19033189	207	Wise DR	Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.	Proceedings of the National Academy of Sciences of the United States of America	2008	504
19110052	207	Chin YR	Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.	Cellular signalling	2009	67
19195051	207	Fabregat I	Dysregulation of apoptosis in hepatocellular carcinoma cells.	World journal of gastroenterology	2009	60
19265662	207	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	219
19270694	207	Lin HK	Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.	Nature cell biology	2009	96
19270695	207	Gao D	Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.	Nature cell biology	2009	96
19357263	207	Arai K	An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells.	The Journal of neuroscience 	2009	60
19402821	207	García-Martínez JM	Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).	The Biochemical journal	2009	168
19425170	207	Salazar M	Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.	The Journal of clinical investigation	2009	166
19475621	207	Huang SC	Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication.	Journal of medical virology	2009	45
19483113	207	El Kebir D	15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.	American journal of respiratory and critical care medicine	2009	60
19584280	207	Yu K	Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.	Cancer research	2009	115
19592505	207	Zong Y	ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	85
19597469	207	Dai J	Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.	Oncogene	2009	52
19713527	207	Yang WL	The E3 ligase TRAF6 regulates Akt ubiquitination and activation.	Science	2009	161
19773745	207	Zhong XS	Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.	Molecular therapy 	2010	99
19778506	207	Kim JY	DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.	Neuron	2009	121
19825827	207	Iliopoulos D	MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.	Science signaling	2009	87
19854140	207	Choudhary C	Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.	Molecular cell	2009	99
19920197	207	Fu L	Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.	Cancer research	2009	49
19959541	207	Gurusamy N	Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.	Cardiovascular research	2010	50
20049901	207	Morigi M	Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.	Stem cells	2010	47
20051626	207	Ginestier C	CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.	The Journal of clinical investigation	2010	205
20068177	207	Yu K	Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.	Cancer research	2010	56
20104019	207	Qin L	ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy.	Autophagy	2010	101
20110532	207	Chimenti I	Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.	Circulation research	2010	176
20133737	207	Ericson K	Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation.	Proceedings of the National Academy of Sciences of the United States of America	2010	43
20299475	207	Houde VP	Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.	Diabetes	2010	107
20299510	207	Bhatt AP	Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.	Blood	2010	54
20360245	207	Meloni M	Nerve growth factor promotes cardiac repair following myocardial infarction.	Circulation research	2010	49
20563248	207	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	59
20571069	207	Hirai H	MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.	Molecular cancer therapeutics	2010	271
20671189	207	Goldstein AS	Identification of a cell of origin for human prostate cancer.	Science	2010	201
20876803	207	Chiarini F	Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.	Cancer research	2010	52
21045808	207	Oh WJ	mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide.	The EMBO journal	2010	100
21062993	207	Fan QW	Akt and autophagy cooperate to promote survival of drug-resistant glioma.	Science signaling	2010	103
21124782	207	Meng J	Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.	PloS one	2010	51
21212100	207	Ricciardi S	Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.	Human molecular genetics	2011	61
21278796	207	Garofalo C	Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling.	Oncogene	2011	57
21302297	207	McCubrey JA	Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.	Journal of cellular physiology	2011	52
21307248	207	Xu Q	Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia.	The Journal of neuroscience 	2011	36
21325072	207	Song L	Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.	Clinical cancer research 	2011	49
21422497	207	Steelman LS	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.	Aging	2011	139
21464307	207	Xie X	IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2011	67
21475304	207	Vara D	Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.	Cell death and differentiation	2011	45
21613576	207	Conrad KP	Maternal vasodilation in pregnancy: the emerging role of relaxin.	American journal of physiology. Regulatory, integrative and comparative physiology	2011	37
21618573	207	You H	c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.	Hepatology	2011	56
21670080	207	Coloff JL	Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.	Cancer research	2011	48
21779001	207	Kato H	mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway.	Cell death and differentiation	2012	60
21884932	207	Sykes SM	AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.	Cell	2011	76
21974986	207	Otvos L Jr	Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.	BMC biotechnology	2011	36
21975935	207	Yoo YA	Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.	Cancer research	2011	80
22057914	207	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	38
22067563	207	Wakimoto H	Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.	Neuro-oncology	2012	59
22116552	207	Rao E	The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.	Leukemia	2012	45
22144101	207	Guardiola-Diaz HM	Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation.	Glia	2012	40
22196333	207	Mazei-Robison MS	Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.	Neuron	2011	36
22205714	207	Su F	Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation.	Cancer research	2012	51
22234835	207	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	88
22248929	207	Garrett JT	Will PI3K pathway inhibitors be effective as single agents in patients with cancer?	Oncotarget	2011	35
22253859	207	Walker CL	Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury.	PloS one	2012	43
22323820	207	Lee C	Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy.	Science translational medicine	2012	102
22355189	207	Sun Y	Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection.	Science signaling	2012	47
22422409	207	Meric-Bernstam F	PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.	Clinical cancer research 	2012	61
22585995	207	Xue G	Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.	Cancer discovery	2012	32
22875023	207	Ramaswamy B	Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.	Cancer research	2012	55
22898879	207	Wu K	Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.	Hepatology	2012	43
22932669	207	Sangai T	Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.	Clinical cancer research 	2012	44
23112296	207	Wang RC	Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation.	Science	2012	146
23135998	207	Xu L	MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway.	Molecular biology of the cell	2013	26
23152054	207	De Palma C	Autophagy as a new therapeutic target in Duchenne muscular dystrophy.	Cell death and disease	2012	51
23185040	207	Cai N	The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1.	RNA	2013	27
23251084	207	Naujokat C	Salinomycin as a drug for targeting human cancer stem cells.	Journal of biomedicine and biotechnology	2012	54
23255107	207	Würth R	Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.	Cell cycle	2013	52
23263555	207	Strainic MG	Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.	Nature immunology	2013	69
23272133	207	Sheth S	Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.	PloS one	2012	49
23287563	207	Lin J	Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.	Clinical cancer research 	2013	34
23579241	207	Azijli K	Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.	Cell death and differentiation	2013	31
23589885	207	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	132
23593475	207	Wu S	Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo.	PloS one	2013	27
23601134	207	Mercken EM	Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile.	Aging cell	2013	51
23766499	207	Talbert EE	Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant.	Journal of applied physiology	2013	26
23778311	207	McCubrey JA	Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.	Leukemia	2014	34
23852728	207	Betz C	Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.	Proceedings of the National Academy of Sciences of the United States of America	2013	63
23911321	207	Chan CH	Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.	Cell	2013	85
24009260	207	Parra V	Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway.	Diabetes	2014	27
24082083	207	Kawamura K	Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment.	Proceedings of the National Academy of Sciences of the United States of America	2013	52
24096870	207	Liu PP	Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.	Cell death and differentiation	2014	38
24194905	207	Chai ZT	MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.	PloS one	2013	26
24525237	207	Grabocka E	Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response.	Cancer cell	2014	31
24606897	207	Yue S	Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.	Cell metabolism	2014	66
24813607	207	Naqvi N	A proliferative burst during preadolescence establishes the final cardiomyocyte number.	Cell	2014	58
24861879	207	Shi Z	MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.	Neuro-oncology	2014	27
24946933	207	Zhang C	NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.	Oncotarget	2014	22
24980823	207	Wang L	MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.	Oncotarget	2014	36
25001183	207	Hu J	microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.	European journal of cancer	2014	23
25012178	207	Wang H	GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.	Journal of the American Society of Nephrology 	2015	18
25187230	207	Yu SH	miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.	Journal of cellular biochemistry	2015	19
25284585	207	Dillon LM	P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.	Oncogene	2015	17
25288745	207	Oosting M	Human TLR10 is an anti-inflammatory pattern-recognition receptor.	Proceedings of the National Academy of Sciences of the United States of America	2014	30
25399420	207	Gao Y	The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells.	Nucleic acids research	2014	34
25541152	207	Musilova K	MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.	Leukemia	2015	32
25600436	207	Frigault MJ	Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.	Cancer immunology research	2015	25
25623055	207	Shu YJ	SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.	Molecular cancer	2015	22
26299803	207	Cheng Z	A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.	Oncotarget	2015	26
26451606	207	Sharma N	PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.	Oncotarget	2015	33
26832662	207	Lechman ER	miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.	Cancer cell	2016	18
26933997	207	Chen MB	KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms.	Oncotarget	2016	15
27014910	207	Chen QY	miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.	Oncotarget	2016	14
27050099	207	Lee JK	N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.	Cancer cell	2016	18
27061150	207	Kim H	Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo.	Molecular carcinogenesis	2017	5
27524440	207	Liang Q	Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy.	Cell stem cell	2016	19
27642729	207	Kaneda MM	PI3Kγ is a molecular switch that controls immune suppression.	Nature	2016	18
28170176	207	Ma J	Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D.	Stem cells translational medicine	2017	6
18371393	216	Ginestier C	ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.	Cell stem cell	2007	1089
18560594	216	Dylla SJ	Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.	PloS one	2008	165
19276181	216	Jiang F	Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.	Molecular cancer research 	2009	215
19336570	216	Huang EH	Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.	Cancer research	2009	319
20010854	216	Li T	ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.	Laboratory investigation; a journal of technical methods and pathology	2010	103
20028757	216	Charafe-Jauffret E	Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	Clinical cancer research 	2010	213
20142235	216	Su Y	Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.	Cancer epidemiology, biomarkers and prevention 	2010	65
20422001	216	Deng S	Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.	PloS one	2010	141
20889728	216	Landen CN Jr	Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.	Molecular cancer therapeutics	2010	101
21118965	216	Sullivan JP	Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.	Cancer research	2010	107
22887839	216	Luo Y	ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.	Stem cells	2012	67
23467088	216	Flesken-Nikitin A	Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche.	Nature	2013	84
23548270	216	Yu CC	miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.	Cancer research	2013	35
24142344	216	Charafe-Jauffret E	ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.	Cancer research	2013	30
24615157	216	Liu L	Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.	International journal of cancer	2014	22
24859412	216	Honjo S	Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.	International journal of oncology	2014	21
25384215	216	Zhao D	NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.	The Journal of clinical investigation	2014	23
26020648	216	Grosse-Wilde A	Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.	PloS one	2015	28
6302308	351	Batterson W	Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes.	Journal of virology	1983	226
8073293	351	Bush AI	Rapid induction of Alzheimer A beta amyloid formation by zinc.	Science	1994	176
8810256	351	Hsiao K	Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.	Science	1996	937
9037091	351	Johnson-Wood K	Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1997	170
10833057	351	Roof RL	Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone.	Journal of neurotrauma	2000	105
11145990	351	Dovey HF	Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain.	Journal of neurochemistry	2001	177
11910111	351	DeMattos RB	Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.	Science	2002	105
11932745	351	Walsh DM	Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.	Nature	2002	991
11959919	351	Rapoport M	Tau is essential to beta -amyloid-induced neurotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2002	178
12210822	351	Kirkitadze MD	Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.	Journal of neuroscience research	2002	165
14643377	351	Oddo S	Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.	Neurobiology of aging	2003	215
14970312	351	Cutler RG	Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	208
15073156	351	Caillé I	Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone.	Development	2004	85
15731448	351	Stokin GB	Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.	Science	2005	295
15834427	351	Klyubin I	Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.	Nature medicine	2005	138
16541076	351	Lesné S	A specific amyloid-beta protein assembly in the brain impairs memory.	Nature	2006	803
16837572	351	Rajendran L	Alzheimer's disease beta-amyloid peptides are released in association with exosomes.	Proceedings of the National Academy of Sciences of the United States of America	2006	227
17187063	351	Fulga TA	Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.	Nature cell biology	2007	110
17286590	351	Walsh DM	A beta oligomers - a decade of discovery.	Journal of neurochemistry	2007	518
17360908	351	Shankar GM	Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.	The Journal of neuroscience 	2007	440
17548355	351	Cheng IH	Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.	The Journal of biological chemistry	2007	142
17785178	351	Palop JJ	Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.	Neuron	2007	321
17855343	351	Townsend M	Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.	The Journal of biological chemistry	2007	90
18359102	351	Selkoe DJ	Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.	Behavioural brain research	2008	303
18417702	351	Klyubin I	Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.	The Journal of neuroscience 	2008	105
18548070	351	Kukar TL	Substrate-targeting gamma-secretase modulators.	Nature	2008	104
18757748	351	Hansson Petersen CA	The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.	Proceedings of the National Academy of Sciences of the United States of America	2008	140
19228952	351	Meilandt WJ	Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2009	54
19433662	351	Dong Y	The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels.	Archives of neurology	2009	53
19581601	351	Britschgi M	Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	46
19828212	351	Vogt DL	Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain.	Neurobiology of aging	2011	35
19951690	351	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	49
20101004	351	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	63
20133839	351	Friedrich RP	Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.	Proceedings of the National Academy of Sciences of the United States of America	2010	55
20237263	351	Kaneko M	Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation.	The Journal of neuroscience 	2010	43
20552018	351	Schonrock N	Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.	PloS one	2010	56
21172309	351	Long JM	MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.	Biochemical and biophysical research communications	2011	45
21262831	351	Watts JC	Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2011	42
22017494	351	Rosen RF	Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.	Journal of neurochemistry	2012	36
22116809	351	Hartz AM	Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.	Stroke	2012	36
22869752	351	Sanchez PE	Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.	Proceedings of the National Academy of Sciences of the United States of America	2012	102
23525040	351	Suberbielle E	Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β.	Nature neuroscience	2013	77
23575824	351	Cohen RM	A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.	The Journal of neuroscience 	2013	40
25253695	351	Benilova I	The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.	The Journal of biological chemistry	2014	27
25620700	351	Matarin M	A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.	Cell reports	2015	20
26931567	351	Maeda S	Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.	EMBO reports	2016	12
27120160	351	Paquet D	Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.	Nature	2016	39
7791873	367	Kelce WR	Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist.	Nature	1995	156
8065934	367	Chamberlain NL	The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.	Nucleic acids research	1994	143
11306464	367	Gregory CW	Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.	Cancer research	2001	138
17045208	367	Guo Z	Regulation of androgen receptor activity by tyrosine phosphorylation.	Cancer cell	2006	142
17510410	367	Gu G	Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.	Cancer research	2007	105
18593950	367	Dehm SM	Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.	Cancer research	2008	248
18676866	367	Locke JA	Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.	Cancer research	2008	215
19118031	367	Snoek R	In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.	Clinical cancer research 	2009	52
20440270	367	Niu Y	Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.	Oncogene	2010	45
20644256	367	Sun S	Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.	The Journal of clinical investigation	2010	231
20823238	367	Watson PA	Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.	Proceedings of the National Academy of Sciences of the United States of America	2010	204
20844012	367	Shen MM	Molecular genetics of prostate cancer: new prospects for old challenges.	Genes and development	2010	243
21099110	367	Sharma A	The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.	The Journal of clinical investigation	2010	103
21135112	367	Cai H	Invasive prostate carcinoma driven by c-Src and androgen receptor synergy.	Cancer research	2011	43
21177307	367	Siddiqui IA	Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.	FASEB journal 	2011	39
21303972	367	Mohler JL	Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.	Cancer research	2011	42
21633166	367	Lehmann BD	Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.	The Journal of clinical investigation	2011	769
22064655	367	Huang WC	Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.	Molecular cancer research 	2012	46
22108827	367	Sun Y	Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.	Cancer research	2012	86
22266222	367	Clegg NJ	ARN-509: a novel antiandrogen for prostate cancer treatment.	Cancer research	2012	95
22266865	367	Li Y	AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.	Oncogene	2012	67
22355276	367	Yamashita S	ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.	Neoplasia	2012	38
22831834	367	Lee SO	New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.	Journal of molecular cell biology	2013	31
23069658	367	Shi XB	Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.	Oncogene	2013	47
23157556	367	Matsumoto T	The androgen receptor in health and disease.	Annual review of physiology	2013	39
23260764	367	Sharma NL	The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.	Cancer cell	2013	108
23518348	367	Qi J	The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.	Cancer cell	2013	44
23580326	367	Balbas MD	Overcoming mutation-based resistance to antiandrogens with rational drug design.	eLife	2013	81
23982944	367	Izumi K	Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.	EMBO molecular medicine	2013	35
24037531	367	Mishra S	Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.	Oncogene	2014	26
24101480	367	Nyquist MD	TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
24177177	367	Schroeder A	Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.	Cancer research	2014	31
24556717	367	Thadani-Mulero M	Androgen receptor splice variants determine taxane sensitivity in prostate cancer.	Cancer research	2014	45
24740322	367	Liu C	Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.	Clinical cancer research 	2014	50
24742458	367	Cortes CJ	Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.	Neuron	2014	36
25108912	367	Cortes CJ	Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.	Nature neuroscience	2014	26
25274033	367	Geng C	Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer.	Cancer research	2014	23
25634993	367	Yamamoto Y	Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth.	Clinical cancer research 	2015	21
25691773	367	de Leeuw R	Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.	Clinical cancer research 	2015	17
25830880	367	Gundem G	The evolutionary history of lethal metastatic prostate cancer.	Nature	2015	108
7832825	759	Wheeler DB	Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission.	Science	1994	156
7902955	759	Hessler NA	The probability of transmitter release at a mammalian central synapse.	Nature	1993	130
8066450	759	Nguyen PV	Requirement of a critical period of transcription for induction of a late phase of LTP.	Science	1994	165
8389057	759	Frey U	Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons.	Science	1993	200
9952257	759	Bragin A	Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures.	Epilepsia	1999	128
10448214	759	Magee JC	Dendritic lh normalizes temporal summation in hippocampal CA1 neurons.	Nature neuroscience	1999	130
12495631	759	Lee AK	Memory of sequential experience in the hippocampus during slow wave sleep.	Neuron	2002	257
15525802	759	Netoff TI	Synchronization in hybrid neuronal networks of the hippocampal formation.	Journal of neurophysiology	2005	70
15884004	759	Cooke BM	Gonadal hormone modulation of dendrites in the mammalian CNS.	Journal of neurobiology	2005	80
21123571	759	Ibarz JM	Emergent dynamics of fast ripples in the epileptic hippocampus.	The Journal of neuroscience 	2010	49
21653864	759	Sullivan D	Relationships between hippocampal sharp waves, ripples, and fast gamma oscillation: influence of dentate and entorhinal cortical activity.	The Journal of neuroscience 	2011	60
22021324	759	Noetzel MJ	Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.	Molecular pharmacology	2012	50
22312444	759	Liu L	Trans-synaptic spread of tau pathology in vivo.	PloS one	2012	258
23269840	759	Oh WC	Synapse-specific and size-dependent mechanisms of spine structural plasticity accompanying synaptic weakening.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
23583108	759	Schobel SA	Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.	Neuron	2013	84
27602521	759	Takeuchi T	Locus coeruleus and dopaminergic consolidation of everyday memory.	Nature	2016	12
8598933	1000	Nagar B	Structural basis of calcium-induced E-cadherin rigidification and dimerization.	Nature	1996	148
16405513	1000	Bentahir M	Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.	Journal of neurochemistry	2006	116
16618740	1000	Liu ZJ	Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.	Cancer research	2006	82
18362184	1000	Shintani Y	Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1.	The Journal of cell biology	2008	64
20368523	1000	Campagnolo P	Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.	Circulation	2010	67
20808935	1000	Klopp AH	Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.	PloS one	2010	50
22402125	1000	Ru P	miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.	Molecular cancer therapeutics	2012	59
23002959	1000	Li T	Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis.	Stem cells and development	2013	80
23299311	1000	Zhang B	Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.	Blood	2013	59
23469181	1000	Wang P	Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.	PloS one	2013	32
24085799	1000	Li LZ	miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.	Carcinogenesis	2014	25
24201814	1000	Huang RY	An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).	Cell death and disease	2013	55
24357672	1000	Lam AQ	Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers.	Journal of the American Society of Nephrology 	2014	42
24704494	1000	Medyouf H	Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.	Cell stem cell	2014	51
25301732	1000	Wang D	Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.	Oncotarget	2014	35
25728352	1000	Islam SS	Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.	Molecular carcinogenesis	2016	13
25797269	1000	Kim HS	MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.	Oncotarget	2015	24
25824139	1000	Zhang B	Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway.	Stem cells translational medicine	2015	21
25863539	1000	Wu Y	The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.	Oncotarget	2015	30
26069251	1000	Mudduluru G	A Systematic Approach to Defining the microRNA Landscape in Metastasis.	Cancer research	2015	15
26668317	1000	Noy PJ	TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.	The Journal of biological chemistry	2016	10
11157668	1003	Gill M	Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.	Circulation research	2001	132
14699017	1003	Hur J	Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2004	207
15067321	1003	Weis S	Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.	The Journal of clinical investigation	2004	85
16141364	1003	Weksler BB	Blood-brain barrier-specific properties of a human adult brain endothelial cell line.	FASEB journal 	2005	269
16524930	1003	Zengin E	Vascular wall resident progenitor cells: a source for postnatal vasculogenesis.	Development	2006	104
17767154	1003	Zheng B	Prospective identification of myogenic endothelial cells in human skeletal muscle.	Nature biotechnology	2007	107
18245446	1003	Ma C	Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.	Genes and development	2008	69
18776942	1003	Murakami M	The FGF system has a key role in regulating vascular integrity.	The Journal of clinical investigation	2008	77
19658191	1003	Alvero AB	Stem-like ovarian cancer cells can serve as tumor vascular progenitors.	Stem cells	2009	56
19875721	1003	Nourse MB	VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.	Arteriosclerosis, thrombosis, and vascular biology	2010	43
20332120	1003	Lampugnani MG	CCM1 regulates vascular-lumen organization by inducing endothelial polarity.	Journal of cell science	2010	70
21102433	1003	Wang R	Glioblastoma stem-like cells give rise to tumour endothelium.	Nature	2010	312
21123455	1003	Lo CW	IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.	Cancer research	2011	39
21630268	1003	Taverna S	Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.	International journal of cancer	2012	40
22326223	1003	Tran KV	The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells.	Cell metabolism	2012	81
23520160	1003	Li J	Conversion of human fibroblasts to functional endothelial cells by defined factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	37
24297996	1003	de Pater E	Gata2 is required for HSC generation and survival.	The Journal of experimental medicine	2013	46
25956031	1003	Good RB	Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.	The American journal of pathology	2015	21
1388288	1017	Koff A	Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.	Science	1992	232
8259216	1017	Gu Y	Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.	Nature	1993	153
9192874	1017	Lukas J	Cyclin E-induced S phase without activation of the pRb/E2F pathway.	Genes and development	1997	105
9889196	1017	Petersen BO	Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.	The EMBO journal	1999	108
10499591	1017	Spruck CH	Deregulated cyclin E induces chromosome instability.	Nature	1999	188
10919634	1017	Sherr CJ	The Pezcoller lecture: cancer cell cycles revisited.	Cancer research	2000	213
11112789	1017	Gardner LB	Hypoxia inhibits G1/S transition through regulation of p27 expression.	The Journal of biological chemistry	2001	90
11359924	1017	Andreassen PR	Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.	Molecular biology of the cell	2001	127
11486031	1017	Ronchini C	Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).	Molecular and cellular biology	2001	107
12928438	1017	Bhat R	Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.	The Journal of biological chemistry	2003	100
16236519	1017	Malumbres M	Mammalian cyclin-dependent kinases.	Trends in biochemical sciences	2005	249
18981479	1017	Ullah Z	Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity.	Genes and development	2008	55
19561645	1017	Satyanarayana A	Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.	Oncogene	2009	174
19738602	1017	Takeshita F	Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.	Molecular therapy 	2010	124
21062975	1017	Lin SL	MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.	Cancer research	2010	50
22231403	1017	Buis J	Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2.	Nature structural and molecular biology	2012	32
23204228	1017	Cai J	miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.	Cancer research	2013	31
24623419	1017	St Gelais C	Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1.	Journal of virology	2014	28
25535366	1017	Baratta MG	An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
26824338	1017	Zakraoui O	Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.	Molecular carcinogenesis	2017	5
26861625	1017	Du WW	Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2.	Nucleic acids research	2016	38
1423597	1019	Matsushime H	Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.	Cell	1992	189
7777060	1019	Lukas J	Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.	Nature	1995	182
8666233	1019	Stepanova L	Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.	Genes and development	1996	112
11960696	1019	Ortega S	Cyclin D-dependent kinases, INK4 inhibitors and cancer.	Biochimica et biophysica acta	2002	156
14612495	1019	Lu F	An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.	Cancer research	2003	80
15542782	1019	Fry DW	Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.	Molecular cancer therapeutics	2004	241
15604268	1019	Ramirez RD	Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.	Cancer research	2004	234
16413469	1019	Yu Q	Requirement for CDK4 kinase function in breast cancer.	Cancer cell	2006	84
16489012	1019	Sato M	Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.	Cancer research	2006	122
17023580	1019	Rodriguez PC	L-arginine availability regulates T-lymphocyte cell-cycle progression.	Blood	2007	144
17559502	1019	Zhu CH	Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies.	Aging cell	2007	72
18413753	1019	Eccles SA	NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.	Cancer research	2008	105
19001083	1019	Joshi I	Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.	Blood	2009	53
20080666	1019	Kim H	Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.	Proceedings of the National Academy of Sciences of the United States of America	2010	79
20577054	1019	Johnson SM	Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.	The Journal of clinical investigation	2010	62
20951943	1019	Aggarwal P	Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.	Cancer cell	2010	66
22222629	1019	Kato K	The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.	Molecular cancer therapeutics	2012	53
22711607	1019	Cen L	p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.	Neuro-oncology	2012	34
23079656	1019	Sawai CM	Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.	Cancer cell	2012	38
23449933	1019	Sato M	Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.	Molecular cancer research 	2013	52
24045179	1019	Rader J	Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.	Clinical cancer research 	2013	51
24919854	1019	Gelbert LM	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.	Investigational new drugs	2014	40
25053825	1019	Fiskus W	BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.	Molecular cancer therapeutics	2014	35
25609060	1019	Di Stefano AL	Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.	Clinical cancer research 	2015	19
26833129	1019	Bouillez A	Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.	Cancer research	2016	14
26977878	1019	Goel S	Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.	Cancer cell	2016	18
27849562	1019	Bollard J	Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.	Gut	2017	6
8090221	1020	Tsai LH	p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.	Nature	1994	184
12796778	1020	Toyo-oka K	14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome.	Nature genetics	2003	95
17610816	1020	Qu D	Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.	Neuron	2007	63
20473298	1020	Huang E	The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death.	Nature cell biology	2010	42
20484029	1020	Feldmann G	Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.	Cancer research	2010	53
20651683	1020	Choi JH	Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.	Nature	2010	233
20826311	1020	Kim SH	CDK5 serves as a major control point in neurotransmitter release.	Neuron	2010	90
21844361	1020	Qu J	S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
24135281	1020	Pozo K	The role of Cdk5 in neuroendocrine thyroid cancer.	Cancer cell	2013	34
24793790	1020	Jin JK	Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.	Oncogene	2015	20
7729684	1026	Matsuoka S	p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.	Genes and development	1995	190
8118801	1026	el-Deiry WS	WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.	Cancer research	1994	376
8242752	1026	el-Deiry WS	WAF1, a potential mediator of p53 tumor suppression.	Cell	1993	1697
8259214	1026	Xiong Y	p21 is a universal inhibitor of cyclin kinases.	Nature	1993	627
9296497	1026	Somasundaram K	Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.	Nature	1997	106
9765202	1026	Zhu J	Senescence of human fibroblasts induced by oncogenic Raf.	Genes and development	1998	211
10200307	1026	Saito A	A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.	Proceedings of the National Academy of Sciences of the United States of America	1999	107
10430607	1026	Bunz F	Disruption of p53 in human cancer cells alters the responses to therapeutic agents.	The Journal of clinical investigation	1999	247
11073822	1026	Ouyang H	Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.	The American journal of pathology	2000	102
11159180	1026	Specht K	Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue.	The American journal of pathology	2001	91
11880176	1026	Roninson IB	Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.	Cancer letters	2002	86
12032080	1026	Lagger G	Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.	The EMBO journal	2002	235
12851486	1026	Liang J	Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.	Cell cycle	2003	219
15617686	1026	Clarke RB	A putative human breast stem cell population is enriched for steroid receptor-positive cells.	Developmental biology	2005	87
17172425	1026	Kuo PL	Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells.	Molecular cancer therapeutics	2006	64
17332326	1026	Li M	Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.	Cancer research	2007	67
18590585	1026	Abukhdeir AM	P21 and p27: roles in carcinogenesis and drug resistance.	Expert reviews in molecular medicine	2008	92
19010882	1026	Godlewski J	Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.	Cancer research	2008	229
19440038	1026	Liu B	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.	Cell cycle	2009	116
19858489	1026	Liu M	p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2009	65
20571512	1026	Wilting RH	Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.	The EMBO journal	2010	60
20851997	1026	Hong L	The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.	Cancer research	2010	55
21331045	1026	Elyada E	CKIα ablation highlights a critical role for p53 in invasiveness control.	Nature	2011	56
21383005	1026	Fan T	EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.	Molecular cancer research 	2011	46
21703415	1026	Cesselli D	Effects of age and heart failure on human cardiac stem cell function.	The American journal of pathology	2011	54
21859835	1026	Munagala R	Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.	Carcinogenesis	2011	45
22108298	1026	Piotrowska H	Biological activity of piceatannol: leaving the shadow of resveratrol.	Mutation research	2012	41
22249270	1026	Yi C	MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.	Oncogene	2012	50
22580610	1026	Yin D	miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.	Oncogene	2013	27
22683204	1026	Ceccaldi R	Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.	Cell stem cell	2012	77
22935696	1026	Capparelli C	CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis.	Cell cycle	2012	41
23074173	1026	Lui GY	The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.	Molecular pharmacology	2013	26
23632475	1026	Storozhuk Y	Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.	British journal of cancer	2013	49
23723074	1026	Dong Y	Tumor suppressor functions of miR-133a in colorectal cancer.	Molecular cancer research 	2013	27
23950209	1026	Segura MF	BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.	Cancer research	2013	41
24027026	1026	Irshad S	A molecular signature predictive of indolent prostate cancer.	Science translational medicine	2013	32
24122720	1026	Wang D	MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts.	Circulation research	2014	37
24699304	1026	Fiskus W	Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.	Leukemia	2014	34
26913601	1026	Zhang E	Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57.	Cell death and disease	2016	17
10482195	1027	Sliwkowski MX	Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).	Seminars in oncology	1999	113
11784790	1027	Back SA	Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia.	The Journal of neuroscience 	2002	171
14576155	1027	Gera JF	AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.	The Journal of biological chemistry	2004	101
15652749	1027	Baldassarre G	p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.	Cancer cell	2005	84
17030811	1027	Pellegata NS	Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.	Proceedings of the National Academy of Sciences of the United States of America	2006	91
18559508	1027	Wei D	Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells.	Cancer research	2008	54
18691549	1027	Majumder PK	A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.	Cancer cell	2008	67
21245089	1027	Gilmartin AG	GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition.	Clinical cancer research 	2011	130
21355095	1027	Lu C	miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.	Blood	2011	74
21523318	1027	Yamaguchi T	Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.	International journal of oncology	2011	43
21750219	1027	Yuan J	PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity.	Molecular cancer therapeutics	2011	46
23479461	1027	Di Martino MT	In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.	Oncotarget	2013	43
27591936	1027	Pan J	Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.	Cancer letters	2016	13
9054499	1029	Serrano M	Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.	Cell	1997	1178
9751761	1029	Belinsky SA	Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.	Proceedings of the National Academy of Sciences of the United States of America	1998	140
9765203	1029	Lin AW	Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.	Genes and development	1998	245
10416987	1029	Ishii N	Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.	Brain pathology	1999	155
10541553	1029	Schmitt CA	INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.	Genes and development	1999	135
10811111	1029	Esteller M	Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.	Cancer research	2000	93
11355949	1029	Vonlanthen S	The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.	British journal of cancer	2001	90
11544531	1029	Sharpless NE	Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.	Nature	2001	231
12169636	1029	Smogorzewska A	Different telomere damage signaling pathways in human and mouse cells.	The EMBO journal	2002	103
12573439	1029	Lowe SW	Tumor suppression by Ink4a-Arf: progress and puzzles.	Current opinion in genetics and development	2003	207
12618505	1029	Cheng JC	Inhibition of DNA methylation and reactivation of silenced genes by zebularine.	Journal of the National Cancer Institute	2003	90
12789288	1029	Wu H	PTEN signaling pathways in melanoma.	Oncogene	2003	86
15082532	1029	Kalinichenko VV	Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.	Genes and development	2004	137
15520862	1029	Krishnamurthy J	Ink4a/Arf expression is a biomarker of aging.	The Journal of clinical investigation	2004	364
16572177	1029	Gonzalez S	Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.	Nature	2006	66
16901784	1029	Narita M	A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.	Cell	2006	185
16957735	1029	Janzen V	Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.	Nature	2006	352
17182830	1029	Fang M	Dietary polyphenols may affect DNA methylation.	The Journal of nutrition	2007	88
17210787	1029	Kotake Y	pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.	Genes and development	2007	121
17654117	1029	Cánepa ET	INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.	IUBMB life	2007	64
18039136	1029	Maitra A	Pancreatic cancer.	Annual review of pathology	2008	210
18394558	1029	Wiedemeyer R	Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.	Cancer cell	2008	59
18922929	1029	Barault L	Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.	Cancer research	2008	106
19074898	1029	Solomon DA	Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.	Cancer research	2008	50
19451217	1029	Agger K	The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.	Genes and development	2009	137
19471117	1029	Demidenko ZN	Rapamycin decelerates cellular senescence.	Cell cycle	2009	172
19638619	1029	Fiskus W	Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.	Blood	2009	107
19668188	1029	Li H	The Ink4/Arf locus is a barrier for iPS cell reprogramming.	Nature	2009	353
19718709	1029	Mohseny AB	Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.	The Journal of pathology	2009	71
20522802	1029	Kajstura J	Cardiomyogenesis in the adult human heart.	Circulation research	2010	101
21248843	1029	Notta F	Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.	Nature	2011	154
21317534	1029	Sindrilaru A	An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.	The Journal of clinical investigation	2011	150
21336312	1029	Di Micco R	Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.	Nature cell biology	2011	92
21952072	1029	Beltran AS	Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.	Breast cancer research 	2011	37
22084097	1029	Nagai H	Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	89
22256804	1029	Su F	RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.	The New England journal of medicine	2012	200
22975375	1029	Navas C	EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.	Cancer cell	2012	91
23373539	1029	Etchin J	KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.	British journal of haematology	2013	63
23680149	1029	Gargiulo G	In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.	Cancer cell	2013	41
24005862	1029	Jin HJ	Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.	International journal of molecular sciences	2013	66
24052950	1029	Mabuchi Y	LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells.	Stem cell reports	2013	30
24163741	1029	Cooper WA	Molecular biology of lung cancer.	Journal of thoracic disease	2013	52
24484372	1029	Hong Y	Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells.	Journal of pineal research	2014	21
24522534	1029	Sousa-Victor P	Geriatric muscle stem cells switch reversible quiescence into senescence.	Nature	2014	126
24681605	1029	Sanoff HK	Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.	Journal of the National Cancer Institute	2014	31
24728135	1029	Piunti A	Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication.	Nature communications	2014	24
25584893	1029	Damsky W	mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.	Cancer cell	2015	15
25890171	1029	Kong R	Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.	Molecular cancer	2015	26
25908244	1029	Montes M	The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence.	Nature communications	2015	25
26024833	1029	Fu WM	Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling.	Journal of hepatology	2015	24
26950362	1029	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	19
27213815	1029	Dauch D	A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.	Nature medicine	2016	15
2494700	1050	Landschulz WH	The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite.	Science	1989	186
11242107	1050	Pabst T	Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.	Nature genetics	2001	172
11283671	1050	Pabst T	AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.	Nature medicine	2001	99
12530969	1050	McKay RM	C elegans: a model for exploring the genetics of fat storage.	Developmental cell	2003	103
15504954	1050	Kim JE	regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.	Diabetes	2004	96
15677503	1050	Cardozo AK	Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells.	Diabetes	2005	154
17681146	1050	Jing E	SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.	Cell metabolism	2007	109
18326822	1050	Pinto JP	Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.	Blood	2008	63
18818206	1050	Nasser MW	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.	The Journal of biological chemistry	2008	130
21038412	1050	Zeng C	A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.	Hepatology	2010	41
21383193	1050	Jan M	Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker.	Proceedings of the National Academy of Sciences of the United States of America	2011	49
21410980	1050	Schmidt SF	Cross species comparison of C/EBPα and PPARγ profiles in mouse and human adipocytes reveals interdependent retention of binding sites.	BMC genomics	2011	42
23665916	1050	Grøntved L	C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements.	The EMBO journal	2013	40
24183681	1050	Zhang H	Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.	Cancer cell	2013	31
24582926	1050	Du Y	Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming.	Cell stem cell	2014	45
25303533	1050	Chen JC	Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.	Cell	2014	42
2112087	1051	Akira S	A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.	The EMBO journal	1990	339
10816306	1051	Hall J	Rapid and selective induction of BDNF expression in the hippocampus during contextual learning.	Nature neuroscience	2000	133
16959612	1051	Gomis RR	C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.	Cancer cell	2006	89
19711427	1051	Wang B	Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.	Hepatology	2009	98
20032975	1051	Carro MS	The transcriptional network for mesenchymal transformation of brain tumours.	Nature	2010	386
20726009	1051	Wethmar K	Upstream open reading frames: molecular switches in (patho)physiology.	BioEssays 	2010	43
21183071	1051	Boström P	C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.	Cell	2010	84
22095691	1051	Hirata M	C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes.	Human molecular genetics	2012	36
22246346	1051	Ahfeldt T	Programming human pluripotent stem cells into white and brown adipocytes.	Nature cell biology	2012	51
23955085	1051	Johansson J	MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.	Oncogene	2013	38
24928992	1051	El Kasmi KC	Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.	Journal of immunology	2014	33
1370653	1080	Rosenfeld MA	In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.	Cell	1992	160
7543698	1080	Stutts MJ	CFTR as a cAMP-dependent regulator of sodium channels.	Science	1995	200
12606185	1080	Ratjen F	Cystic fibrosis.	Lancet	2003	156
14762183	1080	Freedman SD	Association of cystic fibrosis with abnormalities in fatty acid metabolism.	The New England journal of medicine	2004	75
15060012	1080	Bray N	MAVID: constrained ancestral alignment of multiple sequences.	Genome research	2004	101
15105504	1080	Egan ME	Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.	Science	2004	97
15840711	1080	Pagani F	Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
16443646	1080	Van Goor F	Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.	American journal of physiology. Lung cellular and molecular physiology	2006	149
16888286	1080	Guilbault C	Cystic fibrosis mouse models.	American journal of respiratory cell and molecular biology	2007	61
18063840	1080	Sueblinvong V	Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells.	American journal of respiratory and critical care medicine	2008	63
18324337	1080	Rogers CS	Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer.	The Journal of clinical investigation	2008	110
19846789	1080	Van Goor F	Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.	Proceedings of the National Academy of Sciences of the United States of America	2009	219
20398666	1080	Park HW	Dynamic regulation of CFTR bicarbonate permeability by Cl-i and its role in pancreatic bicarbonate secretion.	Gastroenterology	2010	58
20711182	1080	Luciani A	Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.	Nature cell biology	2010	116
21262823	1080	Takiar V	Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21809358	1080	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	69
21914796	1080	Garnett JP	Novel role for pendrin in orchestrating bicarbonate secretion in cystic fibrosis transmembrane conductance regulator (CFTR)-expressing airway serous cells.	The Journal of biological chemistry	2011	36
22265409	1080	Mendoza JL	Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.	Cell	2012	76
22922672	1080	Wong AP	Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein.	Nature biotechnology	2012	67
23727931	1080	Dekkers JF	A functional CFTR assay using primary cystic fibrosis intestinal organoids.	Nature medicine	2013	86
23891399	1080	Van Goor F	Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function.	Journal of cystic fibrosis 	2014	45
24040746	1080	Raju SV	Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.	American journal of respiratory and critical care medicine	2013	35
24251786	1080	Xue X	Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.	American journal of respiratory cell and molecular biology	2014	27
24315439	1080	Schwank G	Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.	Cell stem cell	2013	167
24608905	1080	Tuggle KL	Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.	PloS one	2014	26
25350163	1080	De Stefano D	Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.	Autophagy	2014	29
27320041	1080	Mou H	Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells.	Cell stem cell	2016	14
9278511	1111	Sanchez Y	Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.	Science	1997	303
10859164	1111	Liu Q	Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.	Genes and development	2000	509
11333986	1111	Bulavin DV	Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.	Nature	2001	124
12399544	1111	Zhao H	Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.	Proceedings of the National Academy of Sciences of the United States of America	2002	126
12781359	1111	Bartek J	Chk1 and Chk2 kinases in checkpoint control and cancer.	Cancer cell	2003	347
15798197	1111	Unsal-Kaçmaz K	Coupling of human circadian and cell cycles by the timeless protein.	Molecular and cellular biology	2005	93
15995699	1111	Gasser S	The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.	Nature	2005	342
17051156	1111	Bao S	Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.	Nature	2006	1463
18790776	1111	Zabludoff SD	AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.	Molecular cancer therapeutics	2008	129
20233881	1111	Mitchell JB	In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.	Clinical cancer research 	2010	46
20371347	1111	Davoli T	Persistent telomere damage induces bypass of mitosis and tetraploidy.	Cell	2010	92
20501833	1111	Morgan MA	Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.	Cancer research	2010	95
21321066	1111	Guzi TJ	Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.	Molecular cancer therapeutics	2011	51
21937510	1111	Sørensen CS	Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication.	Nucleic acids research	2012	72
22117197	1111	Bartucci M	Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.	Cell death and differentiation	2012	34
22446188	1111	Ma CX	Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.	The Journal of clinical investigation	2012	50
22713237	1111	Carrassa L	Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo.	Cell cycle	2012	35
23135916	1111	Russell MR	Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.	Cancer research	2013	31
23222511	1111	Fokas E	Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.	Cell death and disease	2012	48
23593991	1111	Thompson R	The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.	British journal of clinical pharmacology	2013	31
25010037	1111	Hall AB	Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.	Oncotarget	2014	24
25132270	1111	Sarmento LM	CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.	Oncogene	2015	17
15601930	1137	Jones IW	Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area.	The Journal of neuroscience 	2004	77
15809354	1137	Saeed RW	Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation.	The Journal of experimental medicine	2005	113
17597586	1137	Gotti C	Heterogeneity and complexity of native brain nicotinic receptors.	Biochemical pharmacology	2007	85
17825262	1137	Grady SR	The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.	Biochemical pharmacology	2007	105
19023041	1137	Buccafusco JJ	Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.	The Journal of pharmacology and experimental therapeutics	2009	50
20331614	1137	Rollema H	Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.	British journal of pharmacology	2010	54
20400469	1137	Jackson KJ	Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.	The Journal of pharmacology and experimental therapeutics	2010	57
21187334	1137	Srinivasan R	Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning.	The Journal of general physiology	2011	62
21795541	1137	McGranahan TM	α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.	The Journal of neuroscience 	2011	40
23143843	1137	Picciotto MR	Molecular mechanisms underlying behaviors related to nicotine addiction.	Cold Spring Harbor perspectives in medicine	2013	45
23201359	1137	Young JW	Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.	Behavioural brain research	2013	29
25460185	1137	Zoli M	Diversity of native nicotinic receptor subtypes in mammalian brain.	Neuropharmacology	2015	27
8943208	1234	Atchison RE	Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines.	Science	1996	118
10393974	1234	Kaul M	Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	1999	135
12368468	1234	Münk C	A dominant block to HIV-1 replication at reverse transcription in simian cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	130
16251317	1234	Dorr P	Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.	Antimicrobial agents and chemotherapy	2005	301
16418398	1234	Glass WG	CCR5 deficiency increases risk of symptomatic West Nile virus infection.	The Journal of experimental medicine	2006	132
16844419	1234	An DS	Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.	Molecular therapy 	2006	65
17013391	1234	Ariel A	Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.	Nature immunology	2006	98
17132723	1234	Zhang L	HIV-1 infection and pathogenesis in a novel humanized mouse model.	Blood	2007	71
17296858	1234	Wu H	T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.	Circulation	2007	192
17914389	1234	Karnoub AE	Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.	Nature	2007	807
18587387	1234	Perez EE	Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.	Nature biotechnology	2008	342
19997090	1234	Kim SS	RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.	Molecular therapy 	2010	67
20018916	1234	Shimizu S	A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.	Blood	2010	73
20601939	1234	Holt N	Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.	Nature biotechnology	2010	236
21133894	1234	Jones KL	Chemokine receptor CCR5: from AIDS to atherosclerosis.	British journal of pharmacology	2011	36
21533216	1234	Wilen CB	Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.	PLoS pathogens	2011	64
22273578	1234	Yuan J	Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.	Molecular therapy 	2012	36
22398281	1234	Walker JE	Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.	Journal of virology	2012	30
22637726	1234	Velasco-Velázquez M	CCR5 antagonist blocks metastasis of basal breast cancer cells.	Cancer research	2012	44
23587921	1234	Li L	Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.	Molecular therapy 	2013	58
24162716	1234	Didigu CA	Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.	Blood	2014	36
25517468	1234	Mandal PK	Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.	Cell stem cell	2014	72
26109379	1234	Mikucki ME	Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.	Nature communications	2015	26
26424571	1234	Sather BD	Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.	Science translational medicine	2015	36
26551060	1234	Wang J	Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.	Nature biotechnology	2015	34
28225754	1234	Eyquem J	Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.	Nature	2017	9
11242036	1236	Müller A	Involvement of chemokine receptors in breast cancer metastasis.	Nature	2001	1154
11592079	1236	Krug A	Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.	European journal of immunology	2001	142
11602640	1236	Bouchon A	A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.	The Journal of experimental medicine	2001	105
12414515	1236	Muller DN	Immunosuppressive treatment protects against angiotensin II-induced renal damage.	The American journal of pathology	2002	83
15067072	1236	Pichyangkul S	Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.	Journal of immunology	2004	83
15090447	1236	Hoffmann P	Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.	Blood	2004	110
15534368	1236	Qu C	Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes.	The Journal of experimental medicine	2004	77
17371966	1236	Romero P	Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.	Journal of immunology	2007	96
19536265	1236	Buonamici S	CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.	Nature	2009	58
19570762	1236	Iliev ID	Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.	Gut	2009	98
21298111	1236	Deiuliis J	Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.	PloS one	2011	62
21926977	1236	Gattinoni L	A human memory T cell subset with stem cell-like properties.	Nature medicine	2011	318
22030090	1236	Tu SP	Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.	Cancer prevention research	2012	39
25715355	1236	Canavan JB	Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.	Gut	2016	14
25787765	1236	Watanabe R	Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.	Science translational medicine	2015	43
7556170	1268	Galiègue S	Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.	European journal of biochemistry	1995	256
7565624	1268	Felder CC	Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.	Molecular pharmacology	1995	139
8819477	1268	Showalter VM	Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.	The Journal of pharmacology and experimental therapeutics	1996	127
9454810	1268	Rinaldi-Carmona M	SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.	The Journal of pharmacology and experimental therapeutics	1998	128
11164622	1268	Pertwee RG	Cannabinoid receptors and pain.	Progress in neurobiology	2001	104
11698100	1268	Schlicker E	Modulation of transmitter release via presynaptic cannabinoid receptors.	Trends in pharmacological sciences	2001	91
12461523	1268	Kathuria S	Modulation of anxiety through blockade of anandamide hydrolysis.	Nature medicine	2003	386
15728830	1268	Ramírez BG	Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.	The Journal of neuroscience 	2005	127
15927244	1268	Viveros MP	Endocannabinoid system and stress and anxiety responses.	Pharmacology, biochemistry, and behavior	2005	83
16715087	1268	Teixeira-Clerc F	CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.	Nature medicine	2006	107
17115043	1268	Robbe D	Cannabinoids reveal importance of spike timing coordination in hippocampal function.	Nature neuroscience	2006	110
17245363	1268	Thomas A	Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.	British journal of pharmacology	2007	83
19887554	1268	Qamri Z	Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.	Molecular cancer therapeutics	2009	46
19942623	1268	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.	Cardiovascular research	2010	42
21525939	1268	Donadelli M	Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.	Cell death and disease	2011	41
22688188	1268	Gunduz-Cinar O	Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.	Molecular psychiatry	2013	80
25981172	1268	Jenniches I	Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.	Biological psychiatry	2016	18
9334309	1270	Bonni A	Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.	Science	1997	209
15199405	1270	Dezawa M	Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.	The Journal of clinical investigation	2004	107
16254185	1270	Kokoeva MV	Neurogenesis in the hypothalamus of adult mice: potential role in energy balance.	Science	2005	169
16330757	1270	Munoz JR	Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	90
16604088	1270	Watt MJ	CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.	Nature medicine	2006	74
18614690	1270	Cota D	The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity.	The Journal of neuroscience 	2008	56
22085254	1270	Hawryluk GW	An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury.	Stem cells and development	2012	32
22182585	1270	Wen R	CNTF and retina.	Progress in retinal and eye research	2012	43
22875916	1270	Lavisse S	Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.	The Journal of neuroscience 	2012	47
23618907	1270	Leibinger M	Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation.	Cell death and disease	2013	31
9687510	1385	Deak M	Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.	The EMBO journal	1998	248
11404397	1385	Dineley KT	Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.	The Journal of neuroscience 	2001	97
12577062	1385	Ehlers MD	Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system.	Nature neuroscience	2003	309
12718894	1385	Conkright MD	Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness.	Molecular cell	2003	104
16477009	1385	Amadoro G	NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.	Proceedings of the National Academy of Sciences of the United States of America	2006	66
17553428	1385	Cheng HY	microRNA modulation of circadian-clock period and entrainment.	Neuron	2007	197
18457678	1385	Williams CM	Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels.	Free radical biology and medicine	2008	61
18687378	1385	Bernardo AS	Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell.	Molecular and cellular endocrinology	2008	50
18940959	1385	Crews FT	Mechanisms of neurodegeneration and regeneration in alcoholism.	Alcohol and alcoholism	2009	147
18982459	1385	Sancho-Pelluz J	Photoreceptor cell death mechanisms in inherited retinal degeneration.	Molecular neurobiology	2008	78
19428444	1385	Lebesgue D	Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.	Steroids	2009	55
20168088	1385	Carloni S	Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia.	Autophagy	2010	46
24636259	1385	Cheng TL	MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex.	Developmental cell	2014	49
27140397	1385	Chen Z	cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.	The Journal of clinical investigation	2016	11
27648837	1385	Hong Z	MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.	American journal of respiratory and critical care medicine	2017	5
7477349	1392	Vaughan J	Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.	Nature	1995	198
9854171	1392	Arborelius L	The role of corticotropin-releasing factor in depression and anxiety disorders.	The Journal of endocrinology	1999	215
10867111	1392	Zobel AW	Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.	Journal of psychiatric research	2000	97
11027914	1392	Holsboer F	The corticosteroid receptor hypothesis of depression.	Neuropsychopharmacology 	2000	306
11238541	1392	Rask E	Tissue-specific dysregulation of cortisol metabolism in human obesity.	The Journal of clinical endocrinology and metabolism	2001	94
11430844	1392	Heim C	The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.	Biological psychiatry	2001	456
11481147	1392	Jacobsen LK	Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.	The American journal of psychiatry	2001	163
11689280	1392	Weinstock M	Alterations induced by gestational stress in brain morphology and behaviour of the offspring.	Progress in neurobiology	2001	102
12047726	1392	Viau V	Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes.	Journal of neuroendocrinology	2002	89
12220880	1392	Avishai-Eliner S	Stressed-out, or in (utero)?	Trends in neurosciences	2002	104
12975524	1392	Dallman MF	Chronic stress and obesity: a new view of "comfort food".	Proceedings of the National Academy of Sciences of the United States of America	2003	251
14728093	1392	Nemeroff CB	Neurobiological consequences of childhood trauma.	The Journal of clinical psychiatry	2004	90
15297468	1392	Heinrichs SC	Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.	The Journal of pharmacology and experimental therapeutics	2004	79
15920504	1392	Plotsky PM	Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring.	Neuropsychopharmacology 	2005	124
15944068	1392	Weinstock M	The potential influence of maternal stress hormones on development and mental health of the offspring.	Brain, behavior, and immunity	2005	109
15996533	1392	Swaab DF	The stress system in the human brain in depression and neurodegeneration.	Ageing research reviews	2005	133
16876134	1392	Funk CK	Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.	Biological psychiatry	2007	140
17115806	1392	Davis M	Neural systems involved in fear and anxiety measured with fear-potentiated startle.	The American psychologist	2006	147
19693004	1392	Davis M	Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.	Neuropsychopharmacology 	2010	321
20160137	1392	Wood SK	Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor.	Endocrinology	2010	68
25402857	1392	Grieder TE	VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.	Nature neuroscience	2014	23
25976297	1392	Mantsch JR	Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.	Neuropsychopharmacology 	2016	40
27109623	1392	Schwandt ML	The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.	Neuropsychopharmacology 	2016	14
7600582	1432	Minden A	Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs.	Cell	1995	352
9393975	1432	Rousseau S	p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.	Oncogene	1997	155
9452444	1432	Vanden Berghe W	p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.	The Journal of biological chemistry	1998	120
10623843	1432	Hartmann G	Mechanism and function of a newly identified CpG DNA motif in human primary B cells.	Journal of immunology	2000	93
10805738	1432	Wu Z	p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.	Molecular and cellular biology	2000	127
10943842	1432	Tamura K	Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis.	Cell	2000	99
10987301	1432	Sodhi A	The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.	Cancer research	2000	125
12185362	1432	Weijzen S	Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.	Nature medicine	2002	143
14634666	1432	Uhlik MT	Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.	Nature cell biology	2003	124
14699082	1432	Doyle SE	Toll-like receptors induce a phagocytic gene program through p38.	The Journal of experimental medicine	2004	95
14997933	1432	Ferrer I	Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.	Brain pathology	2004	152
15746443	1432	Pathak A	Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.	Circulation research	2005	73
15753463	1432	Gutierrez MC	Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.	Journal of clinical oncology 	2005	122
16452201	1432	Zetser A	Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.	Cancer research	2006	80
16799564	1432	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	260
16847328	1432	Guil S	hnRNP A1 relocalization to the stress granules reflects a role in the stress response.	Molecular and cellular biology	2006	88
16901744	1432	Ilan N	Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.	The international journal of biochemistry and cell biology	2006	153
16951163	1432	Park CM	Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.	Cancer research	2006	62
17032753	1432	Engel FB	FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17170118	1432	Sun L	Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.	The Journal of biological chemistry	2007	69
17392283	1432	Medvedev AE	Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.	The Journal of biological chemistry	2007	61
17634369	1432	Yune TY	Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury.	The Journal of neuroscience 	2007	63
17720811	1432	Chang J	Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK.	The Journal of biological chemistry	2007	55
17906618	1432	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	145
18276609	1432	Tang G	Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.	Human molecular genetics	2008	52
18285558	1432	Ali TK	Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.	Diabetes	2008	61
18339885	1432	Lakshman M	Dietary genistein inhibits metastasis of human prostate cancer in mice.	Cancer research	2008	57
18629684	1432	Nieto-Vazquez I	Insulin resistance associated to obesity: the link TNF-alpha.	Archives of physiology and biochemistry	2008	72
19411199	1432	Wilkins A	Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.	Stem cell research	2009	54
19617536	1432	Markovic DS	Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.	Proceedings of the National Academy of Sciences of the United States of America	2009	68
19995751	1432	Hammaker D	"Go upstream, young man": lessons learned from the p38 saga.	Annals of the rheumatic diseases	2010	40
20089617	1432	Ma K	12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.	The Journal of clinical endocrinology and metabolism	2010	43
20643109	1432	Paine A	Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.	Biochemical pharmacology	2010	135
20802523	1432	Wendt MK	Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.	Oncogene	2010	75
20957344	1432	Ali TK	Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.	Diabetologia	2011	44
21144973	1432	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	56
21163347	1432	Henriksen EJ	Oxidative stress and the etiology of insulin resistance and type 2 diabetes.	Free radical biology and medicine	2011	80
21306997	1432	Sunaga N	Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.	Molecular cancer therapeutics	2011	54
21490934	1432	Crişan TO	Inflammasome-independent modulation of cytokine response by autophagy in human cells.	PloS one	2011	40
22298955	1432	Chen G	TGF-β and BMP signaling in osteoblast differentiation and bone formation.	International journal of biological sciences	2012	200
22696230	1432	Chung LY	Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.	Clinical cancer research 	2012	35
24185179	1432	Sato A	Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.	Stem cell research	2014	21
24362529	1432	Xiang T	Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.	Oncogene	2015	21
24746804	1432	Shiraki N	Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells.	Cell metabolism	2014	50
24928860	1432	Wang J	Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.	Blood	2014	35
25083993	1432	Henson SM	p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells.	The Journal of clinical investigation	2014	34
25595279	1432	Gonzalez-Villasana V	Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.	Clinical cancer research 	2015	16
25799226	1432	Wu Y	Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo.	Nature medicine	2015	18
26483953	1432	Ichihara M	Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.	Medical gas research	2015	18
27135739	1432	Fukawa T	Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.	Nature medicine	2016	15
27563484	1432	Wu M	TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease.	Bone research	2016	16
15062647	1435	Barreda DR	Regulation of myeloid development and function by colony stimulating factors.	Developmental and comparative immunology	2004	74
19934330	1435	Patsialou A	Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.	Cancer research	2009	94
22161841	1435	Laoui D	Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.	The International journal of developmental biology	2011	57
22547697	1435	Lacey DC	Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models.	Journal of immunology	2012	85
24898549	1435	Ries CH	Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.	Cancer cell	2014	126
25429076	1435	Pignatelli J	Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.	Science signaling	2014	23
25446896	1435	Ruffell B	Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.	Cancer cell	2014	76
26538619	1435	Stafford JH	Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.	Neuro-oncology	2016	15
8006603	1437	Romani N	Proliferating dendritic cell progenitors in human blood.	The Journal of experimental medicine	1994	266
9500607	1437	Nestle FO	Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.	Nature medicine	1998	310
10811870	1437	Santini SM	Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.	The Journal of experimental medicine	2000	112
10866317	1437	Mach N	Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.	Cancer research	2000	115
12473579	1437	Giaccone G	A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.	Clinical cancer research 	2002	124
12952922	1437	Doran KS	Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis.	The Journal of clinical investigation	2003	76
14688315	1437	Finney HM	Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.	Journal of immunology	2004	96
15322213	1437	Kao CY	IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways.	Journal of immunology	2004	133
15661881	1437	Gorden KB	Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.	Journal of immunology	2005	147
16951685	1437	Rossi AG	Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.	Nature medicine	2006	138
17577033	1437	Filipazzi P	Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.	Journal of clinical oncology 	2007	230
17965776	1437	Thorne SH	Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.	The Journal of clinical investigation	2007	65
18292469	1437	O'Reilly MA	Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.	American journal of respiratory and critical care medicine	2008	53
18535155	1437	Banas A	IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.	Stem cells	2008	58
18550585	1437	Smithgall MD	IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.	International immunology	2008	130
19609242	1437	Weide B	Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.	Journal of immunotherapy	2009	45
19966223	1437	Chen Q	Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
20145120	1437	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	111
20406969	1437	Ko JS	Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.	Cancer research	2010	81
20484626	1437	Emmanouilidou E	Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.	The Journal of neuroscience 	2010	237
20528232	1437	Kaufman HL	OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma.	Future oncology	2010	56
21315783	1437	Finke J	MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.	International immunopharmacology	2011	64
22271649	1437	Sharkey DJ	Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus.	Journal of immunology	2012	60
23393196	1437	Breitbach CJ	Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.	Cancer research	2013	40
24823638	1437	Su S	A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.	Cancer cell	2014	85
26783184	1437	Scheibe K	IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.	Gut	2017	7
27374224	1437	Singhal S	Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.	Cancer cell	2016	13
11152469	1490	Holmes A	CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.	The Journal of biological chemistry	2001	113
12842083	1490	Kang Y	A multigenic program mediating breast cancer metastasis to bone.	Cancer cell	2003	660
16878133	1490	Dews M	Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.	Nature genetics	2006	334
19096030	1490	Duisters RF	miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.	Circulation research	2009	227
20393144	1490	Wang B	E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.	Diabetes	2010	81
20679726	1490	Lee CH	CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.	The Journal of clinical investigation	2010	82
22684333	1490	Capparelli C	CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.	Cell cycle	2012	37
25003330	1490	Tsai HC	CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.	Oncotarget	2014	29
25294165	1490	Kubota S	Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.	Clinical science	2015	25
25738362	1490	Chuang JY	WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.	Oncotarget	2015	16
1323143	1493	Lenschow DJ	Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.	Science	1992	176
11390435	1493	Jonuleit H	Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.	The Journal of experimental medicine	2001	227
11390436	1493	Levings MK	Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.	The Journal of experimental medicine	2001	180
11390437	1493	Dieckmann D	Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.	The Journal of experimental medicine	2001	209
11722623	1493	Shevach EM	Control of T-cell activation by CD4+ CD25+ suppressor T cells.	Immunological reviews	2001	98
12193750	1493	Liyanage UK	Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.	Journal of immunology	2002	314
12576425	1493	Wolf AM	Increase of regulatory T cells in the peripheral blood of cancer patients.	Clinical cancer research 	2003	159
17606980	1493	Okazaki T	PD-1 and PD-1 ligands: from discovery to clinical application.	International immunology	2007	172
18000991	1493	O'Day SJ	Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.	Cancer	2007	57
19009291	1493	Galustian C	The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.	Cancer immunology, immunotherapy 	2009	78
20038811	1493	Derré L	BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.	The Journal of clinical investigation	2010	67
21474713	1493	Qureshi OS	Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.	Science	2011	248
21723783	1493	Wing K	Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.	Trends in immunology	2011	50
22071969	1493	Dias JD	Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.	Gene therapy	2012	34
23028051	1493	Corrales L	Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.	Journal of immunology	2012	36
24277834	1493	Feig C	Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	124
24388175	1493	Rong Z	An effective approach to prevent immune rejection of human ESC-derived allografts.	Cell stem cell	2014	25
24860567	1493	Corthay A	Does the immune system naturally protect against cancer?	Frontiers in immunology	2014	29
25213377	1493	Kuehn HS	Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.	Science	2014	83
25415283	1493	Soares KC	PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.	Journal of immunotherapy	2015	49
25589619	1493	Liu L	The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4.	Clinical cancer research 	2015	31
25672397	1493	Beavis PA	Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.	Cancer immunology research	2015	16
25918390	1493	Romano E	Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	38
26317466	1493	Chiappinelli KB	Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.	Cell	2015	86
26323609	1493	Nduom EK	PD-L1 expression and prognostic impact in glioblastoma.	Neuro-oncology	2016	30
27828943	1493	De Henau O	Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.	Nature	2016	12
8638126	1499	Rubinfeld B	Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.	Science	1996	318
9065403	1499	Rubinfeld B	Stabilization of beta-catenin by genetic defects in melanoma cell lines.	Science	1997	285
9601641	1499	Hart MJ	Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.	Current biology 	1998	201
9990852	1499	Winston JT	The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.	Genes and development	1999	271
10192393	1499	Chan EF	A common human skin tumour is caused by activating mutations in beta-catenin.	Nature genetics	1999	126
11533658	1499	Ryo A	Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.	Nature cell biology	2001	131
11940574	1499	Leung JY	Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.	The Journal of biological chemistry	2002	119
12923068	1499	Kim HS	C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression.	FASEB journal 	2003	84
12952940	1499	Topol L	Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.	The Journal of cell biology	2003	212
14739782	1499	Howe LR	Wnt signaling and breast cancer.	Cancer biology and therapy	2004	90
15072585	1499	Sugimura T	Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish.	Cancer science	2004	109
15300008	1499	Brennan KR	Wnt proteins in mammary development and cancer.	Journal of mammary gland biology and neoplasia	2004	79
15342948	1499	Etheridge SL	Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells.	Stem cells	2004	70
15542433	1499	Bafico A	An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.	Cancer cell	2004	119
15592430	1499	Chamorro MN	FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.	The EMBO journal	2005	85
15720724	1499	Itoh K	Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling.	Journal of biology	2005	74
15778706	1499	van Es JH	Wnt signalling induces maturation of Paneth cells in intestinal crypts.	Nature cell biology	2005	174
15905404	1499	Essers MA	Functional interaction between beta-catenin and FOXO in oxidative stress signaling.	Science	2005	206
15925592	1499	Pinto D	Wnt control of stem cells and differentiation in the intestinal epithelium.	Experimental cell research	2005	79
15973414	1499	Batlle E	EphB receptor activity suppresses colorectal cancer progression.	Nature	2005	110
16002782	1499	Dravid G	Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells.	Stem cells	2005	105
16230409	1499	Thomson S	Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.	Cancer research	2005	193
16239965	1499	Balint K	Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression.	The Journal of clinical investigation	2005	94
16251967	1499	Lie DC	Wnt signalling regulates adult hippocampal neurogenesis.	Nature	2005	376
16357527	1499	Kim KA	R-Spondin proteins: a novel link to beta-catenin activation.	Cell cycle	2006	72
16823493	1499	Garcia-Gras E	Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.	The Journal of clinical investigation	2006	135
17145894	1499	Wang Y	Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.	Cancer research	2006	66
17208432	1499	Polakis P	The many ways of Wnt in cancer.	Current opinion in genetics and development	2007	269
17395698	1499	Baron R	Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.	Endocrinology	2007	117
17452641	1499	Sukhdeo K	Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.	Proceedings of the National Academy of Sciences of the United States of America	2007	60
17638895	1499	Vignjevic D	Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.	Cancer research	2007	73
17785413	1499	Tward AD	Distinct pathways of genomic progression to benign and malignant tumors of the liver.	Proceedings of the National Academy of Sciences of the United States of America	2007	64
18339862	1499	Li H	PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.	Cancer research	2008	76
18364678	1499	Qiao L	Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.	Cell research	2008	76
18371348	1499	Qyang Y	The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway.	Cell stem cell	2007	117
18381440	1499	Sawada K	Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.	Cancer research	2008	104
18385740	1499	Malanchi I	Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.	Nature	2008	169
18519688	1499	Yang W	Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.	Cancer research	2008	101
18679417	1499	Chang YM	Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.	Oncogene	2008	55
18697834	1499	Otto A	Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration.	Journal of cell science	2008	66
18949017	1499	Pu P	Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.	Cancer gene therapy	2009	58
18987168	1499	Smallridge RC	Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.	Endocrine-related cancer	2009	84
19061838	1499	Cairo S	Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.	Cancer cell	2008	56
19144919	1499	Chien AJ	Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.	Proceedings of the National Academy of Sciences of the United States of America	2009	106
19270709	1499	Hong HS	A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells.	Nature medicine	2009	50
19418460	1499	Wexler EM	Endogenous Wnt signaling maintains neural progenitor cell potency.	Stem cells	2009	53
19492080	1499	Korkaya H	Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.	PLoS biology	2009	184
19493674	1499	Spencer L	The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential.	European journal of cancer	2009	47
19666525	1499	Chan KS	Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	149
19882675	1499	Cai Y	Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.	The Journal of pathology	2010	42
19893025	1499	Chen Y	Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.	The American journal of pathology	2009	55
20227366	1499	Tauriello DV	Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.	Molecular cell	2010	46
20227497	1499	Haussler MR	The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging.	The Journal of steroid biochemistry and molecular biology	2010	47
20348907	1499	Zhang L	Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.	Nature	2010	41
20395444	1499	Khramtsov AI	Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.	The American journal of pathology	2010	108
20610629	1499	Gu Y	GlcNAcylation plays an essential role in breast cancer metastasis.	Cancer research	2010	44
20713706	1499	Ettenberg SA	Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.	Proceedings of the National Academy of Sciences of the United States of America	2010	45
20978119	1499	He BC	Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.	Molecular pharmacology	2011	43
21108734	1499	Marchand A	The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans.	Aging cell	2011	35
21156284	1499	Yeung J	β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells.	Cancer cell	2010	66
21199802	1499	Waaler J	Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.	Cancer research	2011	35
21346776	1499	Syed DN	Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.	The Journal of investigative dermatology	2011	39
21393571	1499	Gonsalves FC	An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21518267	1499	Kikuchi A	Wnt5a: its signalling, functions and implication in diseases.	Acta physiologica	2012	83
21531761	1499	Osada T	Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.	Cancer research	2011	54
21636786	1499	Gaston-Massuet C	Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
21685890	1499	Lyashenko N	Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation.	Nature cell biology	2011	91
21704588	1499	Froeling FE	Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.	Gastroenterology	2011	57
21821917	1499	Alastalo TP	Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.	The Journal of clinical investigation	2011	53
21880956	1499	Zemans RL	Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
22056988	1499	Yang W	Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.	Nature	2011	210
22080605	1499	Sánchez-Tilló E	β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.	Proceedings of the National Academy of Sciences of the United States of America	2011	96
22083670	1499	Kim Y	Wnt activation is implicated in glioblastoma radioresistance.	Laboratory investigation; a journal of technical methods and pathology	2012	42
22083958	1499	Nishiyama M	Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway.	Molecular and cellular biology	2012	30
22095546	1499	Mackinnon AC	Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.	American journal of respiratory and critical care medicine	2012	42
22095947	1499	He W	Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.	Journal of the American Society of Nephrology 	2012	40
22115830	1499	Freeman TJ	Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.	Gastroenterology	2012	39
22328737	1499	Beyer C	β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.	Annals of the rheumatic diseases	2012	40
22392999	1499	Davidson KC	Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4.	Proceedings of the National Academy of Sciences of the United States of America	2012	80
22484120	1499	Zhang J	MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.	Gastroenterology	2012	47
22494971	1499	Jeong WJ	Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.	Science signaling	2012	32
22610277	1499	Tenbaum SP	β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.	Nature medicine	2012	82
22610915	1499	Zhang Y	Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.	Hepatology	2012	74
22723415	1499	Hoffmeyer K	Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.	Science	2012	126
22738915	1499	Casás-Selves M	Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.	Cancer research	2012	33
22784633	1499	Najdi R	A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities.	Differentiation; research in biological diversity	2012	33
22851508	1499	Ibrahim EE	Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms.	Stem cells	2012	35
22914623	1499	Takada K	Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.	Science translational medicine	2012	48
23034650	1499	Grivennikov SI	Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.	Nature	2012	215
23139209	1499	Gong A	FoxM1 and Wnt/β-catenin signaling in glioma stem cells.	Cancer research	2012	34
23142810	1499	Li Q	WNT4 acts downstream of BMP2 and functions via β-catenin signaling pathway to regulate human endometrial stromal cell differentiation.	Endocrinology	2013	26
23178882	1499	Youssef KK	Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation.	Nature cell biology	2012	32
23188675	1499	Hsieh IS	MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.	Carcinogenesis	2013	66
23300485	1499	Francis JC	β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.	PLoS genetics	2013	28
23307470	1499	Wend P	WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.	EMBO molecular medicine	2013	36
23377377	1499	Bugaj LJ	Optogenetic protein clustering and signaling activation in mammalian cells.	Nature methods	2013	67
23454242	1499	Seshacharyulu P	Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.	Cancer letters	2013	58
23945276	1499	Pegoraro S	HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.	Oncotarget	2013	33
23999433	1499	Neviani P	PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.	The Journal of clinical investigation	2013	54
24087794	1499	Berthon A	WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.	Human molecular genetics	2014	23
24335145	1499	Tang X	Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.	Nucleic acids research	2014	21
24429522	1499	Kode A	Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts.	Nature	2014	80
24582836	1499	Lau CC	Viral-human chimeric transcript predisposes risk to liver cancer development and progression.	Cancer cell	2014	43
24614104	1499	Tucci V	Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.	The Journal of clinical investigation	2014	26
24837430	1499	Amini-Nik S	β-Catenin-regulated myeloid cell adhesion and migration determine wound healing.	The Journal of clinical investigation	2014	23
24837480	1499	Tao J	Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.	Gastroenterology	2014	34
24859161	1499	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	27
25123931	1499	Wroblewski LE	Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.	Gut	2015	23
25371073	1499	Tang Q	MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.	Tumour biology 	2015	20
25444902	1499	Zhang J	EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.	Cancer letters	2015	18
25449213	1499	Cao C	The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells.	Gastroenterology	2015	37
25500543	1499	Lemieux E	Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.	Oncogene	2015	27
25501033	1499	Penna E	miR-214 as a key hub that controls cancer networks: small player, multiple functions.	The Journal of investigative dermatology	2015	20
25670168	1499	Cojoc M	Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.	Cancer research	2015	25
25820276	1499	Bol GM	Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.	EMBO molecular medicine	2015	22
25871400	1499	Zhou Y	Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation.	Oncotarget	2015	18
26125441	1499	Nagaraj AB	Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.	Oncotarget	2015	24
26202299	1499	Jang GB	Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.	Scientific reports	2015	25
26364599	1499	Zhou L	Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.	Oncogene	2016	25
26684358	1499	Zheng H	MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.	Oncotarget	2016	13
27042933	1499	Kaur A	sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.	Nature	2016	27
2188135	1756	Ervasti JM	Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.	Nature	1990	177
2662404	1756	Sicinski P	The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.	Science	1989	278
3773991	1756	Monaco AP	Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.	Nature	1986	184
7545544	1756	Brenman JE	Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.	Cell	1995	187
11087833	1756	Sander M	Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.	Proceedings of the National Academy of Sciences of the United States of America	2000	110
15867092	1756	Rodriguez AM	Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse.	The Journal of experimental medicine	2005	82
16025101	1756	Yasuda S	Dystrophic heart failure blocked by membrane sealant poloxamer.	Nature	2005	87
16724091	1756	McClorey G	Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.	Gene therapy	2006	61
17095633	1756	Tidball JG	The role of free radicals in the pathophysiology of muscular dystrophy.	Journal of applied physiology	2007	60
18641643	1756	Sato S	Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation.	Nature neuroscience	2008	70
20517938	1756	Malik V	Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.	Annals of neurology	2010	71
20956307	1756	Adamo CM	Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.	Proceedings of the National Academy of Sciences of the United States of America	2010	55
20978473	1756	Lu QL	The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy.	Molecular therapy 	2011	38
21212803	1756	Cacchiarelli D	miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.	EMBO reports	2011	48
21425469	1756	Cacchiarelli D	miRNAs as serum biomarkers for Duchenne muscular dystrophy.	EMBO molecular medicine	2011	65
23764775	1756	Alexander MS	MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.	Cell death and differentiation	2013	34
24349052	1756	Finkel RS	Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.	PloS one	2013	45
24434629	1756	Guan X	Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.	Stem cell research	2014	23
24793134	1756	Wang Y	Dystrophin is a tumor suppressor in human cancers with myogenic programs.	Nature genetics	2014	27
25042693	1756	Leung DG	Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.	Annals of neurology	2014	21
25492562	1756	Ousterout DG	Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases.	Molecular therapy 	2015	29
25692716	1756	Ousterout DG	Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.	Nature communications	2015	62
25791035	1756	Lin B	Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.	Disease models and mechanisms	2015	19
26877224	1756	Young CS	A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.	Cell stem cell	2016	26
10325416	1786	Robertson KD	The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.	Nucleic acids research	1999	196
10551868	1786	Pradhan S	Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation.	The Journal of biological chemistry	1999	112
10888872	1786	Rountree MR	DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.	Nature genetics	2000	244
10888886	1786	Robertson KD	DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.	Nature genetics	2000	227
11005794	1786	Bestor TH	The DNA methyltransferases of mammals.	Human molecular genetics	2000	414
11932749	1786	Rhee I	DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.	Nature	2002	332
12473678	1786	Kimura H	Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.	The Journal of biological chemistry	2003	79
12496760	1786	Robert MF	DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.	Nature genetics	2003	140
12867029	1786	Lehnertz B	Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin.	Current biology 	2003	344
15956212	1786	Mortusewicz O	Recruitment of DNA methyltransferase I to DNA repair sites.	Proceedings of the National Academy of Sciences of the United States of America	2005	92
16963560	1786	Egger G	Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival.	Proceedings of the National Academy of Sciences of the United States of America	2006	67
17312023	1786	Spada F	DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.	The Journal of cell biology	2007	61
17322882	1786	Chen T	Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells.	Nature genetics	2007	93
17673620	1786	Bostick M	UHRF1 plays a role in maintaining DNA methylation in mammalian cells.	Science	2007	324
18772889	1786	Avvakumov GV	Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1.	Nature	2008	134
20081831	1786	Sen GL	DNMT1 maintains progenitor function in self-renewing somatic tissue.	Nature	2010	115
20093774	1786	Lin RK	The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.	The Journal of clinical investigation	2010	58
20529999	1786	Archer SL	Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.	Circulation	2010	102
20613874	1786	Hervouet E	Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells.	PloS one	2010	43
21074545	1786	Guidotti A	Epigenetic GABAergic targets in schizophrenia and bipolar disorder.	Neuropharmacology	2011	62
21163962	1786	Song J	Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation.	Science	2011	86
21321201	1786	Shock LS	DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria.	Proceedings of the National Academy of Sciences of the United States of America	2011	102
21682946	1786	Melas PA	Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.	The international journal of neuropsychopharmacology	2012	31
24077826	1786	Turcan S	Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.	Oncotarget	2013	39
25595591	1786	Ning X	DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.	Cancer letters	2015	19
25607372	1786	Baubec T	Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.	Nature	2015	79
25641194	1786	Zhuo H	The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.	Molecular carcinogenesis	2016	24
26065575	1786	Qin W	DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination.	Cell research	2015	20
26503055	1786	Peng D	Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.	Nature	2015	49
7995938	1822	Shultz LD	Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.	Journal of immunology	1995	216
10677521	1822	Yu L	Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2000	121
10828007	1822	Peled A	The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.	Blood	2000	152
11104786	1822	Ponomaryov T	Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.	The Journal of clinical investigation	2000	135
15879151	1822	Shultz LD	Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.	Journal of immunology	2005	397
16410443	1822	Lan P	Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.	Blood	2006	116
16863903	1822	Dar A	Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.	Experimental hematology	2006	93
17088535	1822	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	175
18178393	1822	Zhang L	Insulin as an autoantigen in NOD/human diabetes.	Current opinion in immunology	2008	68
18598943	1822	le Viseur C	In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.	Cancer cell	2008	61
20404133	1822	McDermott SP	Comparison of human cord blood engraftment between immunocompromised mouse strains.	Blood	2010	81
20936253	1822	Levitt HE	Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice.	Diabetologia	2011	48
22508028	1822	Tentler JJ	Patient-derived tumour xenografts as models for oncology drug development.	Nature reviews. Clinical oncology	2012	200
11034215	1869	Irwin M	Role for the p53 homologue p73 in E2F-1-induced apoptosis.	Nature	2000	153
15944709	1869	O'Donnell KA	c-Myc-regulated microRNAs modulate E2F1 expression.	Nature	2005	914
16096373	1869	Mendell JT	MicroRNAs: critical regulators of development, cellular physiology and malignancy.	Cell cycle	2005	113
16299810	1869	Hanada N	Co-regulation of B-Myb expression by E2F1 and EGF receptor.	Molecular carcinogenesis	2006	62
16892051	1869	Wang C	Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.	Nature cell biology	2006	125
17135268	1869	Woods K	Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.	The Journal of biological chemistry	2007	179
17894887	1869	Cho WC	OncomiRs: the discovery and progress of microRNAs in cancers.	Molecular cancer	2007	195
18644991	1869	Yi T	Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.	Molecular cancer therapeutics	2008	52
21857159	1869	Lizé M	MicroRNA-449 in cell fate determination.	Cell cycle	2011	40
23306062	1869	Laine A	Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.	Cancer discovery	2013	29
23868977	1869	Wu Q	MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells.	Journal of cell science	2013	27
24357161	1869	Shi X	A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.	Molecular carcinogenesis	2015	48
24362522	1869	Andrechek ER	HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.	Oncogene	2015	16
26540633	1869	Lu Z	Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1).	Oncotarget	2016	20
6602130	1950	Assoian RK	Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.	The Journal of biological chemistry	1983	234
10436156	1950	Sassone-Corsi P	Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3.	Science	1999	118
11967021	1950	Strutz F	Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.	Kidney international	2002	103
16086633	1950	Conti L	Niche-independent symmetrical self-renewal of a mammalian tissue stem cell.	PLoS biology	2005	240
16150920	1950	Tamama K	Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells.	Stem cells	2006	67
17121914	1950	Buck E	Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors.	Molecular cancer therapeutics	2006	67
17477732	1950	Adams KE	Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer.	Journal of biomedical optics	2007	86
18292095	1950	Soeda A	Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells.	The Journal of biological chemistry	2008	56
19091002	1950	Hanson LR	Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.	BMC neuroscience	2008	68
19544429	1950	Gonzalez-Perez O	Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes.	Stem cells	2009	69
24207025	1950	Schröder S	Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells.	Molecular cell	2013	26
24610630	1950	Sareen D	Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.	The Journal of comparative neurology	2014	33
25143389	1950	Nair V	Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.	The Journal of biological chemistry	2014	23
25924068	1950	Drost J	Sequential cancer mutations in cultured human intestinal stem cells.	Nature	2015	71
2999974	1956	Coussens L	Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.	Science	1985	261
9006938	1956	Huang HS	The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.	The Journal of biological chemistry	1997	162
9403702	1956	Petit AM	Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.	The American journal of pathology	1997	115
9815926	1956	Goldstein NI	Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.	Clinical cancer research 	1995	117
10075741	1956	Biscardi JS	c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.	The Journal of biological chemistry	1999	174
10202547	1956	Hatten ME	Central nervous system neuronal migration.	Annual review of neuroscience	1999	158
10722725	1956	Jo M	Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells.	The Journal of biological chemistry	2000	104
10760290	1956	Grandis JR	Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2000	149
10815932	1956	Ciardiello F	Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.	Clinical cancer research 	2000	107
10873065	1956	Huang SM	Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.	Clinical cancer research 	2000	98
11156248	1956	Sirotnak FM	Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.	Clinical cancer research 	2000	94
11420660	1956	Garcia R	Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.	Oncogene	2001	164
11426640	1956	Mendelsohn J	The EGF receptor family as targets for cancer therapy.	Oncogene	2000	206
11431323	1956	Sonoda Y	Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.	Cancer research	2001	86
11431346	1956	Viloria-Petit A	Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.	Cancer research	2001	110
11595683	1956	Ciardiello F	A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.	Clinical cancer research 	2001	135
11836430	1956	Simmons G	Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.	Journal of virology	2002	85
12183421	1956	Wedge SR	ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.	Cancer research	2002	158
12297049	1956	Garrett TP	Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.	Cell	2002	188
12359858	1956	Wang F	Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.	Journal of the National Cancer Institute	2002	111
12384534	1956	Wakeling AE	ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.	Cancer research	2002	132
12435727	1956	Andl CD	Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.	The Journal of biological chemistry	2003	90
12499279	1956	Ang KK	Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.	Cancer research	2002	224
15173008	1956	Rabindran SK	Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.	Cancer research	2004	92
15345710	1956	Laederich MB	The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.	The Journal of biological chemistry	2004	75
15735034	1956	Stabile LP	Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.	Cancer research	2005	82
15831234	1956	Giannini C	Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.	Neuro-oncology	2005	158
15833866	1956	Chinnaiyan P	Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).	Cancer research	2005	84
15994331	1956	Clayton AH	Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.	The Journal of biological chemistry	2005	82
16020518	1956	Means AL	Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates.	Development	2005	106
16452222	1956	Konecny GE	Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.	Cancer research	2006	213
16540667	1956	Alvarez JV	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.	Cancer research	2006	61
16624948	1956	Almeida CG	Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system.	The Journal of neuroscience 	2006	75
16730237	1956	Ji H	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.	Cancer cell	2006	125
16980555	1956	Zhen G	IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production.	American journal of respiratory cell and molecular biology	2007	74
17047074	1956	Morgillo F	Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.	Cancer research	2006	101
17251932	1956	Ventura A	Restoration of p53 function leads to tumour regression in vivo.	Nature	2007	502
17332301	1956	Kurai J	Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.	Clinical cancer research 	2007	86
17360479	1956	Scott AM	A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.	Proceedings of the National Academy of Sciences of the United States of America	2007	59
17483330	1956	Palmieri D	Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.	Cancer research	2007	101
17646646	1956	Huang PH	Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2007	147
17699871	1956	Ritter CA	Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network.	Clinical cancer research 	2007	166
17974918	1956	Okawa T	The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.	Genes and development	2007	65
18024868	1956	Tabernero J	Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.	Journal of clinical oncology 	2007	63
18060032	1956	Gao SP	Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.	The Journal of clinical investigation	2007	193
18211286	1956	Vazquez-Martin A	Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.	Cell proliferation	2008	54
18381447	1956	Fuchs BC	Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.	Cancer research	2008	86
18408761	1956	Li D	BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.	Oncogene	2008	267
18413800	1956	Godin-Heymann N	The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor.	Molecular cancer therapeutics	2008	58
18425114	1956	Al-Nedawi K	Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.	Nature cell biology	2008	350
18565887	1956	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	213
18604200	1956	Kolev V	EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer.	Nature cell biology	2008	67
18632642	1956	Lee-Hoeflich ST	A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.	Cancer research	2008	168
18782861	1956	Tao RH	All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.	Journal of cell science	2008	69
18829483	1956	Lo HW	Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.	Clinical cancer research 	2008	65
18922904	1956	Buck E	Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.	Cancer research	2008	82
18927285	1956	Fichtner I	Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.	Clinical cancer research 	2008	85
19060928	1956	Scaltriti M	Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.	Oncogene	2009	103
19089838	1956	Yang L	Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.	Small	2009	87
19091906	1956	Aerts HJ	Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.	Journal of nuclear medicine 	2009	53
19109410	1956	Graner MW	Proteomic and immunologic analyses of brain tumor exosomes.	FASEB journal 	2009	101
19147502	1956	Griffero F	Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.	The Journal of biological chemistry	2009	49
19170230	1956	Wong DW	The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.	Cancer	2009	157
19234131	1956	Al-Nedawi K	Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR.	Proceedings of the National Academy of Sciences of the United States of America	2009	141
19238632	1956	Tang Z	Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.	British journal of cancer	2008	57
19366827	1956	Yu J	Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.	Clinical cancer research 	2009	54
19412429	1956	Pillay V	The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.	Neoplasia	2009	48
19421193	1956	Bos PD	Genes that mediate breast cancer metastasis to the brain.	Nature	2009	433
19421880	1956	Dembinski JL	Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma.	Clinical and experimental metastasis	2009	60
19433789	1956	O'Keeffe GC	Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19447865	1956	Naumov GN	Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.	Clinical cancer research 	2009	55
19544433	1956	Kelly JJ	Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.	Stem cells	2009	62
19625624	1956	Guo D	The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
19690143	1956	Lu KV	Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.	Cancer research	2009	55
19840943	1956	Demory ML	Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.	The Journal of biological chemistry	2009	48
19852961	1956	Goetz M	In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.	Gastroenterology	2010	59
19934333	1956	Scheuer W	Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models.	Cancer research	2009	118
20048743	1956	Zhou X	Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.	Laboratory investigation; a journal of technical methods and pathology	2010	94
20049729	1956	Watt FM	Epidermal stem cell diversity and quiescence.	EMBO molecular medicine	2009	69
20129249	1956	Turke AB	Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.	Cancer cell	2010	279
20621056	1956	Curtis SJ	Primary tumor genotype is an important determinant in identification of lung cancer propagating cells.	Cell stem cell	2010	50
20647323	1956	Hadjipanayis CG	EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.	Cancer research	2010	82
20671236	1956	Zhu WZ	Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.	Circulation research	2010	59
20824720	1956	da Cunha Santos G	Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3.	Cancer	2010	42
20858720	1956	Mazzoleni S	Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.	Cancer research	2010	65
20861192	1956	Hochgräfe F	Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.	Cancer research	2010	56
20874002	1956	Katakowski M	MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.	Cancer investigation	2010	47
21081655	1956	John T	The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.	Clinical cancer research 	2011	38
21220474	1956	Donev IS	Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.	Clinical cancer research 	2011	37
21253578	1956	Gu TL	Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.	PloS one	2011	89
21258250	1956	Ludovini V	Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.	Journal of thoracic oncology 	2011	44
21266349	1956	Liccardi G	EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.	Cancer research	2011	65
21266357	1956	Qi J	Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.	Cancer research	2011	49
21273060	1956	Krumbach R	Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance.	European journal of cancer	2011	39
21407195	1956	Maretzky T	Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.	Nature communications	2011	38
21653320	1956	Wang X	A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.	Blood	2011	95
21690342	1956	Jin K	The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.	Proceedings of the National Academy of Sciences of the United States of America	2012	30
21720997	1956	Kim HR	Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.	Cancer	2012	33
21734175	1956	Chmielecki J	Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.	Science translational medicine	2011	156
21893191	1956	Wertheimer E	Rac signaling in breast cancer: a tale of GEFs and GAPs.	Cellular signalling	2012	62
21900593	1956	Yonesaka K	Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab.	Science translational medicine	2011	134
21909139	1956	Yue P	Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.	Oncogene	2012	36
21990576	1956	Terwisscha van Scheltinga AG	Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.	Journal of nuclear medicine 	2011	51
22065080	1956	Koul D	Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.	Clinical cancer research 	2012	44
22139077	1956	Bonavia R	EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.	Oncogene	2012	52
22186794	1956	Parato KA	The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.	Molecular therapy 	2012	47
22228822	1956	Kim Y	The EGFR T790M mutation in acquired resistance to an irreversible second-generation EGFR inhibitor.	Molecular cancer therapeutics	2012	34
22281684	1956	Prahallad A	Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.	Nature	2012	392
22282022	1956	Doebele RC	Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.	Cancer	2012	48
22305568	1956	Spike BT	A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.	Cell stem cell	2012	56
22414764	1956	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	37
22418026	1956	Oliveira S	Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.	Molecular imaging	2012	34
22448344	1956	Corcoran RB	EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.	Cancer discovery	2012	179
22588883	1956	Vivanco I	Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.	Cancer discovery	2012	73
22591372	1956	Gorges TM	Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.	BMC cancer	2012	110
22780919	1956	Morgan RA	Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.	Human gene therapy	2012	71
22834827	1956	Arora S	Honokiol: a novel natural agent for cancer prevention and therapy.	Current molecular medicine	2012	32
22888144	1956	Solca F	Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker.	The Journal of pharmacology and experimental therapeutics	2012	95
22891331	1956	Fenton TR	Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.	Proceedings of the National Academy of Sciences of the United States of America	2012	32
22956577	1956	Overdijk MB	Crosstalk between human IgG isotypes and murine effector cells.	Journal of immunology	2012	39
22961667	1956	Ercan D	Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.	Cancer discovery	2012	77
22964225	1956	Johnson H	Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.	Molecular and cellular proteomics 	2012	30
23070115	1956	Uchida H	Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.	Molecular therapy 	2013	26
23091115	1956	Byers LA	An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.	Clinical cancer research 	2013	176
23123196	1956	Yang W	EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.	Molecular cell	2012	55
23136247	1956	Gasch C	Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.	Clinical chemistry	2013	55
23172311	1956	Huang S	Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation.	Cancer research	2013	34
23242808	1956	Girotti MR	Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.	Cancer discovery	2013	99
23319610	1956	Ferraro DA	Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23333074	1956	Zaiss DM	Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.	Immunity	2013	49
23576557	1956	Keysar SB	Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer.	Cancer research	2013	26
23607916	1956	Keysar SB	A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins.	Molecular oncology	2013	32
23633480	1956	Chettouh H	Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.	Cancer research	2013	32
23653350	1956	Balanis N	Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.	The Journal of biological chemistry	2013	29
23707073	1956	Babic I	EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.	Cell metabolism	2013	30
23729478	1956	Bardelli A	Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.	Cancer discovery	2013	126
23964022	1956	Giachino C	Molecular diversity subdivides the adult forebrain neural stem cell population.	Stem cells	2014	24
24034250	1956	Wei Y	EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.	Cell	2013	104
24065731	1956	Walter AO	Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.	Cancer discovery	2013	122
24122793	1956	Troiani T	Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.	Clinical cancer research 	2013	36
24141978	1956	Zhang L	A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy.	Scientific reports	2013	28
24165158	1956	Rho JK	MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.	Cancer research	2014	29
24310612	1956	Nathanson DA	Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.	Science	2014	70
24335959	1956	Huang WC	miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.	Cancer research	2014	31
24390343	1956	Scafidi J	Intranasal epidermal growth factor treatment rescues neonatal brain injury.	Nature	2014	43
24425048	1956	Kim J	microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.	Cancer research	2014	25
24448239	1956	Luraghi P	MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.	Cancer research	2014	23
24553387	1956	Misale S	Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer.	Science translational medicine	2014	58
24644001	1956	Li L	Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.	Clinical cancer research 	2014	43
24651011	1956	Arteaga CL	ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.	Cancer cell	2014	116
24670642	1956	Sun C	Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.	Nature	2014	139
24677197	1956	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	60
24685132	1956	Sun C	Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.	Cell reports	2014	43
24747441	1956	Seguin L	An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.	Nature cell biology	2014	58
24919575	1956	Yoshida T	Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.	Clinical cancer research 	2014	20
24939055	1956	Qu Y	Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.	Journal of experimental and clinical cancer research 	2014	22
25009231	1956	Rebouissou S	EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.	Science translational medicine	2014	33
25115304	1956	Sorich MJ	Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials.	Annals of oncology 	2015	68
25136066	1956	Brand TM	AXL mediates resistance to cetuximab therapy.	Cancer research	2014	27
25193862	1956	Wilson C	Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.	Oncotarget	2014	28
25271963	1956	Finlay MR	Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor.	Journal of medicinal chemistry	2014	27
25409146	1956	Cheng CJ	MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.	Nature	2015	97
25444907	1956	Hao C	Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.	Cancer letters	2015	18
25583986	1956	Liu Z	A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.	The Journal of biological chemistry	2015	16
25629630	1956	Fillmore CM	EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.	Nature	2015	49
25726255	1956	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	20
25807485	1956	Obenauf AC	Therapy-induced tumour secretomes promote resistance and tumour progression.	Nature	2015	63
25870145	1956	Eberlein CA	Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models.	Cancer research	2015	30
25873175	1956	Elkabets M	AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.	Cancer cell	2015	35
25956936	1956	Rizzo S	CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.	European radiology	2016	12
26036643	1956	Tricker EM	Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer.	Cancer discovery	2015	28
26124204	1956	Della Corte CM	SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.	Clinical cancer research 	2015	18
26330164	1956	Caruso HG	Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.	Cancer research	2015	36
26392303	1956	Misale S	Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers.	Nature communications	2015	17
26637667	1956	Lastwika KJ	Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.	Cancer research	2016	31
26942675	1956	Li X	Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.	Molecular cell	2016	14
27688480	1956	Yip SS	Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.	Journal of nuclear medicine 	2017	7
2062846	2056	Semenza GL	Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.	Proceedings of the National Academy of Sciences of the United States of America	1991	144
8616713	2056	Tripathy SK	Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors.	Nature medicine	1996	117
12393428	2056	Weinstein DA	Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.	Blood	2002	104
12663857	2056	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	85
12975460	2056	Villa P	Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.	The Journal of experimental medicine	2003	103
14523037	2056	Parsa CJ	A novel protective effect of erythropoietin in the infarcted heart.	The Journal of clinical investigation	2003	88
15178821	2056	Wang L	Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.	Stroke	2004	196
15247477	2056	Leist M	Derivatives of erythropoietin that are tissue protective but not erythropoietic.	Science	2004	157
15284297	2056	Sharples EJ	Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.	Journal of the American Society of Nephrology 	2004	81
17576662	2056	Westenbrink BD	Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.	European heart journal	2007	56
18279854	2056	Theus MH	In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain.	Experimental neurology	2008	55
18458324	2056	Tong Z	Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.	Proceedings of the National Academy of Sciences of the United States of America	2008	53
18466917	2056	Robey TE	Systems approaches to preventing transplanted cell death in cardiac repair.	Journal of molecular and cellular cardiology	2008	106
21127173	2056	England SJ	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	Blood	2011	44
21898543	2056	Kim J	Erythropoietin mediated bone formation is regulated by mTOR signaling.	Journal of cellular biochemistry	2012	30
22023617	2056	Shang YC	Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia.	Current neurovascular research	2011	40
22449939	2056	Hruska M	Ephrin regulation of synapse formation, function and plasticity.	Molecular and cellular neurosciences	2012	44
23502961	2056	Ramos P	Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia.	Nature medicine	2013	54
25728669	2056	Moraga I	Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.	Cell	2015	23
1350088	2064	Carter P	Humanization of an anti-p185HER2 antibody for human cancer therapy.	Proceedings of the National Academy of Sciences of the United States of America	1992	276
3003577	2064	Yamamoto T	Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.	Nature	1986	184
7538656	2064	Alimandi M	Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.	Oncogene	1995	135
7657393	2064	Bellacosa A	Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.	International journal of cancer	1995	174
11694782	2064	Yarden Y	Biology of HER2 and its importance in breast cancer.	Oncology	2001	104
11751413	2064	Moulder SL	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.	Cancer research	2001	96
11907566	2064	Izumi Y	Tumour biology: herceptin acts as an anti-angiogenic cocktail.	Nature	2002	117
11948130	2064	Park JW	Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.	Clinical cancer research 	2002	101
12610629	2064	Cho HS	Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.	Nature	2003	322
12646923	2064	Vermeer PD	Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.	Nature	2003	121
14578209	2064	Lin EY	Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.	The American journal of pathology	2003	327
15150302	2064	Pegram MD	Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.	Journal of the National Cancer Institute	2004	74
15324695	2064	Nagata Y	PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.	Cancer cell	2004	432
15542430	2064	Li YM	Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.	Cancer cell	2004	144
16618759	2064	Orlova A	Tumor imaging using a picomolar affinity HER2 binding affibody molecule.	Cancer research	2006	90
16868082	2064	Kinoshita M	Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.	Proceedings of the National Academy of Sciences of the United States of America	2006	143
17440164	2064	Scaltriti M	Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer.	Journal of the National Cancer Institute	2007	170
17470737	2064	Arpino G	Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.	Journal of the National Cancer Institute	2007	58
17471238	2064	Moasser MM	The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.	Oncogene	2007	133
17493932	2064	Bourguignon LY	Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.	The Journal of biological chemistry	2007	55
17494760	2064	Mahajan NP	Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2007	91
17606733	2064	Marangoni E	A new model of patient tumor-derived breast cancer xenografts for preclinical assays.	Clinical cancer research 	2007	106
17761519	2064	Wang L	Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.	Blood	2007	106
18048329	2064	Gupta GP	ID genes mediate tumor reinitiation during breast cancer lung metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2007	89
18591932	2064	Korkaya H	HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.	Oncogene	2008	203
18829560	2064	Serra V	NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.	Cancer research	2008	251
18841463	2064	Tan AR	Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?	Breast cancer research and treatment	2009	48
19010894	2064	Eichhorn PJ	Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.	Cancer research	2008	140
19276287	2064	Magnifico A	Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab.	Clinical cancer research 	2009	78
19443585	2064	Dijkers EC	Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.	Journal of nuclear medicine 	2009	72
19509167	2064	Yao E	Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab.	Clinical cancer research 	2009	47
19617568	2064	Ponzo MG	Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	76
19735549	2064	Behbod F	An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ.	Breast cancer research 	2009	60
19766563	2064	Cicalese A	The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.	Cell	2009	231
20371474	2064	Amin DN	Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.	Science translational medicine	2010	63
20404194	2064	John R	In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes.	Proceedings of the National Academy of Sciences of the United States of America	2010	42
20453058	2064	O'Brien C	Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.	Clinical cancer research 	2010	82
20535745	2064	Toullec A	Oxidative stress promotes myofibroblast differentiation and tumour spreading.	EMBO molecular medicine	2010	65
20622894	2064	Meng L	Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis.	Oncogene	2010	40
20711231	2064	Arias-Romero LE	A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.	Oncogene	2010	52
20730488	2064	Junttila TT	Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer.	Breast cancer research and treatment	2011	61
20805300	2064	Junutula JR	Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.	Clinical cancer research 	2010	45
20876285	2064	Cittelly DM	Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.	Carcinogenesis	2010	50
21385943	2064	Garrett JT	Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase.	Proceedings of the National Academy of Sciences of the United States of America	2011	152
21498634	2064	Zhao Y	Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.	Cancer research	2011	43
21518778	2064	Hartman ZC	HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis.	Cancer research	2011	39
21847123	2064	Pandya K	Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.	British journal of cancer	2011	45
21884641	2064	Holliday DL	Choosing the right cell line for breast cancer research.	Breast cancer research 	2011	189
22123186	2064	Wang YC	Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.	Breast cancer research 	2011	52
22248472	2064	McDonagh CF	Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.	Molecular cancer therapeutics	2012	70
22294718	2064	Davies BR	Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.	Molecular cancer therapeutics	2012	62
22388088	2064	Aceto N	Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.	Nature medicine	2012	65
22407832	2064	García-García C	Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy.	Clinical cancer research 	2012	49
22467215	2064	Thiel KW	Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.	Nucleic acids research	2012	59
22517885	2064	Yao YD	Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.	Science translational medicine	2012	34
22586653	2064	Bertotti A	A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.	Cancer discovery	2011	125
22956644	2064	Takezawa K	HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.	Cancer discovery	2012	134
22988081	2064	Axup JY	Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.	Proceedings of the National Academy of Sciences of the United States of America	2012	81
23000189	2064	Park EJ	Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.	Journal of controlled release 	2012	37
23204226	2064	Chakrabarty A	Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors.	Cancer research	2013	31
23220880	2064	Bose R	Activating HER2 mutations in HER2 gene amplification negative breast cancer.	Cancer discovery	2013	135
23302230	2064	Alkins R	Focused ultrasound delivers targeted immune cells to metastatic brain tumors.	Cancer research	2013	32
23442322	2064	Ithimakin S	HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.	Cancer research	2013	55
23737486	2064	Zhang X	A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.	Cancer research	2013	71
23740771	2064	Korkaya H	HER2 and breast cancer stem cells: more than meets the eye.	Cancer research	2013	32
23965851	2064	Cufí S	The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer.	Scientific reports	2013	27
24056965	2064	Nair R	c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.	Oncogene	2014	32
24130112	2064	Walsh AJ	Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.	Cancer research	2013	43
24162158	2064	Prat A	Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.	Breast cancer research and treatment	2013	48
24220145	2064	Pfefferle AD	Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.	Genome biology	2013	41
24297508	2064	Chung SS	STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.	International journal of oncology	2014	30
24518603	2064	Liu YJ	HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.	British journal of cancer	2014	28
24523301	2064	Gross MI	Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.	Molecular cancer therapeutics	2014	85
24569463	2064	Yoshida T	Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.	British journal of cancer	2014	36
24721646	2064	Chittaranjan S	Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.	Clinical cancer research 	2014	22
24967516	2064	Lambert JM	Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer.	Journal of medicinal chemistry	2014	25
26559813	2064	Suck G	NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.	Cancer immunology, immunotherapy 	2016	15
10650002	2081	Urano F	Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.	Science	2000	680
11779464	2081	Yoshida H	XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.	Cell	2001	926
11850408	2081	Lee K	IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response.	Genes and development	2002	276
12050113	2081	Nishitoh H	ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.	Genes and development	2002	312
17991856	2081	Lin JH	IRE1 signaling affects cell fate during the unfolded protein response.	Science	2007	453
20702765	2081	Auf G	Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
20798350	2081	Li H	Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
21081713	2081	Papandreou I	Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.	Blood	2011	110
21303903	2081	Volkmann K	Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease.	The Journal of biological chemistry	2011	49
21691147	2081	Shi YH	Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis.	Autophagy	2011	72
23699409	2081	Young RM	Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.	Genes and development	2013	46
26210990	2081	Scheper W	The unfolded protein response in neurodegenerative diseases: a neuropathological perspective.	Acta neuropathologica	2015	28
9048584	2099	Kuiper GG	Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.	Endocrinology	1997	564
9662379	2099	Kononen J	Tissue microarrays for high-throughput molecular profiling of tumor specimens.	Nature medicine	1998	753
9751507	2099	Kuiper GG	Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.	Endocrinology	1998	566
9875847	2099	Shiau AK	The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.	Cell	1998	433
10536138	2099	Indra AK	Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.	Nucleic acids research	1999	198
11719442	2099	Hayward SW	Malignant transformation in a nontumorigenic human prostatic epithelial cell line.	Cancer research	2001	99
11773442	2099	Razandi M	ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions.	Molecular endocrinology	2002	91
11929836	2099	Stabile LP	Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.	Cancer research	2002	101
15001666	2099	Bourdeau V	Genome-wide identification of high-affinity estrogen response elements in human and mouse.	Molecular endocrinology	2004	97
15223047	2099	Dontu G	Breast cancer, stem/progenitor cells and the estrogen receptor.	Trends in endocrinology and metabolism	2004	90
15345050	2099	Lin CY	Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.	Genome biology	2004	102
16009131	2099	Carroll JS	Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.	Cell	2005	509
16467147	2099	Kriegsfeld LJ	Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals.	Proceedings of the National Academy of Sciences of the United States of America	2006	107
16515478	2099	Ariazi EA	Estrogen receptors as therapeutic targets in breast cancer.	Current topics in medicinal chemistry	2006	61
17169390	2099	Jordan VC	Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.	Steroids	2007	77
17640948	2099	Straub RH	The complex role of estrogens in inflammation.	Endocrine reviews	2007	243
18219273	2099	Krum SA	Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.	The EMBO journal	2008	77
18593897	2099	Kondo N	miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.	Cancer research	2008	97
18593923	2099	Rizzo P	Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.	Cancer research	2008	103
19116762	2099	Toh Y	The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.	Clinical and experimental metastasis	2009	63
21123450	2099	Rhodes LV	Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.	Cancer research	2011	55
21844907	2099	Prossnitz ER	The G-protein-coupled estrogen receptor GPER in health and disease.	Nature reviews. Endocrinology	2011	129
22049316	2099	Miller TW	ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.	Cancer discovery	2011	64
22438791	2099	Anbalagan M	Post-translational modifications of nuclear receptors and human disease.	Nuclear receptor signaling	2012	46
22503553	2099	Klinge CM	miRNAs and estrogen action.	Trends in endocrinology and metabolism	2012	44
22949852	2099	Singh S	Epigenetic effects of environmental chemicals bisphenol A and phthalates.	International journal of molecular sciences	2012	43
23845444	2099	Vaillant F	Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer.	Cancer cell	2013	62
24055055	2099	Li S	Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.	Cell reports	2013	117
24076218	2099	Gertz J	Distinct properties of cell-type-specific and shared transcription factor binding sites.	Molecular cell	2013	36
24210818	2099	Wu Q	27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.	Cell reports	2013	48
24451109	2099	Cochrane DR	Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.	Breast cancer research 	2014	46
24469049	2099	Cyr AR	TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.	Oncogene	2015	18
24874954	2099	Feng Q	An epigenomic approach to therapy for tamoxifen-resistant breast cancer.	Cell research	2014	38
25013076	2099	Yu M	Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.	Science	2014	133
25168343	2099	Santen RJ	Estrogen metabolites and breast cancer.	Steroids	2015	23
25877889	2099	Bosch A	PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer.	Science translational medicine	2015	28
25879485	2099	Lai A	Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.	Journal of medicinal chemistry	2015	24
26947176	2099	Sflomos G	A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.	Cancer cell	2016	14
14532106	2146	Bracken AP	EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.	The EMBO journal	2003	331
19079346	2146	Gonzalez ME	Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.	Oncogene	2009	70
19351856	2146	Hussain M	Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.	Cancer research	2009	54
20946108	2146	Orzan F	Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.	Neuropathology and applied neurobiology	2011	38
20952513	2146	Zhang B	Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.	Carcinogenesis	2011	63
21172659	2146	Zhao J	Genome-wide identification of polycomb-associated RNAs by RIP-seq.	Molecular cell	2010	310
21216927	2146	Rizzo S	Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.	Molecular cancer therapeutics	2011	61
21321380	2146	Smits M	miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.	Oncotarget	2010	76
21659531	2146	Wu SC	Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability.	The Journal of biological chemistry	2011	44
21672940	2146	Zheng F	The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.	Gut	2012	106
21685935	2146	Tong ZT	EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.	Oncogene	2012	54
22086681	2146	Bao B	Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.	Cancer prevention research	2012	91
22108826	2146	Bao B	Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.	Cancer research	2012	87
22237151	2146	Ntziachristos P	Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.	Nature medicine	2012	127
22370893	2146	Au SL	Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.	Hepatology	2012	62
22659877	2146	Guil S	Intronic RNAs mediate EZH2 regulation of epigenetic targets.	Nature structural and molecular biology	2012	59
23354591	2146	Luo M	Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.	Cancer letters	2013	117
23764001	2146	Tiwari N	Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.	Cancer cell	2013	82
24123378	2146	Hemming S	EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.	Stem cells	2014	40
24211739	2146	Xu L	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.	Journal of hepatology	2014	30
24516139	2146	Gonzalez ME	EZH2 expands breast stem cells through activation of NOTCH1 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2014	37
24612432	2146	Liu L	Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.	BJU international	2016	17
24882207	2146	Cifuentes-Rojas C	Regulatory interactions between RNA and polycomb repressive complex 2.	Molecular cell	2014	64
25457180	2146	Bradley WD	EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.	Chemistry and biology	2014	31
25601206	2146	Kim SH	EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.	Stem cell reports	2015	26
25653233	2146	Toden S	Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.	Carcinogenesis	2015	17
25693145	2146	Zheng F	Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets.	PLoS genetics	2015	19
25965569	2146	Kim E	SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.	Cancer cell	2015	49
26005520	2146	Campbell JE	EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity.	ACS medicinal chemistry letters	2015	17
26424790	2146	Dudakovic A	Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.	The Journal of biological chemistry	2015	16
26501191	2146	Huang L	Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.	Nature medicine	2015	19
26516927	2146	Wang D	LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.	Oncotarget	2015	18
26523864	2146	Zhao E	Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.	Nature immunology	2016	29
26552009	2146	Kim KH	SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.	Nature medicine	2015	30
26766588	2146	Serresi M	Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.	Cancer cell	2016	15
26908628	2146	Wan L	Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.	Molecular cancer therapeutics	2016	19
19620983	2187	Labrijn AF	Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.	Nature biotechnology	2009	49
21690412	2187	Schaefer W	Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies.	Proceedings of the National Academy of Sciences of the United States of America	2011	71
21737702	2187	Ekiert DC	A highly conserved neutralizing epitope on group 2 influenza A viruses.	Science	2011	234
22286059	2187	Hino T	G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.	Nature	2012	58
22474370	2187	Smith P	Mouse model recapitulating human Fcγ receptor structural and functional diversity.	Proceedings of the National Academy of Sciences of the United States of America	2012	54
22723463	2187	Teoh EP	The structural basis for serotype-specific neutralization of dengue virus by a human antibody.	Science translational medicine	2012	69
24421336	2187	Fibriansah G	A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.	EMBO molecular medicine	2014	37
25275316	2187	de Alwis R	Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.	PLoS pathogens	2014	23
25698059	2187	Fibriansah G	A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.	Nature communications	2015	43
26759369	2187	Rodgers DT	Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.	Proceedings of the National Academy of Sciences of the United States of America	2016	18
8626565	2247	Whitelock JM	The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.	The Journal of biological chemistry	1996	119
9214605	2247	Bello D	Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.	Carcinogenesis	1997	126
9626049	2247	Nissen NN	Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.	The American journal of pathology	1998	116
10493749	2247	Palmer TD	Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS.	The Journal of neuroscience 	1999	146
11731781	2247	Zhang SC	In vitro differentiation of transplantable neural precursors from human embryonic stem cells.	Nature biotechnology	2001	367
15749926	2247	Xu C	Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.	Stem cells	2005	75
16179608	2247	Vallier L	Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.	Journal of cell science	2005	231
16282444	2247	Levenstein ME	Basic fibroblast growth factor support of human embryonic stem cell self-renewal.	Stem cells	2006	111
16540670	2247	Xie TX	Activation of stat3 in human melanoma promotes brain metastasis.	Cancer research	2006	103
16697959	2247	Lee J	Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.	Cancer cell	2006	670
17426693	2247	Jiang W	In vitro derivation of functional insulin-producing cells from human embryonic stem cells.	Cell research	2007	86
18232728	2247	Pietras K	Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.	PLoS medicine	2008	105
18329368	2247	Keller M	Active caspase-1 is a regulator of unconventional protein secretion.	Cell	2008	245
19026649	2247	Basma H	Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.	Gastroenterology	2009	139
19197140	2247	Izikki M	Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.	The Journal of clinical investigation	2009	49
19232461	2247	Qiang L	Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.	Cancer letters	2009	55
19439615	2247	Perez JA	A new role for FGF2 as an endogenous inhibitor of anxiety.	The Journal of neuroscience 	2009	48
19614919	2247	Lee EY	Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF.	Wound repair and regeneration 	2009	87
20186512	2247	International Stem Cell Initiative Consortium.	Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.	In vitro cellular and developmental biology. Animal	2010	46
20569691	2247	Buecker C	A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells.	Cell stem cell	2010	75
20616342	2247	Johansson A	Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.	The American journal of pathology	2010	43
20643952	2247	Evseenko D	Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	65
21262528	2247	Bhang SH	Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells.	Biomaterials	2011	51
21390254	2247	Yu J	Efficient feeder-free episomal reprogramming with small molecules.	PloS one	2011	55
21494607	2247	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	120
21712446	2247	Sharpe R	FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.	Clinical cancer research 	2011	38
22134360	2247	Xie G	IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.	International journal of oncology	2012	33
23060229	2247	Ellman MB	Fibroblast growth factor control of cartilage homeostasis.	Journal of cellular biochemistry	2013	28
24209627	2247	Xu C	A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.	Cell	2013	39
24481949	2247	Ricard N	Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.	Circulation	2014	23
24839982	2247	Raimondi L	Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.	Oncotarget	2014	23
24960162	2247	Bertero T	Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.	The Journal of clinical investigation	2014	43
25968054	2247	Chen H	Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.	Nature communications	2015	22
10868964	2305	Hohmeier HE	Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.	Diabetes	2000	284
12183437	2305	Teh MT	FOXM1 is a downstream target of Gli1 in basal cell carcinomas.	Cancer research	2002	106
16585184	2305	Liu M	FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.	Cancer research	2006	116
17149590	2305	Wang H	MAFA controls genes implicated in insulin biosynthesis and secretion.	Diabetologia	2007	58
17404569	2305	Dai B	Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.	Oncogene	2007	64
18020943	2305	Wierstra I	FOXM1, a typical proliferation-associated transcription factor.	Biological chemistry	2007	81
18974115	2305	Zhang Y	FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.	Cancer research	2008	73
19351851	2305	Li Q	Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.	Cancer research	2009	72
19696738	2305	Park HJ	FoxM1, a critical regulator of oxidative stress during oncogenesis.	The EMBO journal	2009	71
21204266	2305	Park HJ	Deregulation of FoxM1b leads to tumour metastasis.	EMBO molecular medicine	2011	42
21518729	2305	Millour J	ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.	Molecular cancer therapeutics	2011	38
21888875	2305	Liu S	MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.	Journal of hepatology	2012	49
22194465	2305	Huang C	A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.	Cancer research	2012	50
22613004	2305	Xia L	Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.	Journal of hepatology	2012	34
22617326	2305	Szabova L	Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.	Cancer research	2012	34
23109430	2305	Chen X	The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism.	Molecular and cellular biology	2013	47
23297075	2305	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	29
23598278	2305	Kong X	Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.	Cancer research	2013	31
24141789	2305	Khongkow P	FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.	Oncogene	2014	22
24382352	2305	Xue J	Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.	The Journal of clinical investigation	2014	44
24634381	2305	Cui J	FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.	Clinical cancer research 	2014	24
25686834	2305	Xu X	miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.	Oncotarget	2015	20
26877780	2305	Zhang Z	BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.	Theranostics	2016	10
7680480	2335	Yamamoto T	Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.	Proceedings of the National Academy of Sciences of the United States of America	1993	133
8127021	2335	Ryan MJ	HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney.	Kidney international	1994	155
8446901	2335	Xing Y	Higher level organization of individual gene transcription and RNA splicing.	Science	1993	127
9520466	2335	Azizi SA	Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts.	Proceedings of the National Academy of Sciences of the United States of America	1998	136
10751360	2335	Kim S	Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.	The American journal of pathology	2000	135
11553710	2335	Arthur WT	RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity.	Molecular biology of the cell	2001	149
12451003	2335	Tepper OM	Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.	Circulation	2002	300
12815434	2335	Sakai T	Fibronectin requirement in branching morphogenesis.	Nature	2003	150
14627547	2335	Amit M	Feeder layer- and serum-free culture of human embryonic stem cells.	Biology of reproduction	2004	92
16436674	2335	McDaniel SM	Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.	The American journal of pathology	2006	65
17251138	2335	Metcalfe AD	Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.	Journal of the Royal Society, Interface	2007	62
18424525	2335	Valle J	UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli.	Journal of bacteriology	2008	54
18599809	2335	Braam SR	Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin.	Stem cells	2008	98
19027948	2335	Martino MM	Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability.	Biomaterials	2009	69
19079190	2335	Blanchard C	Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses.	Mucosal immunology	2008	68
20129247	2335	Mehrotra S	IAP regulation of metastasis.	Cancer cell	2010	107
20133714	2335	Sugii S	Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	48
20507231	2335	Hollands A	Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.	The Journal of infectious diseases	2010	44
20516121	2335	Nam JM	Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.	Cancer research	2010	43
21368175	2335	Antonyak MA	Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	105
22153870	2335	Cheng NC	The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities.	Biomaterials	2012	36
22169009	2335	Sanchez-Niño MD	Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.	American journal of physiology. Renal physiology	2012	37
22293174	2335	Salmon H	Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.	The Journal of clinical investigation	2012	37
23047680	2335	Reticker-Flynn NE	A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis.	Nature communications	2012	47
23487783	2335	Martino MM	Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.	Proceedings of the National Academy of Sciences of the United States of America	2013	55
26811325	2335	Oudin MJ	Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.	Cancer discovery	2016	13
2414012	2353	Treisman R	Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.	Cell	1985	264
8425553	2353	Wasylyk B	The Ets family of transcription factors.	European journal of biochemistry	1993	180
8770536	2353	Hayes JD	The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.	Critical reviews in biochemistry and molecular biology	1995	463
11017702	2353	Schmittgen TD	Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods.	Analytical biochemistry	2000	242
11283317	2353	Willie JT	To eat or to sleep? Orexin in the regulation of feeding and wakefulness.	Annual review of neuroscience	2001	116
15820702	2353	Roth TL	Memory of early maltreatment: neonatal behavioral and neural correlates of maternal maltreatment within the context of classical conditioning.	Biological psychiatry	2005	80
17406653	2353	Mahler SV	Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward.	Neuropsychopharmacology 	2007	93
19940184	2353	Tom VJ	Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord.	The Journal of neuroscience 	2009	46
20962767	2353	Nair SG	Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine.	Neuropsychopharmacology 	2011	39
21385848	2353	Dunand-Sauthier I	Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function.	Blood	2011	37
22649253	2353	Raineki C	Effects of early-life abuse differ across development: infant social behavior deficits are followed by adolescent depressive-like behaviors mediated by the amygdala.	The Journal of neuroscience 	2012	53
24343528	2353	Rey CD	Dopamine D1 receptor activation rescues extinction impairments in low-estrogen female rats and induces cortical layer-specific activation changes in prefrontal-amygdala circuits.	Neuropsychopharmacology 	2014	24
25071168	2353	Debiec J	Intergenerational transmission of emotional trauma through amygdala-dependent mother-to-infant transfer of specific fear.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
25449699	2353	Schmidt K	Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.	Psychopharmacology	2015	23
25762666	2353	Slaker M	Removal of perineuronal nets in the medial prefrontal cortex impairs the acquisition and reconsolidation of a cocaine-induced conditioned place preference memory.	The Journal of neuroscience 	2015	19
7539137	2475	Chen J	Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.	Proceedings of the National Academy of Sciences of the United States of America	1995	142
7822316	2475	Sabers CJ	Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.	The Journal of biological chemistry	1995	171
12101249	2475	Peng T	The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.	Molecular and cellular biology	2002	111
14623952	2475	Cammalleri M	Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.	Proceedings of the National Academy of Sciences of the United States of America	2003	77
15467718	2475	Jacinto E	Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.	Nature cell biology	2004	597
15525761	2475	Takei N	Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites.	The Journal of neuroscience 	2004	111
15604215	2475	Khamzina L	Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.	Endocrinology	2005	141
15772076	2475	Smith EM	The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.	The Journal of biological chemistry	2005	131
15958750	2475	Tsokas P	Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation.	The Journal of neuroscience 	2005	79
16339024	2475	Kumar V	Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.	The Journal of neuroscience 	2005	158
16341243	2475	Thomas GV	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	Nature medicine	2006	163
16354680	2475	Tzatsos A	Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.	Molecular and cellular biology	2006	123
16497721	2475	Ravikumar B	Rapamycin pre-treatment protects against apoptosis.	Human molecular genetics	2006	105
16715128	2475	Liu L	Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.	Oncogene	2006	73
16769083	2475	Khan S	Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.	Journal of molecular and cellular cardiology	2006	64
17023663	2475	Raab-Graham KF	Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.	Science	2006	95
17072337	2475	Vaira V	Regulation of survivin expression by IGF-1/mTOR signaling.	Oncogene	2007	56
17167087	2475	Parsons RG	Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons.	The Journal of neuroscience 	2006	81
17182613	2475	Sarkar S	Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.	The Journal of biological chemistry	2007	245
17277121	2475	Zheng Y	A role for mammalian target of rapamycin in regulating T cell activation versus anergy.	Journal of immunology	2007	82
17277771	2475	Vander Haar E	Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.	Nature cell biology	2007	353
17287212	2475	Gleason CE	The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.	The Journal of biological chemistry	2007	56
17360704	2475	Roux PP	RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.	The Journal of biological chemistry	2007	202
17595159	2475	Chan EY	siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy.	The Journal of biological chemistry	2007	134
17693255	2475	Lee DF	IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.	Cell	2007	182
17911267	2475	Zhou J	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.	Proceedings of the National Academy of Sciences of the United States of America	2007	188
17921520	2475	Sarkar S	A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.	Human molecular genetics	2008	87
17928295	2475	Li Y	Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb.	The Journal of biological chemistry	2007	64
18006825	2475	Dowling RJ	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	Cancer research	2007	250
18332467	2475	Tanaka C	Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data.	Journal of clinical oncology 	2008	54
18372248	2475	Wang L	Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.	The Journal of biological chemistry	2008	70
18393362	2475	Yin XM	Autophagy in the liver.	Hepatology	2008	69
18398477	2475	Jiménez-Díaz L	Local translation in primary afferent fibers regulates nociception.	PloS one	2008	65
18596100	2475	Wang FZ	Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication.	Journal of virology	2008	63
18614546	2475	Rosner M	Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.	Human molecular genetics	2008	71
18650261	2475	Buller CL	A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.	American journal of physiology. Cell physiology	2008	58
18722121	2475	Carrière A	Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.	Current biology 	2008	116
18725988	2475	Carracedo A	Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.	The Journal of clinical investigation	2008	478
18758466	2475	Cao W	Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.	Nature immunology	2008	121
18787170	2475	Mao JH	FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.	Science	2008	130
18848473	2475	Weichhart T	The TSC-mTOR signaling pathway regulates the innate inflammatory response.	Immunity	2008	184
18925875	2475	García-Martínez JM	mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).	The Biochemical journal	2008	291
19209957	2475	Feldman ME	Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.	PLoS biology	2009	400
19211835	2475	Hosokawa N	Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy.	Molecular biology of the cell	2009	457
19223493	2475	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	47
19225151	2475	Jung CH	ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery.	Molecular biology of the cell	2009	488
19234517	2475	Hartman TR	The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.	Oncogene	2009	59
19258318	2475	Ganley IG	ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy.	The Journal of biological chemistry	2009	325
19346248	2475	Wang L	Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR.	The Journal of biological chemistry	2009	47
19356713	2475	Newgard CB	A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.	Cell metabolism	2009	534
19357233	2475	Trendelenburg AU	Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.	American journal of physiology. Cell physiology	2009	156
19439614	2475	Tyler WA	Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.	The Journal of neuroscience 	2009	76
19470781	2475	O'Neil TK	The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions.	The Journal of physiology	2009	54
19501590	2475	Mueller MT	Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.	Gastroenterology	2009	80
19547753	2475	Slipczuk L	BDNF activates mTOR to regulate GluR1 expression required for memory formation.	PloS one	2009	70
19553465	2475	Buckmaster PS	Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy.	The Journal of neuroscience 	2009	82
19553991	2475	Scott KL	GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.	Nature	2009	96
19771169	2475	Balgi AD	Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.	PloS one	2009	108
19788500	2475	Säemann MD	The multifunctional role of mTOR in innate immunity: implications for transplant immunity.	American journal of transplantation 	2009	48
19817806	2475	Wong M	Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.	Epilepsia	2010	59
19935711	2475	Treins C	Rictor is a novel target of p70 S6 kinase-1.	Oncogene	2010	54
19940197	2475	Géranton SM	A rapamycin-sensitive signaling pathway is essential for the full expression of persistent pain states.	The Journal of neuroscience 	2009	59
19963289	2475	Hoeffer CA	mTOR signaling: at the crossroads of plasticity, memory and disease.	Trends in neurosciences	2010	270
20008564	2475	Risson V	Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.	The Journal of cell biology	2009	106
20022946	2475	Soliman GA	mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.	The Journal of biological chemistry	2010	79
20038818	2475	Tsang CK	mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes.	Cell cycle	2010	42
20068094	2475	Manara MC	NVP-BEZ235 as a new therapeutic option for sarcomas.	Clinical cancer research 	2010	50
20082935	2475	Buss SJ	Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.	Journal of the American College of Cardiology	2009	50
20114074	2475	Grotemeier A	AMPK-independent induction of autophagy by cytosolic Ca2+ increase.	Cellular signalling	2010	42
20139716	2475	Blagosklonny MV	Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans).	Cell cycle	2010	81
20196784	2475	Harhaji-Trajkovic L	AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells.	Journal of cellular and molecular medicine	2009	56
20335217	2475	Turnquist HR	mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.	Blood	2010	45
20484036	2475	Doghman M	Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.	Cancer research	2010	64
20566381	2475	Huang X	Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.	Neurobiology of disease	2010	71
20606252	2475	Korotchkina LG	The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.	Aging	2010	160
20615870	2475	Abe N	Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves.	The Journal of biological chemistry	2010	46
20668229	2475	Green AS	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.	Blood	2010	45
20670887	2475	Düvel K	Activation of a metabolic gene regulatory network downstream of mTOR complex 1.	Molecular cell	2010	385
20682696	2475	Saha AK	Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle.	Diabetes	2010	61
20724638	2475	Li N	mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.	Science	2010	485
20810672	2475	Memmott RM	Metformin prevents tobacco carcinogen--induced lung tumorigenesis.	Cancer prevention research	2010	129
20857497	2475	Sunayama J	Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.	Stem cells	2010	56
20860370	2475	Liu Q	Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzoh1,6naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer.	Journal of medicinal chemistry	2010	63
20977912	2475	Shinmura K	Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging.	Journal of molecular and cellular cardiology	2011	46
21115526	2475	McCormick MA	TOR and ageing: a complex pathway for a complex process.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2011	36
21145759	2475	Procaccini C	An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.	Immunity	2010	92
21228155	2475	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	39
21258367	2475	Kim J	AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1.	Nature cell biology	2011	965
21269838	2475	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	107
21284988	2475	Kim S	Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase.	Cell metabolism	2011	43
21292242	2475	Li N	Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.	Biological psychiatry	2011	210
21307269	2475	Buckmaster PS	Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy.	The Journal of neuroscience 	2011	82
21317208	2475	Prasad G	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro-oncology	2011	44
21331075	2475	Evangelisti C	Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.	Leukemia	2011	35
21363918	2475	Falcon BL	Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.	Cancer research	2011	37
21372221	2475	Santiskulvong C	Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.	Clinical cancer research 	2011	42
21460621	2475	Egan D	The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR.	Autophagy	2011	86
21512002	2475	Narita M	Spatial coupling of mTOR and autophagy augments secretory phenotypes.	Science	2011	115
21606591	2475	Gödel M	Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.	The Journal of clinical investigation	2011	124
21613612	2475	Pirkmajer S	Serum starvation: caveat emptor.	American journal of physiology. Cell physiology	2011	36
21659604	2475	Hsu PP	The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.	Science	2011	325
21659605	2475	Yu Y	Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.	Science	2011	251
21676631	2475	Liu J	Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.	Urologic oncology	2013	25
21678117	2475	Mirzoeva OK	Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma.	Journal of molecular medicine	2011	35
21840335	2475	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	138
21890410	2475	Crino PB	mTOR: A pathogenic signaling pathway in developmental brain malformations.	Trends in molecular medicine	2011	51
21975930	2475	Patel V	Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.	Cancer research	2011	49
21998291	2475	Wallin JJ	GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.	Molecular cancer therapeutics	2011	64
22014210	2475	Deblon N	Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.	British journal of pharmacology	2012	44
22268788	2475	Hoeffer CA	Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.	Genes, brain, and behavior	2012	46
22287548	2475	Chen W	Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.	Cancer research	2012	31
22340590	2475	Pei Y	An animal model of MYC-driven medulloblastoma.	Cancer cell	2012	81
22349822	2475	Wen ZH	Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.	Oncogene	2013	25
22356678	2475	Zhang Q	Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway.	Stem cells and development	2012	34
22367541	2475	Hsieh AC	The translational landscape of mTOR signalling steers cancer initiation and metastasis.	Nature	2012	296
22378068	2475	Shi WY	Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.	Cell death and disease	2012	50
22408252	2475	Tan SH	Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin).	The Journal of biological chemistry	2012	41
22409888	2475	Molinolo AA	mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.	Clinical cancer research 	2012	36
22439642	2475	Vinci M	Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.	BMC biology	2012	120
22500211	2475	Song CW	Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells.	Scientific reports	2012	62
22562464	2475	Luo Z	The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.	Cancer research	2012	60
22612226	2475	van Vliet EA	Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.	Epilepsia	2012	33
22672902	2475	Pospelova TV	Suppression of replicative senescence by rapamycin in rodent embryonic cells.	Cell cycle	2012	40
22848625	2475	Bray K	Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition.	PloS one	2012	43
22958932	2475	Iglesias-Bartolome R	mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.	Cell stem cell	2012	75
22980985	2475	Lu P	Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.	Cell	2012	127
23012248	2475	Acquaviva J	Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespib.	Molecular cancer therapeutics	2012	32
23142822	2475	Huang J	Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways.	Nature medicine	2012	44
23238015	2475	Britschgi A	JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer.	Cancer cell	2012	60
23246963	2475	Montero JC	Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer.	Oncogene	2014	26
23454761	2475	Lamming DW	Rapalogs and mTOR inhibitors as anti-aging therapeutics.	The Journal of clinical investigation	2013	104
23549875	2475	Coffee EM	Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.	Clinical cancer research 	2013	28
23680942	2475	Liu RJ	GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.	Neuropsychopharmacology 	2013	44
23686371	2475	Sen S	Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.	Journal of the American Heart Association	2013	31
23832089	2475	Pajvani UB	Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.	Nature medicine	2013	32
23872332	2475	Theodoropoulou M	Somatostatin receptors: from signaling to clinical practice.	Frontiers in neuroendocrinology	2013	31
23911927	2475	Linares JF	K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells.	Molecular cell	2013	41
23929677	2475	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	36
24055102	2475	Lee JH	Sestrins orchestrate cellular metabolism to attenuate aging.	Cell metabolism	2013	53
24100461	2475	Perl A	Oxidative stress in the pathology and treatment of systemic lupus erythematosus.	Nature reviews. Rheumatology	2013	41
24185040	2475	Francipane MG	Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.	Oncotarget	2013	28
24231729	2475	Matsubara S	mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.	Scientific reports	2013	27
24270265	2475	Goncharov DA	Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.	Circulation	2014	32
24382350	2475	Xu JT	Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia.	The Journal of clinical investigation	2014	27
24390152	2475	Freret T	Mechanisms underlying the neuroprotective effect of brain reserve against late life depression.	Journal of neural transmission	2015	22
24430184	2475	Li H	Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.	The Journal of clinical investigation	2014	21
24474794	2475	Liu X	Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.	Proceedings of the National Academy of Sciences of the United States of America	2014	56
24534190	2475	Gomez-Rodriguez J	Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.	The Journal of experimental medicine	2014	37
24534455	2475	Martinet W	mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.	Atherosclerosis	2014	22
24553191	2475	Li X	LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway.	Oncotarget	2014	21
24569374	2475	Ma XH	Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma.	The Journal of clinical investigation	2014	77
24651621	2475	Zhang Y	Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.	Annals of the rheumatic diseases	2015	36
24662833	2475	Nguyen HG	Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.	Oncogene	2014	26
24899720	2475	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	30
24973821	2475	Marçais A	The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.	Nature immunology	2014	52
25203323	2475	Wang Y	The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.	Cancer cell	2014	28
25432176	2475	Kolev VN	PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.	Cancer research	2015	33
25450580	2475	Xu K	mTOR signaling in tumorigenesis.	Biochimica et biophysica acta	2014	28
25500094	2475	Ritprajak P	Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.	Oral oncology	2015	35
25540326	2475	Mannick JB	mTOR inhibition improves immune function in the elderly.	Science translational medicine	2014	66
25591831	2475	Curatolo P	Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.	Pediatric neurology	2015	15
25714620	2475	Guo S	A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications.	Autophagy	2015	17
25749036	2475	Yang H	FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.	Oncotarget	2015	17
25813405	2475	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	33
25867026	2475	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	18
25902704	2475	Longo VD	Interventions to Slow Aging in Humans: Are We Ready?	Aging cell	2015	58
25913192	2475	Venkatesh HS	Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.	Cell	2015	38
26004684	2475	Han B	Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.	Cancer cell	2015	20
26293922	2475	Liu P	PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.	Cancer discovery	2015	30
26310906	2475	Wong PM	Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A.	Nature communications	2015	23
26463117	2475	Arriola Apelo SI	Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.	Aging cell	2016	12
26627594	2475	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	13
27074515	2475	Feeney KA	Daily magnesium fluxes regulate cellular timekeeping and energy balance.	Nature	2016	14
27134180	2475	Jiménez-Valerio G	Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients.	Cell reports	2016	15
27279227	2475	Rodrik-Outmezguine VS	Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.	Nature	2016	19
9425002	2670	Wolswijk G	Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells.	The Journal of neuroscience 	1998	105
11138011	2670	Brenner M	Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.	Nature genetics	2001	112
11668683	2670	Zhuo L	hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.	Genesis	2001	208
15280535	2670	Kelly S	Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex.	Proceedings of the National Academy of Sciences of the United States of America	2004	155
15367883	2670	Apte MV	Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.	Pancreas	2004	119
15495269	2670	Pekny M	Astrocyte intermediate filaments in CNS pathologies and regeneration.	The Journal of pathology	2004	77
18240313	2670	Lee Y	GFAP promoter elements required for region-specific and astrocyte-specific expression.	Glia	2008	62
19279265	2670	Oberheim NA	Uniquely hominid features of adult human astrocytes.	The Journal of neuroscience 	2009	183
19638961	2670	Lawlor PA	Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.	Molecular therapy 	2009	53
20140958	2670	Olabarria M	Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease.	Glia	2010	53
21865643	2670	Joseph NM	Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut.	The Journal of clinical investigation	2011	54
21930157	2670	Kane MJ	A mouse model of human repetitive mild traumatic brain injury.	Journal of neuroscience methods	2012	42
23431204	2670	Ponti G	Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	47
23769173	2670	Yuan T	Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.	Stem cell research and therapy	2013	25
24419315	2670	Williams EC	Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons.	Human molecular genetics	2014	38
24667434	2670	Zhang Z	Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.	PloS one	2014	24
25034944	2670	Chen C	Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells.	Nature communications	2014	35
12742992	2697	Mummery C	Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.	Circulation	2003	243
15070671	2697	Bhattacharya B	Gene expression in human embryonic stem cell lines: unique molecular signature.	Blood	2004	95
16037090	2697	Valiunas V	Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions.	The Journal of physiology	2005	89
18064002	2697	Roell W	Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.	Nature	2007	122
19786631	2697	Zwi L	Cardiomyocyte differentiation of human induced pluripotent stem cells.	Circulation	2009	107
20037143	2697	Bai X	Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction.	European heart journal	2010	46
20038810	2697	Smyth JW	Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium.	The Journal of clinical investigation	2010	74
23321642	2697	Stoletov K	Role of connexins in metastatic breast cancer and melanoma brain colonization.	Journal of cell science	2013	32
24852842	2697	Hirt MN	Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.	Journal of molecular and cellular cardiology	2014	41
26291556	2697	Riegler J	Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.	Circulation research	2015	27
2105456	2735	Kinzler KW	The GLI gene encodes a nuclear protein which binds specific sequences in the human genome.	Molecular and cellular biology	1990	142
9216996	2735	Lee J	Gli1 is a target of Sonic hedgehog that induces ventral neural tube development.	Development	1997	145
10559945	2735	Kogerman P	Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1.	Nature cell biology	1999	138
11719506	2735	Yoon JW	Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation.	The Journal of biological chemistry	2002	97
15132968	2735	Fan L	Hedgehog signaling promotes prostate xenograft tumor growth.	Endocrinology	2004	75
16421275	2735	Huntzicker EG	Dual degradation signals control Gli protein stability and tumor formation.	Genes and development	2006	67
17196391	2735	Clement V	HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.	Current biology 	2007	283
17332349	2735	Feldmann G	Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.	Cancer research	2007	236
17392427	2735	Stecca B	Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.	Proceedings of the National Academy of Sciences of the United States of America	2007	163
17494766	2735	Lauth M	Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.	Proceedings of the National Academy of Sciences of the United States of America	2007	196
18756266	2735	Ferretti E	Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells.	The EMBO journal	2008	96
18790753	2735	Feldmann G	An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.	Molecular cancer therapeutics	2008	84
19214186	2735	Stecca B	A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers.	The EMBO journal	2009	75
19351822	2735	Northcott PA	The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.	Cancer research	2009	108
19445942	2735	Kolterud A	Paracrine Hedgehog signaling in stomach and intestine: new roles for hedgehog in gastrointestinal patterning.	Gastroenterology	2009	50
20049737	2735	Varnat F	Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion.	EMBO molecular medicine	2009	130
21076395	2735	Jagani Z	Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.	Nature medicine	2010	62
21183792	2735	Beauchamp EM	Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.	The Journal of clinical investigation	2011	66
21632555	2735	O'Toole SA	Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer.	Cancer research	2011	38
22730244	2735	Santini R	Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.	Stem cells	2012	40
24493717	2735	Kim DJ	Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.	Journal of clinical oncology 	2014	38
26053182	2735	Gonnissen A	Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.	Oncotarget	2015	20
9636198	2736	Ricote M	Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1998	116
11160388	2736	Combs CK	beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.	The Journal of neuroscience 	2001	132
12508154	2736	Lewis KN	Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.	The Journal of infectious diseases	2003	163
19701203	2736	Han YG	Dual and opposing roles of primary cilia in medulloblastoma development.	Nature medicine	2009	120
20660365	2736	Alexaki VI	GLI2-mediated melanoma invasion and metastasis.	Journal of the National Cancer Institute	2010	47
20718462	2736	Meng H	Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.	Journal of the American Chemical Society	2010	68
21102562	2736	Akao Y	Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages.	Molecular therapy 	2011	42
21123452	2736	Dijkgraaf GJ	Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.	Cancer research	2011	92
22472194	2736	Murphy FA	The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells.	Particle and fibre toxicology	2012	41
23649538	2736	Xia T	Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium.	Environmental health perspectives	2013	43
24367916	2736	Zhang B	Mesenchymal stem cells secrete immunologically active exosomes.	Stem cells and development	2014	59
24651015	2736	Kool M	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer cell	2014	102
12805203	2902	Furukawa H	Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.	The EMBO journal	2003	128
15828859	2902	Han K	A combinatorial code for splicing silencing: UAGG and GGGG motifs.	PLoS biology	2005	82
16281028	2902	Furukawa H	Subunit arrangement and function in NMDA receptors.	Nature	2005	234
16427029	2902	Rujescu D	A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.	Biological psychiatry	2006	63
17262855	2902	Dalmau J	Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.	Annals of neurology	2007	274
18851928	2902	Dalmau J	Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.	The Lancet. Neurology	2008	361
19020013	2902	Li W	NMDA receptor activation by HIV-Tat protein is clade dependent.	The Journal of neuroscience 	2008	60
22875940	2902	Gleichman AJ	Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.	The Journal of neuroscience 	2012	42
24360484	2902	Gresa-Arribas N	Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.	The Lancet. Neurology	2014	71
24876489	2902	Karakas E	Crystal structure of a heterotetrameric NMDA receptor ion channel.	Science	2014	118
25340958	2902	Miller OH	GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.	eLife	2014	30
28095420	2902	Ogden KK	Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.	PLoS genetics	2017	6
3037703	2908	Arriza JL	Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.	Science	1987	171
8223438	2908	Muchardt C	A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor.	The EMBO journal	1993	174
14617768	2908	Rogatsky I	Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor.	Proceedings of the National Academy of Sciences of the United States of America	2003	91
15554887	2908	Seckl JR	Prenatal glucocorticoids and long-term programming.	European journal of endocrinology	2004	104
15866175	2908	Lu NZ	Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.	Molecular cell	2005	105
17559307	2908	So AY	Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor.	PLoS genetics	2007	123
18846204	2908	Yan J	Analysis of gene regulatory networks in the mammalian circadian rhythm.	PLoS computational biology	2008	97
19234457	2908	McGowan PO	Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.	Nature neuroscience	2009	629
21496643	2908	Surjit M	Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor.	Cell	2011	119
24315100	2908	Arora VK	Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.	Cell	2013	141
24615402	2908	Isikbay M	Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.	Hormones and cancer	2014	31
25336632	2908	Jing D	Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.	Blood	2015	21
25687413	2908	Turecki G	Effects of the Social Environment and Stress on Glucocorticoid Receptor Gene Methylation: A Systematic Review.	Biological psychiatry	2016	37
26792867	2908	Asangani IA	BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.	Molecular cancer research 	2016	16
9267033	3064	Davies SW	Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.	Cell	1997	452
11988536	3064	Dunah AW	Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.	Science	2002	173
12747895	3064	Bates G	Huntingtin aggregation and toxicity in Huntington's disease.	Lancet	2003	103
12873381	3064	Tang TS	Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.	Neuron	2003	118
12881722	3064	Zuccato C	Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.	Nature genetics	2003	216
15340079	3064	Trushina E	Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.	Molecular and cellular biology	2004	138
16141322	3064	Iwata A	Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.	Proceedings of the National Academy of Sciences of the United States of America	2005	96
16522639	3064	Shibata M	Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1.	The Journal of biological chemistry	2006	133
16980959	3064	Tam S	The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions.	Nature cell biology	2006	108
17118264	3064	Williams A	Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.	Current topics in developmental biology	2006	104
17687326	3064	Bennett EJ	Global changes to the ubiquitin system in Huntington's disease.	Nature	2007	175
18550760	3064	Gray M	Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.	The Journal of neuroscience 	2008	183
18625748	3064	Björkqvist M	A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.	The Journal of experimental medicine	2008	126
18981372	3064	Aziz NA	Weight loss in Huntington disease increases with higher CAG repeat number.	Neurology	2008	52
19487684	3064	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	78
20383138	3064	Martinez-Vicente M	Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.	Nature neuroscience	2010	180
21971427	3064	Carroll JB	Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.	Molecular therapy 	2011	69
21997870	3064	Shirendeb UP	Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.	Human molecular genetics	2012	60
22613578	3064	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	62
22709585	3064	Siddiqui A	Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.	Free radical biology and medicine	2012	32
22735540	3064	Pieri L	Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells.	Biophysical journal	2012	52
23160193	3064	Kwan W	Mutant huntingtin impairs immune cell migration in Huntington disease.	The Journal of clinical investigation	2012	33
23341638	3064	Ng CW	Extensive changes in DNA methylation are associated with expression of mutant huntingtin.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
23963702	3064	Østergaard ME	Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.	Nucleic acids research	2013	31
24584051	3064	Crotti A	Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.	Nature neuroscience	2014	49
24586208	3064	Hoss AG	MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.	PLoS genetics	2014	22
25017010	3064	Pecho-Vrieseling E	Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.	Nature neuroscience	2014	26
2531289	3082	Nakamura T	Molecular cloning and expression of human hepatocyte growth factor.	Nature	1989	282
12865405	3082	Kollet O	HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.	The Journal of clinical investigation	2003	127
17283128	3082	Verras M	The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.	Cancer research	2007	67
17483355	3082	Zou HY	An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.	Cancer research	2007	158
18519697	3082	Jin H	MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.	Cancer research	2008	84
19074827	3082	Zhao D	Neural stem cell tropism to glioma: critical role of tumor hypoxia.	Molecular cancer research 	2008	59
21249190	3082	Tyan SW	Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis.	PloS one	2011	41
21464397	3082	De Bacco F	Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.	Journal of the National Cancer Institute	2011	65
24259426	3082	Yang X	MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.	Hepatology	2014	42
24327602	3082	Eterno V	Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling.	Oncotarget	2014	24
24607406	3082	Todaro M	CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.	Cell stem cell	2014	92
26432786	3082	Sameni M	Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.	Clinical cancer research 	2016	11
8756616	3091	Forsythe JA	Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.	Molecular and cellular biology	1996	763
10582706	3091	Zhong H	Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.	Cancer research	1999	499
10640274	3091	Ravi R	Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.	Genes and development	2000	212
11486006	3091	Sánchez-Elsner T	Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.	The Journal of biological chemistry	2001	90
12840067	3091	Danet GH	Expansion of human SCID-repopulating cells under hypoxic conditions.	The Journal of clinical investigation	2003	77
13130303	3091	Semenza GL	Targeting HIF-1 for cancer therapy.	Nature reviews. Cancer	2003	1379
15498848	3091	Hong KH	Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A.	Blood	2005	71
15630139	3091	Walmsley SR	Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity.	The Journal of experimental medicine	2005	158
16408279	3091	Risbud MV	Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment.	Journal of cellular biochemistry	2006	71
17101781	3091	Pan Y	Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.	Molecular and cellular biology	2007	96
17245699	3091	Trastour C	HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.	International journal of cancer	2007	61
17304217	3091	Li W	Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing.	The EMBO journal	2007	84
17483326	3091	Hiraga T	Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.	Cancer research	2007	61
17502379	3091	Land SC	Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.	The Journal of biological chemistry	2007	113
17785204	3091	Gao P	HIF-dependent antitumorigenic effect of antioxidants in vivo.	Cancer cell	2007	165
18083891	3091	Archer SL	Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.	American journal of physiology. Heart and circulatory physiology	2008	104
18259201	3091	Weidemann A	Biology of HIF-1alpha.	Cell death and differentiation	2008	158
18297062	3091	Yang MH	Direct regulation of TWIST by HIF-1alpha promotes metastasis.	Nature cell biology	2008	316
18551130	3091	Papandreou I	Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L.	Cell death and differentiation	2008	94
18754863	3091	Kyo S	Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.	Cancer science	2008	83
18984735	3091	Regazzetti C	Hypoxia decreases insulin signaling pathways in adipocytes.	Diabetes	2009	57
19118021	3091	Chiche J	Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.	Cancer research	2009	110
19727403	3091	Dunn LK	Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.	PloS one	2009	65
19782034	3091	Huang X	Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.	Molecular cell	2009	181
19801454	3091	Zhou G	Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1.	American journal of physiology. Lung cellular and molecular physiology	2009	54
19946328	3091	Semenza GL	Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.	Oncogene	2010	414
20176937	3091	Horak P	Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
20515450	3091	Méndez O	Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.	Molecular cancer	2010	46
20864819	3091	Chiavarina B	HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.	Cell cycle	2010	75
20952688	3091	Tsai CC	Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.	Blood	2011	92
20972335	3091	Ghosh G	Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.	The Journal of clinical investigation	2010	120
21278237	3091	Kim TH	NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.	Cancer research	2011	59
21321221	3091	Keunen O	Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2011	167
21782234	3091	Szot CS	3D in vitro bioengineered tumors based on collagen I hydrogels.	Biomaterials	2011	39
21911388	3091	Wong CC	Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.	Proceedings of the National Academy of Sciences of the United States of America	2011	92
21917858	3091	Xu Q	MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.	Nucleic acids research	2012	66
21984483	3091	Jing Y	Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.	Toxicological sciences 	2012	39
21998407	3091	Kryczek I	Human TH17 cells are long-lived effector memory cells.	Science translational medicine	2011	81
22231744	3091	Wong CC	Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis.	Journal of molecular medicine	2012	61
22446391	3091	Zhou W	HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition.	The EMBO journal	2012	102
22785173	3091	Xu X	Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21.	Kidney international	2012	46
22885334	3091	Chen Y	Hedgehog controls hepatic stellate cell fate by regulating metabolism.	Gastroenterology	2012	40
23012449	3091	Schito L	Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
23082126	3091	De Saedeleer CJ	Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.	PloS one	2012	33
23378577	3091	Gilkes DM	Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis.	Molecular cancer research 	2013	45
23389731	3091	Yeh YM	MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α.	International journal of cancer	2013	53
23633488	3091	Spivak-Kroizman TR	Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer.	Cancer research	2013	29
23674815	3091	Clem BF	Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.	Molecular cancer therapeutics	2013	35
23842546	3091	Chae YC	Landscape of the mitochondrial Hsp90 metabolome in tumours.	Nature communications	2013	33
24086109	3091	Eckle T	HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium.	PLoS biology	2013	27
24366912	3091	Chesnelong C	Lactate dehydrogenase A silencing in IDH mutant gliomas.	Neuro-oncology	2014	23
24434214	3091	Li J	Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity.	Cancer cell	2014	24
24550282	3091	Faubert B	Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
24670641	3091	Chen X	XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.	Nature	2014	108
24843020	3091	Wheaton WW	Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis.	eLife	2014	104
24857547	3091	Ferrer CM	O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.	Molecular cell	2014	38
25186948	3091	Ye J	Serine catabolism regulates mitochondrial redox control during hypoxia.	Cancer discovery	2014	47
25746953	3091	Shalova IN	Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α.	Immunity	2015	26
25891797	3091	Zhou J	miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.	Cancer biology and therapy	2015	17
26365179	3091	Dupuy F	PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.	Cell metabolism	2015	31
26579469	3091	Masoud GN	HIF-1α pathway: role, regulation and intervention for cancer therapy.	Acta pharmaceutica Sinica. B	2015	49
27322552	3091	Lu PH	Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings.	Oncotarget	2016	21
15502843	3146	Wang H	Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.	Nature medicine	2004	249
17114460	3146	Youn JH	Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.	Journal of immunology	2006	97
17185418	3146	Carriere V	IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2007	198
17704786	3146	Apetoh L	Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.	Nature medicine	2007	613
18354232	3146	Youn JH	High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.	Journal of immunology	2008	70
18519658	3146	Apetoh L	Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.	Cancer research	2008	58
18631454	3146	Kazama H	Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.	Immunity	2008	155
19064698	3146	Urbonaviciute V	Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.	The Journal of experimental medicine	2008	154
19564572	3146	Hreggvidsdottir HS	The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.	Journal of leukocyte biology	2009	92
20530955	3146	de Jong HK	The systemic pro-inflammatory response in sepsis.	Journal of innate immunity	2010	44
21395369	3146	Tang D	High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress.	Antioxidants and redox signaling	2011	37
21602432	3146	Fucikova J	Human tumor cells killed by anthracyclines induce a tumor-specific immune response.	Cancer research	2011	62
21738444	3146	Celona B	Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output.	PLoS biology	2011	53
21871094	3146	Wähämaa H	High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.	Arthritis research and therapy	2011	37
22102692	3146	Huang J	HMGB1 promotes drug resistance in osteosarcoma.	Cancer research	2012	74
22277195	3146	Belarbi K	TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.	Journal of neuroinflammation	2012	48
22461509	3146	Miyamoto S	Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.	Cancer research	2012	40
22552293	3146	Jube S	Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.	Cancer research	2012	61
23649808	3146	Davalos AR	p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes.	The Journal of cell biology	2013	36
24572365	3146	Bald T	Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma.	Nature	2014	82
25636263	3146	Woolbright BL	Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.	Toxicology and applied pharmacology	2015	29
9884342	3162	Yachie A	Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.	The Journal of clinical investigation	1999	246
12130498	3162	Jeney V	Pro-oxidant and cytotoxic effects of circulating heme.	Blood	2002	116
15930299	3162	Liby K	The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.	Cancer research	2005	101
16487043	3162	Igarashi K	The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation.	Antioxidants and redox signaling	2006	68
17363558	3162	Liby K	The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.	Cancer research	2007	59
18769149	3162	Kim HP	Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1.	Autophagy	2008	67
20028456	3162	Son TG	Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.	Journal of neurochemistry	2010	45
21529713	3162	Ferreira A	Sickle hemoglobin confers tolerance to Plasmodium infection.	Cell	2011	72
23100518	3162	Cunnington AJ	Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction.	Journal of immunology	2012	33
23617628	3162	Skrzypek K	Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.	Antioxidants and redox signaling	2013	34
23858469	3162	Teng H	Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
24121491	3162	Wegiel B	Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.	Cancer research	2013	30
24456852	3162	Baisch BL	Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation.	Particle and fibre toxicology	2014	32
1672545	3458	Chan SH	Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.	The Journal of experimental medicine	1991	182
8445253	3458	Jung T	Detection of intracellular cytokines by flow cytometry.	Journal of immunological methods	1993	149
9603732	3458	Altare F	Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.	Science	1998	172
10646872	3458	Jaiswal M	Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.	Cancer research	2000	104
11717429	3458	Bennett BL	SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.	Proceedings of the National Academy of Sciences of the United States of America	2001	591
11781358	3458	Kukreja A	Multiple immuno-regulatory defects in type-1 diabetes.	The Journal of clinical investigation	2002	156
12750172	3458	Dufour C	TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.	Blood	2003	82
12942579	3458	Sasada T	CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.	Cancer	2003	81
15546386	3458	Kovanen PE	Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.	Immunological reviews	2004	78
15764907	3458	Ngoc PL	Cytokines, allergy, and asthma.	Current opinion in allergy and clinical immunology	2005	70
16505141	3458	Trumpfheller C	Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.	The Journal of experimental medicine	2006	96
16678181	3458	Hunt NH	Immunopathogenesis of cerebral malaria.	International journal for parasitology	2006	80
17255300	3458	Ochoa AC	Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.	Clinical cancer research 	2007	133
17438063	3458	Aspord C	Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development.	The Journal of experimental medicine	2007	79
17507983	3458	Barton ES	Herpesvirus latency confers symbiotic protection from bacterial infection.	Nature	2007	194
17995965	3458	Reddy N	Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.	British journal of haematology	2008	62
18391061	3458	Luger D	Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.	The Journal of experimental medicine	2008	221
18420999	3458	Kintscher U	T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.	Arteriosclerosis, thrombosis, and vascular biology	2008	181
19017986	3458	Bertholet S	Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.	Journal of immunology	2008	52
19029905	3458	Cupedo T	Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.	Nature immunology	2009	149
19055947	3458	Terabe M	The role of NKT cells in tumor immunity.	Advances in cancer research	2008	91
19105661	3458	Martinez FO	Alternative activation of macrophages: an immunologic functional perspective.	Annual review of immunology	2009	630
19330474	3458	Wolk K	IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.	Journal of molecular medicine	2009	58
19458616	3458	Hadjur S	Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus.	Nature	2009	211
19487422	3458	Strowig T	Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.	The Journal of experimental medicine	2009	92
19497992	3458	Moodley Y	Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.	The American journal of pathology	2009	77
19536809	3458	Xu Q	Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.	Stem cells	2009	54
19542050	3458	Gao B	Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.	Journal of leukocyte biology	2009	93
19585513	3458	Lynch L	Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.	European journal of immunology	2009	55
19818653	3458	Feuerer M	How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.	Immunity	2009	83
19890056	3458	Jäger A	Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.	Journal of immunology	2009	186
19923445	3458	Zhang Q	Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.	Journal of immunology	2009	111
20050849	3458	Schafer PH	Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.	British journal of pharmacology	2010	44
20200277	3458	Unsinger J	IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.	Journal of immunology	2010	75
20231693	3458	Wu X	Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses.	Journal of immunology	2010	50
20368733	3458	Shi Y	Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.	Cell research	2010	112
20491796	3458	Harris J	How tumour necrosis factor blockers interfere with tuberculosis immunity.	Clinical and experimental immunology	2010	52
20881185	3458	Silverman JM	Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.	Journal of immunology	2010	56
21102458	3458	Wilhelm K	Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.	Nature medicine	2010	95
21106641	3458	Brandau S	Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.	Journal of leukocyte biology	2011	65
21169542	3458	Jagannathan-Bogdan M	Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.	Journal of immunology	2011	70
21187448	3458	Rajasagi NK	Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.	Journal of immunology	2011	44
21377040	3458	Akdis M	Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.	The Journal of allergy and clinical immunology	2011	98
21624938	3458	Zoller EE	Hemophagocytosis causes a consumptive anemia of inflammation.	The Journal of experimental medicine	2011	37
21706005	3458	Rossi RL	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b.	Nature immunology	2011	86
22297636	3458	Harris JE	A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.	The Journal of investigative dermatology	2012	31
22378844	3458	Trotta R	miR-155 regulates IFN-γ production in natural killer cells.	Blood	2012	61
22466287	3458	Zielinski CE	Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.	Nature	2012	190
22761577	3458	Niedelman W	The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response.	PLoS pathogens	2012	48
22772450	3458	Smith KM	miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.	Journal of immunology	2012	45
22983442	3458	Romee R	Cytokine activation induces human memory-like NK cells.	Blood	2012	82
23271808	3458	Fu B	Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
23323860	3458	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	54
24434782	3458	Leong JW	Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.	Biology of blood and marrow transplantation 	2014	40
24563254	3458	Ohshima J	Role of mouse and human autophagy proteins in IFN-γ-induced cell-autonomous responses against Toxoplasma gondii.	Journal of immunology	2014	31
24655295	3458	Lowes MA	Immunology of psoriasis.	Annual review of immunology	2014	88
25244096	3458	Kirabo A	DC isoketal-modified proteins activate T cells and promote hypertension.	The Journal of clinical investigation	2014	60
26350966	3458	Selleck EM	A Noncanonical Autophagy Pathway Restricts Toxoplasma gondii Growth in a Strain-Specific Manner in IFN-γ-Activated Human Cells.	mBio	2015	17
27111145	3458	Bal SM	IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.	Nature immunology	2016	14
8052854	3552	Kopp E	Inhibition of NF-kappa B by sodium salicylate and aspirin.	Science	1994	266
9759850	3552	Schönbeck U	Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.	Journal of immunology	1998	139
12220547	3552	Arend WP	The balance between IL-1 and IL-1Ra in disease.	Cytokine and growth factor reviews	2002	140
12429706	3552	Hoffmann E	Multiple control of interleukin-8 gene expression.	Journal of leukocyte biology	2002	263
17088043	3552	Dantzer R	Twenty years of research on cytokine-induced sickness behavior.	Brain, behavior, and immunity	2007	262
19362022	3552	Chung Y	Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.	Immunity	2009	337
19919576	3552	Fraser DA	C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.	Journal of neurochemistry	2010	42
20061650	3552	McGeer EG	Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.	Journal of Alzheimer's disease 	2010	80
20110505	3552	Boilard E	Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.	Science	2010	197
20177398	3552	Gabay C	IL-1 pathways in inflammation and human diseases.	Nature reviews. Rheumatology	2010	126
22142165	3552	Rossol M	LPS-induced cytokine production in human monocytes and macrophages.	Critical reviews in immunology	2011	80
22418018	3552	Ravelli A	Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.	Genes and immunity	2012	44
23790398	3552	Bradfute SB	Autophagy as an immune effector against tuberculosis.	Current opinion in microbiology	2013	34
23922312	3552	Bartosh TJ	Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1).	Stem cells	2013	29
23995233	3552	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	46
24990750	3552	Mayer-Barber KD	Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.	Nature	2014	116
25278425	3552	Cayrol C	IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.	Current opinion in immunology	2014	77
26686024	3552	Wiley CD	Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.	Cell metabolism	2016	33
28099414	3552	Liddelow SA	Neurotoxic reactive astrocytes are induced by activated microglia.	Nature	2017	36
10430608	3553	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	106
11058758	3553	Fournier T	Alpha-1-acid glycoprotein.	Biochimica et biophysica acta	2000	114
15855327	3553	Brusko TM	Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.	Diabetes	2005	83
16740164	3553	Cone RA	Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.	BMC infectious diseases	2006	63
17404311	3553	Li H	Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release.	Journal of immunology	2007	77
17429439	3553	Watanabe H	Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity.	The Journal of investigative dermatology	2007	76
17600714	3553	Feldmeyer L	The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.	Current biology 	2007	104
17853946	3553	Schenk M	TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.	The Journal of clinical investigation	2007	73
17965775	3553	Araya J	Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients.	The Journal of clinical investigation	2007	62
18276918	3553	Ganter MT	Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms.	Circulation research	2008	60
18504291	3553	Pott Godoy MC	Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease.	Brain 	2008	76
19503839	3553	Liu PT	Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.	PloS one	2009	85
19717510	3553	Muñoz-Planillo R	A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.	Journal of immunology	2009	99
19833175	3553	Lewis SS	Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.	Neuroscience	2010	43
20398664	3553	Ng J	Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.	Gastroenterology	2010	54
20482831	3553	Wilms H	Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.	Journal of neuroinflammation	2010	49
20545607	3553	Goldberg JE	Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.	Current drug targets	2010	55
21459803	3553	Dirat B	Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion.	Cancer research	2011	131
21599903	3553	Brochu ME	Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study.	Journal of neuroinflammation	2011	36
21752263	3553	Chang BY	The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.	Arthritis research and therapy	2011	46
21762124	3553	Menu P	The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.	Clinical and experimental immunology	2011	61
21784976	3553	Novikov A	Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.	Journal of immunology	2011	60
21864400	3553	Levesque S	Air pollution &amp;amp; the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease.	Journal of neuroinflammation	2011	45
21901289	3553	Dayan V	Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction.	Basic research in cardiology	2011	47
21945322	3553	Rieder F	Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.	The American journal of pathology	2011	60
21949132	3553	Wang J	TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc.	The Journal of biological chemistry	2011	37
22101528	3553	Poole DC	Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.	American journal of physiology. Heart and circulatory physiology	2012	60
22412385	3553	Eizirik DL	The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.	PLoS genetics	2012	82
22993202	3553	Duboc H	Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.	Gut	2013	61
23139215	3553	Ganguli K	Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation.	American journal of physiology. Gastrointestinal and liver physiology	2013	40
23401508	3553	Scotti C	Engineering of a functional bone organ through endochondral ossification.	Proceedings of the National Academy of Sciences of the United States of America	2013	49
24225954	3553	Bretz NP	Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling.	The Journal of biological chemistry	2013	37
24277153	3553	Guiducci C	RNA recognition by human TLR8 can lead to autoimmune inflammation.	The Journal of experimental medicine	2013	25
24509090	3553	Mattei D	Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia.	Brain, behavior, and immunity	2014	24
24550444	3553	de Luca A	IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	55
24556663	3553	Wollin L	Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.	The Journal of pharmacology and experimental therapeutics	2014	38
24736635	3553	Fernando MR	The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages.	PloS one	2014	28
24876674	3553	Wojdasiewicz P	The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.	Mediators of inflammation	2014	58
24952505	3553	Franklin BS	The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.	Nature immunology	2014	84
25043017	3553	Arranz L	Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.	Nature	2014	52
25453823	3553	Chittezhath M	Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.	Immunity	2014	26
25762540	3553	Dudek-Perić AM	Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.	Cancer research	2015	16
25879289	3553	Jorgensen I	Pyroptotic cell death defends against intracellular pathogens.	Immunological reviews	2015	41
26055245	3553	Szabo G	Inflammasome activation and function in liver disease.	Nature reviews. Gastroenterology and hepatology	2015	34
26187413	3553	Bernink JH	Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.	Immunity	2015	37
27270401	3553	Park YH	Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.	Nature immunology	2016	15
27382171	3553	Koopman FA	Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis.	Proceedings of the National Academy of Sciences of the United States of America	2016	17
27383986	3553	Liu X	Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.	Nature	2016	45
3056758	3630	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1192
9054944	3630	Vafiadis P	Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.	Nature genetics	1997	137
9710447	3630	Barber AJ	Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.	The Journal of clinical investigation	1998	263
10868930	3630	Soria B	Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.	Diabetes	2000	111
11742415	3630	Moller DE	New drug targets for type 2 diabetes and the metabolic syndrome.	Nature	2001	107
15044359	3630	Dallman MF	Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004.	Endocrinology	2004	76
16556766	3630	Wiederkehr A	Minireview: implication of mitochondria in insulin secretion and action.	Endocrinology	2006	69
16644702	3630	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	80
17204604	3630	McLean AB	Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.	Stem cells	2007	124
17981116	3630	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	143
18288110	3630	Kroon E	Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.	Nature biotechnology	2008	489
18436705	3630	Scheuner D	The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.	Endocrine reviews	2008	153
18451997	3630	Colombo C	Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.	The Journal of clinical investigation	2008	60
18796548	3630	Cacho J	Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats.	American journal of physiology. Endocrinology and metabolism	2008	78
19202385	3630	Fedor D	Prevention of insulin resistance by n-3 polyunsaturated fatty acids.	Current opinion in clinical nutrition and metabolic care	2009	58
19742322	3630	Kuroda A	Insulin gene expression is regulated by DNA methylation.	PloS one	2009	61
19940134	3630	Alkhouri N	Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis.	The Journal of biological chemistry	2010	82
20022465	3630	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	45
20357360	3630	Wentworth JM	Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity.	Diabetes	2010	106
20522594	3630	Kars M	Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.	Diabetes	2010	93
20798346	3630	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
20870709	3630	Huang-Doran I	Lipodystrophy: metabolic insights from a rare disorder.	The Journal of endocrinology	2010	49
21045171	3630	LeBrasseur NK	Metabolic benefits of resistance training and fast glycolytic skeletal muscle.	American journal of physiology. Endocrinology and metabolism	2011	36
21070248	3630	Belgardt BF	CNS leptin and insulin action in the control of energy homeostasis.	Annals of the New York Academy of Sciences	2010	67
21104225	3630	Yang BT	Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.	Diabetologia	2011	47
21362568	3630	Smukler SR	The adult mouse and human pancreas contain rare multipotent stem cells that express insulin.	Cell stem cell	2011	58
21599535	3630	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	37
21865645	3630	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	72
22167125	3630	Dai C	Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.	Diabetologia	2012	53
22278418	3630	Chen G	Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.	The Journal of clinical endocrinology and metabolism	2012	33
22332072	3630	Kalupahana NS	(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights.	Advances in nutrition	2011	49
22352879	3630	King AJ	The use of animal models in diabetes research.	British journal of pharmacology	2012	98
22560210	3630	Jornayvaz FR	Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.	Cell metabolism	2012	65
22740171	3630	Rezania A	Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.	Diabetes	2012	98
22974438	3630	Rorsman P	Regulation of insulin secretion in human pancreatic islets.	Annual review of physiology	2013	74
23159341	3630	Shen J	The gut microbiota, obesity and insulin resistance.	Molecular aspects of medicine	2013	69
23169676	3630	Girgis CM	The roles of vitamin D in skeletal muscle: form, function, and metabolism.	Endocrine reviews	2013	55
23269411	3630	Ye J	Inflammation during obesity is not all bad: evidence from animal and human studies.	American journal of physiology. Endocrinology and metabolism	2013	27
23638642	3630	Gu Z	Injectable nano-network for glucose-mediated insulin delivery.	ACS nano	2013	27
23764390	3630	Croze ML	Potential role and therapeutic interests of myo-inositol in metabolic diseases.	Biochimie	2013	27
23994581	3630	Rettberg JR	Estrogen: a master regulator of bioenergetic systems in the brain and body.	Frontiers in neuroendocrinology	2014	33
24316517	3630	Vrieze A	Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.	Journal of hepatology	2014	48
24899308	3630	Perry RJ	The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.	Nature	2014	100
25176147	3630	Khan MT	Microbial modulation of insulin sensitivity.	Cell metabolism	2014	22
25211370	3630	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	126
26549485	3630	Tian XY	Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance.	Cell metabolism	2016	13
27409811	3630	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	31
9892193	3791	Fong TA	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.	Cancer research	1999	145
15082792	3791	Shao R	Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression.	Molecular and cellular biology	2004	85
15172975	3791	Tong RT	Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.	Cancer research	2004	250
15896706	3791	Cao Y	Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.	Biochemical and biophysical research communications	2005	119
15899831	3791	Wedge SR	AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.	Cancer research	2005	160
17148580	3791	Kennedy M	Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.	Blood	2007	134
17569886	3791	Ferreira LS	Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.	Circulation research	2007	74
18559524	3791	Hilberg F	BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.	Cancer research	2008	123
18818406	3791	Swendeman S	VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.	Circulation research	2008	58
18977327	3791	Würdinger T	miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.	Cancer cell	2008	120
20488920	3791	Jutooru I	Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.	Molecular pharmacology	2010	41
22654102	3791	Francescone R	Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation.	The Journal of biological chemistry	2012	40
22718841	3791	Jiang T	CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis.	Blood	2012	36
23056481	3791	Janeczek Portalska K	Endothelial differentiation of mesenchymal stromal cells.	PloS one	2012	31
23139354	3791	Hodgin JB	Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.	Diabetes	2013	39
23454747	3791	Chatterjee S	Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.	The Journal of clinical investigation	2013	42
23516391	3791	Shah MA	Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer.	PloS one	2013	47
23536763	3791	Yao X	Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.	PloS one	2013	28
24529377	3791	Croci DO	Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.	Cell	2014	68
24803676	3791	Karajannis MA	Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.	Neuro-oncology	2014	26
6888561	3845	Schwab M	Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.	Nature	1983	261
14966562	3845	Chan IT	Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.	The Journal of clinical investigation	2004	104
15494427	3845	Yu JL	Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.	Blood	2005	108
15608639	3845	Sweet-Cordero A	An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.	Nature genetics	2005	159
17982507	3845	Pasca di Magliano M	Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.	PloS one	2007	71
18224685	3845	Barault L	Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.	International journal of cancer	2008	84
19270292	3845	Balsitis SJ	Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining.	The American journal of tropical medicine and hygiene	2009	83
19323605	3845	Torrisani J	let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.	Human gene therapy	2009	54
19401449	3845	Wee S	PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers.	Cancer research	2009	116
19490892	3845	Scholl C	Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.	Cell	2009	189
19561589	3845	DuPage M	Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.	Nature protocols	2009	159
19661383	3845	Yun J	Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.	Science	2009	210
20512148	3845	Lauth M	DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.	Nature structural and molecular biology	2010	48
20570890	3845	Janakiraman M	Genomic and biological characterization of exon 4 KRAS mutations in human cancer.	Cancer research	2010	92
20607356	3845	Lee ST	Let-7 microRNA inhibits the proliferation of human glioblastoma cells.	Journal of neuro-oncology	2011	41
20610624	3845	Yu S	miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.	Cancer research	2010	96
20699365	3845	Halilovic E	PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.	Cancer research	2010	49
20814421	3845	Morris JP 4th	KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.	Nature reviews. Cancer	2010	171
21159816	3845	Kent OA	Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.	Genes and development	2010	102
21300795	3845	Kim MJ	Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.	The Journal of biological chemistry	2011	71
21985784	3845	Ebi H	Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.	The Journal of clinical investigation	2011	63
22185891	3845	Mancias JD	Targeting autophagy addiction in cancer.	Oncotarget	2011	57
22247021	3845	Ihle NT	Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.	Journal of the National Cancer Institute	2012	83
22266220	3845	O'Dell MR	Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.	Cancer research	2012	33
22282465	3845	Miranda C	KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors.	Clinical cancer research 	2012	38
22341439	3845	Singh A	TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.	Cell	2012	84
22869577	3845	McPhee F	Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).	Antimicrobial agents and chemotherapy	2012	35
22898602	3845	Ward AF	Targeting oncogenic Ras signaling in hematologic malignancies.	Blood	2012	50
23122493	3845	Karachaliou N	KRAS mutations in lung cancer.	Clinical lung cancer	2013	31
23334325	3845	Huang H	Oncogenic K-Ras requires activation for enhanced activity.	Oncogene	2014	31
23453624	3845	Eser S	Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.	Cancer cell	2013	78
23698361	3845	Zimmermann G	Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.	Nature	2013	112
23943799	3845	Licciulli S	Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53.	Cancer research	2013	27
24293274	3845	Liao WT	MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.	The Journal of pathology	2014	28
24297898	3845	Zorde Khvalevsky E	Mutant KRAS is a druggable target for pancreatic cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
25342560	3845	Sun Q	Competition between human cells by entosis.	Cell research	2014	25
25644265	3845	Kamphorst JJ	Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.	Cancer research	2015	67
25706875	3845	Matano M	Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.	Nature medicine	2015	74
25961927	3845	Garcia PL	The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.	Oncogene	2016	23
26080442	3845	Nan X	Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway.	Proceedings of the National Academy of Sciences of the United States of America	2015	29
26084335	3845	Kim KT	Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.	Genome biology	2015	32
26091037	3845	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	62
26178787	3845	Chiou SH	Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.	Genes and development	2015	28
15637055	4170	Weng C	Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.	The Journal of biological chemistry	2005	66
17043651	4170	Iwamaru A	A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.	Oncogene	2007	97
17178882	4170	Liu L	Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.	Cancer research	2006	270
17761520	4170	Liu Q	FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.	Blood	2008	60
18040043	4170	Nguyen M	Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	2007	213
18451169	4170	Konopleva M	Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).	Cancer research	2008	76
18451170	4170	Tse C	ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.	Cancer research	2008	426
20023629	4170	Schwickart M	Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.	Nature	2010	194
20189983	4170	Eckenrode EF	Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling.	The Journal of biological chemistry	2010	49
20335218	4170	Buchner M	Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.	Blood	2010	60
20587533	4170	Voss V	The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma.	Molecular cancer research 	2010	47
21368833	4170	Inuzuka H	SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.	Nature	2011	177
21368834	4170	Wertz IE	Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.	Nature	2011	217
21648427	4170	Wu Y	MicroRNA delivery by cationic lipoplexes for lung cancer therapy.	Molecular pharmaceutics	2011	42
22056880	4170	Wang C	Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.	Oncogene	2012	32
22064351	4170	Konopleva M	MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.	Leukemia	2012	39
22128299	4170	Tromp JM	Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.	Clinical cancer research 	2012	35
22516262	4170	Wei G	Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency.	Cancer cell	2012	54
22544066	4170	Perciavalle RM	Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration.	Nature cell biology	2012	89
23756231	4170	Ji F	MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.	Bone	2013	30
23948298	4170	Petrocca F	A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.	Cancer cell	2013	35
24019208	4170	Abulwerdi F	A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.	Molecular cancer therapeutics	2014	44
25733019	4170	Huskey NE	CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation.	Stem cell reports	2015	17
26711051	4170	Zhu Y	Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.	Aging cell	2016	29
27760111	4170	Kotschy A	The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.	Nature	2016	21
7791904	4193	Xiao ZX	Interaction between the retinoblastoma protein and the oncoprotein MDM2.	Nature	1995	133
12393500	4193	Hideshima T	Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.	Blood	2003	122
14704432	4193	Vassilev LT	In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.	Science	2004	1114
15004525	4193	Vassilev LT	Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics.	Cell cycle	2004	81
15558054	4193	Issaeva N	Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.	Nature medicine	2004	195
15652475	4193	Vousden KH	P53 and prognosis: new insights and further complexity.	Cell	2005	67
15720184	4193	Bond GL	MDM2 is a central node in the p53 pathway: 12 years and counting.	Current cancer drug targets	2005	93
16443686	4193	Tovar C	Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.	Proceedings of the National Academy of Sciences of the United States of America	2006	196
17116689	4193	Lindström MS	Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.	Molecular and cellular biology	2007	59
17157787	4193	Courtois-Cox S	A negative feedback signaling network underlies oncogene-induced senescence.	Cancer cell	2006	183
18316739	4193	Shangary S	Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition.	Proceedings of the National Academy of Sciences of the United States of America	2008	188
19147532	4193	Wade M	Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?	Molecular cancer research 	2009	61
19524506	4193	Xu XL	Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.	Cell	2009	69
20080970	4193	Reed D	Identification and characterization of the first small molecule inhibitor of MDMX.	The Journal of biological chemistry	2010	64
20660730	4193	Liu M	D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms.	Proceedings of the National Academy of Sciences of the United States of America	2010	41
23400593	4193	Tovar C	MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.	Cancer research	2013	53
24356649	4193	Zheng T	Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.	Nature communications	2013	34
25193859	4193	Zhang C	MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.	Oncotarget	2014	23
3915782	4609	Evan GI	Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.	Molecular and cellular biology	1985	802
6414718	4609	Battey J	The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma.	Cell	1983	212
9927431	4609	Salghetti SE	Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.	The EMBO journal	1999	112
10360173	4609	Pelengaris S	Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.	Molecular cell	1999	129
10713166	4609	Gregory MA	c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.	Molecular and cellular biology	2000	117
12360279	4609	Pelengaris S	c-MYC: more than just a matter of life and death.	Nature reviews. Cancer	2002	285
12529326	4609	O'Connell BC	A large scale genetic analysis of c-Myc-regulated gene expression patterns.	The Journal of biological chemistry	2003	76
12529648	4609	Gomez-Roman N	Direct activation of RNA polymerase III transcription by c-Myc.	Nature	2003	127
13679853	4609	Yin X	Low molecular weight inhibitors of Myc-Max interaction and function.	Oncogene	2003	111
15048125	4609	Yeh E	A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.	Nature cell biology	2004	237
15498494	4609	Welcker M	A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.	Current biology 	2004	90
15988031	4609	Li F	Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis.	Molecular and cellular biology	2005	181
16094360	4609	Hemann MT	Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.	Nature	2005	152
16767079	4609	Guccione E	Myc-binding-site recognition in the human genome is determined by chromatin context.	Nature cell biology	2006	162
17597761	4609	Dominguez-Sola D	Non-transcriptional control of DNA replication by c-Myc.	Nature	2007	194
17906636	4609	Soucek L	Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.	Nature medicine	2007	136
18035408	4609	Takahashi K	Induction of pluripotent stem cells from adult human fibroblasts by defined factors.	Cell	2007	4123
18397753	4609	Wong DJ	Module map of stem cell genes guides creation of epithelial cancer stem cells.	Cell stem cell	2008	251
18568017	4609	Huangfu D	Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.	Nature biotechnology	2008	453
18678733	4609	Takizawa M	AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.	The Journal of experimental medicine	2008	69
18849973	4609	Huangfu D	Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.	Nature biotechnology	2008	392
19200803	4609	Marion RM	Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.	Cell stem cell	2009	131
19448666	4609	Morrish F	c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.	Oncogene	2009	54
19620500	4609	Nelson TJ	Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.	Circulation	2009	150
19697349	4609	Zhou W	Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.	Stem cells	2009	119
20014278	4609	Tsai SY	Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.	Stem cells	2010	44
20041972	4609	Germanguz I	Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells.	Journal of cellular and molecular medicine	2011	44
20380514	4609	West FD	Porcine induced pluripotent stem cells produce chimeric offspring.	Stem cells and development	2010	54
20434984	4609	Rahl PB	c-Myc regulates transcriptional pause release.	Cell	2010	492
20670936	4609	Honda A	Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine.	The Journal of biological chemistry	2010	47
21040726	4609	Yoshida Y	iPS cells: a source of cardiac regeneration.	Journal of molecular and cellular cardiology	2011	44
21098095	4609	Takayama N	Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.	The Journal of experimental medicine	2010	80
21285958	4609	Balaj L	Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.	Nature communications	2011	218
21478273	4609	Sodir NM	Endogenous Myc maintains the tumor microenvironment.	Genes and development	2011	50
21628574	4609	Wakao S	Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
21949375	4609	Nori S	Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21949397	4609	Mertz JA	Targeting MYC dependence in cancer by inhibiting BET bromodomains.	Proceedings of the National Academy of Sciences of the United States of America	2011	284
22333578	4609	Vazquez-Martin A	Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.	Cell cycle	2012	35
22463982	4609	De Los Angeles A	Accessing naïve human pluripotency.	Current opinion in genetics and development	2012	32
23001146	4609	Calado DP	The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.	Nature immunology	2012	53
24002871	4609	Wang L	c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.	Hepatology	2014	41
24394663	4609	Roderick JE	c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.	Blood	2014	28
25009295	4609	Trabucco SE	Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.	Clinical cancer research 	2015	22
25043018	4609	Walz S	Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.	Nature	2014	89
25158628	4609	West JA	Nucleosomal occupancy changes locally over key regulatory regions during cell differentiation and reprogramming.	Nature communications	2014	22
10430945	4758	Neumann G	Generation of influenza A viruses entirely from cloned cDNAs.	Proceedings of the National Academy of Sciences of the United States of America	1999	465
12103431	4758	Ives JA	The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.	Antiviral research	2002	110
12477845	4758	Hutson AM	Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.	Journal of virology	2003	81
12504552	4758	Subbarao K	Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.	Virology	2003	75
14730275	4758	Peltola VT	Respiratory viruses predisposing to bacterial infections: role of neuraminidase.	The Pediatric infectious disease journal	2004	80
15470432	4758	Kobasa D	Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.	Nature	2004	139
16282492	4758	Tumpey TM	Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.	Journal of virology	2005	168
16420364	4758	King SJ	Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae.	Molecular microbiology	2006	82
16533883	4758	Salomon R	The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.	The Journal of experimental medicine	2006	152
17088346	4758	Nelson AL	Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.	Infection and immunity	2007	87
17298168	4758	Sandbulte MR	Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.	PLoS medicine	2007	96
17855542	4758	Yen HL	Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.	Journal of virology	2007	67
18523003	4758	Zheng BJ	Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.	Proceedings of the National Academy of Sciences of the United States of America	2008	86
19392624	4758	Trappetti C	Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host.	The Journal of infectious diseases	2009	63
19687228	4758	Uchiyama S	The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.	The Journal of experimental medicine	2009	47
20080770	4758	Kiso M	T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
21715659	4758	Walsh KB	Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
23641061	4758	Zhang Y	H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet.	Science	2013	62
24326875	4758	Hai R	Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.	Nature communications	2013	40
24453375	4758	Krammer F	Divergent H7 immunogens offer protection from H7N9 virus challenge.	Journal of virology	2014	23
24501418	4758	Wang G	H6 influenza viruses pose a potential threat to human health.	Journal of virology	2014	23
25124927	4758	Marjuki H	Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.	The Journal of infectious diseases	2015	15
25759506	4758	Wohlbold TJ	Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.	mBio	2015	17
10748519	5460	Reubinoff BE	Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.	Nature biotechnology	2000	410
12161760	5460	Richards M	Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells.	Nature biotechnology	2002	113
12923055	5460	Reményi A	Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers.	Genes and development	2003	111
14702635	5460	Sato N	Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.	Nature medicine	2004	535
15513931	5460	Tai MH	Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis.	Carcinogenesis	2005	150
15743839	5460	Kuroda T	Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.	Molecular and cellular biology	2005	137
16002783	5460	Gerrard L	Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling.	Stem cells	2005	74
16153702	5460	Boyer LA	Core transcriptional regulatory circuitry in human embryonic stem cells.	Cell	2005	1326
16723703	5460	Yu H	Isolation of a novel population of multipotent adult stem cells from human hair follicles.	The American journal of pathology	2006	69
16929302	5460	Klimanskaya I	Human embryonic stem cell lines derived from single blastomeres.	Nature	2006	68
16951404	5460	Lee J	The human OCT-4 isoforms differ in their ability to confer self-renewal.	The Journal of biological chemistry	2006	68
17136117	5460	Kucia M	Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report.	Leukemia	2007	98
17140114	5460	O'Geen H	Comparison of sample preparation methods for ChIP-chip assays.	BioTechniques	2006	80
18029452	5460	Yu J	Induced pluripotent stem cell lines derived from human somatic cells.	Science	2007	2703
18388306	5460	Fong H	Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.	Stem cells	2008	71
18583537	5460	Bar M	MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.	Stem cells	2008	126
18593985	5460	Chiou SH	Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.	Clinical cancer research 	2008	172
18594515	5460	Kim JB	Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.	Nature	2008	271
18710938	5460	Card DA	Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells.	Molecular and cellular biology	2008	181
18725401	5460	Barroso-delJesus A	Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter.	Molecular and cellular biology	2008	65
18755840	5460	Lin SL	Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.	RNA	2008	136
18818365	5460	Stadtfeld M	Induced pluripotent stem cells generated without viral integration.	Science	2008	427
18832592	5460	Zhang ZY	Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.	Stem cells	2009	53
19250903	5460	Xie W	Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells.	Molecular cell	2009	80
19696409	5460	Martinez-Fernandez A	iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.	Circulation research	2009	49
19718018	5460	Kim JB	Direct reprogramming of human neural stem cells by OCT4.	Nature	2009	186
19763270	5460	Marchetto MC	Transcriptional signature and memory retention of human-induced pluripotent stem cells.	PloS one	2009	119
20027182	5460	Bhutani N	Reprogramming towards pluripotency requires AID-dependent DNA demethylation.	Nature	2010	259
20139068	5460	Cai J	Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells.	The Journal of biological chemistry	2010	45
20526341	5460	Kunarso G	Transposable elements have rewired the core regulatory network of human embryonic stem cells.	Nature genetics	2010	214
20696700	5460	Sarig R	Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.	The Journal of experimental medicine	2010	54
20953172	5460	Chia NY	A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity.	Nature	2010	158
21112560	5460	Zhu S	Reprogramming of human primary somatic cells by OCT4 and chemical compounds.	Cell stem cell	2010	187
21159654	5460	Chiou SH	Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.	Cancer research	2010	163
21602794	5460	Adamo A	LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.	Nature cell biology	2011	77
21631526	5460	Gillis AJ	Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.	International journal of andrology	2011	38
22482508	5460	Wang Z	Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells.	Cell stem cell	2012	100
22865647	5460	Hassiotou F	Breastmilk is a novel source of stem cells with multilineage differentiation potential.	Stem cells	2012	38
23333246	5460	Kim SY	Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.	Cellular signalling	2013	41
23582322	5460	Whyte WA	Master transcription factors and mediator establish super-enhancers at key cell identity genes.	Cell	2013	529
23765801	5460	Mathieu J	Hypoxia induces re-entry of committed cells into pluripotency.	Stem cells	2013	31
24296783	5460	Zhu S	Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells.	Cell research	2014	22
24362523	5460	Hayashi H	The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer.	Oncogene	2015	17
24608791	5460	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	48
25090446	5460	Theunissen TW	Systematic identification of culture conditions for induction and maintenance of naive human pluripotency.	Cell stem cell	2014	124
25684226	5460	Nori S	Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.	Stem cell reports	2015	27
10618385	5621	Zahn R	NMR solution structure of the human prion protein.	Proceedings of the National Academy of Sciences of the United States of America	2000	225
10766242	5621	Matsunami H	A family of candidate taste receptors in human and mouse.	Nature	2000	119
11504948	5621	Korth C	Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	111
12456643	5621	Asante EA	BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.	The EMBO journal	2002	96
15618225	5621	Féraudet C	Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.	The Journal of biological chemistry	2005	97
16135751	5621	Kong Q	Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models.	The Journal of neuroscience 	2005	78
16391566	5621	Mead S	Prion disease genetics.	European journal of human genetics 	2006	63
16518470	5621	Nonno R	Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles.	PLoS pathogens	2006	62
17242357	5621	Lu X	Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.	Proceedings of the National Academy of Sciences of the United States of America	2007	72
17923484	5621	Barron RM	High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo.	The Journal of biological chemistry	2007	69
18025469	5621	Cobb NJ	Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.	Proceedings of the National Academy of Sciences of the United States of America	2007	111
18096717	5621	Colby DW	Prion detection by an amyloid seeding assay.	Proceedings of the National Academy of Sciences of the United States of America	2007	67
18519020	5621	Béringue V	Prion agent diversity and species barrier.	Veterinary research	2008	51
19436715	5621	Barria MA	De novo generation of infectious prions in vitro produces a new disease phenotype.	PLoS pathogens	2009	50
20547859	5621	Bishop MT	Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21350487	5621	Sandberg MK	Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.	Nature	2011	94
21654636	5621	Freir DB	Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.	Nature communications	2011	87
22282814	5621	Béringue V	Facilitated cross-species transmission of prions in extraneural tissue.	Science	2012	40
22307640	5621	You H	Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	53
24336048	5621	Joshi P	Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles.	Cell death and differentiation	2014	31
26086786	5621	Orrú CD	Bank Vole Prion Protein As an Apparently Universal Substrate for RT-QuIC-Based Detection and Discrimination of Prion Strains.	PLoS pathogens	2015	24
26324905	5621	Prusiner SB	Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2015	63
12068293	6387	Petit I	G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.	Nature immunology	2002	291
12357350	6387	Lapidot T	The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice.	Leukemia	2002	97
15548717	6387	Zou L	Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.	Cancer research	2004	92
15695388	6387	Kryczek I	CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.	Cancer research	2005	92
15882617	6387	Orimo A	Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.	Cell	2005	902
16337237	6387	Jung Y	Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.	Bone	2006	82
16489019	6387	Yasumoto K	Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.	Cancer research	2006	61
17298974	6387	Seeger FH	Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.	European heart journal	2007	74
17476353	6387	Brem H	Cellular and molecular basis of wound healing in diabetes.	The Journal of clinical investigation	2007	190
17724466	6387	Wendt MK	Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.	Oncogene	2008	53
18371365	6387	Hermann PC	Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.	Cell stem cell	2007	712
18519693	6387	Mishra PJ	Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.	Cancer research	2008	207
19181699	6387	Muehlberg FL	Tissue-resident stem cells promote breast cancer growth and metastasis.	Carcinogenesis	2009	72
19324903	6387	Hoggatt J	Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.	Blood	2009	118
20460522	6387	Nimmagadda S	Molecular imaging of CXCR4 receptor expression in human cancer xenografts with 64CuAMD3100 positron emission tomography.	Cancer research	2010	43
21041659	6387	Kojima Y	Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.	Proceedings of the National Academy of Sciences of the United States of America	2010	155
21508321	6387	Godier-Furnémont AF	Composite scaffold provides a cell delivery platform for cardiovascular repair.	Proceedings of the National Academy of Sciences of the United States of America	2011	45
22927248	6387	Xu J	Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.	Blood	2012	43
23540695	6387	Cheng L	Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.	Cell	2013	132
24511463	6387	Cheng K	Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair.	JACC. Heart failure	2014	24
25368021	6387	Lee KW	Twist1 is a key regulator of cancer-associated fibroblasts.	Cancer research	2015	17
25825601	6387	Wester HJ	Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.	Theranostics	2015	17
10678833	6622	Masliah E	Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.	Science	2000	326
11572944	6622	Masliah E	beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	110
11590439	6622	Chung KK	Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.	Nature medicine	2001	138
11923443	6622	Kirik D	Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.	The Journal of neuroscience 	2002	150
12062037	6622	Giasson BI	Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.	Neuron	2002	239
12084935	6622	Lee MK	Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --&amp;gt; Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	148
12122208	6622	Lo Bianco C	alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2002	112
12714745	6622	Giasson BI	Initiation and synergistic fibrillization of tau and alpha-synuclein.	Science	2003	162
12807436	6622	Lakso M	Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.	Journal of neurochemistry	2003	82
15496679	6622	Fleming SM	Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.	The Journal of neuroscience 	2004	129
15576511	6622	Lo Bianco C	Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	71
15590933	6622	Yavich L	Role of alpha-synuclein in presynaptic dopamine recruitment.	The Journal of neuroscience 	2004	76
15791003	6622	Zhang W	Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.	FASEB journal 	2005	243
16399671	6622	Martin LJ	Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.	The Journal of neuroscience 	2006	165
16794039	6622	Cooper AA	Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.	Science	2006	396
17088319	6622	Marsh JA	Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.	Protein science 	2006	167
17537546	6622	Su X	Synuclein activates microglia in a model of Parkinson's disease.	Neurobiology of aging	2008	88
17949715	6622	Chesselet MF	In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?	Experimental neurology	2008	55
18036154	6622	Reynolds AD	Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.	Journal of neurochemistry	2008	59
18178617	6622	Gorbatyuk OS	The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	73
18182484	6622	Hamamichi S	Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.	Proceedings of the National Academy of Sciences of the United States of America	2008	93
18182779	6622	Barbour R	Red blood cells are the major source of alpha-synuclein in blood.	Neuro-degenerative diseases	2008	65
18451726	6622	Waxman EA	Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.	Journal of neuropathology and experimental neurology	2008	72
18566453	6622	Vogiatzi T	Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.	The Journal of biological chemistry	2008	145
18625222	6622	Mollenhauer B	Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration.	Experimental neurology	2008	86
18704197	6622	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
18769546	6622	Tsigelny IF	Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.	PloS one	2008	69
19018246	6622	Theodore S	Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.	Journal of neuropathology and experimental neurology	2008	64
19074459	6622	Azeredo da Silveira S	Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.	Human molecular genetics	2009	55
19295143	6622	Chung CY	Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.	The Journal of neuroscience 	2009	88
19385059	6622	Cannon JR	A highly reproducible rotenone model of Parkinson's disease.	Neurobiology of disease	2009	96
19436756	6622	Xilouri M	Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.	PloS one	2009	90
19651612	6622	Desplats P	Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.	Proceedings of the National Academy of Sciences of the United States of America	2009	403
19686384	6622	Danzer KM	Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.	Journal of neurochemistry	2009	71
19745811	6622	Karpinar DP	Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.	The EMBO journal	2009	94
20038714	6622	Su LJ	Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.	Disease models and mechanisms	2010	51
20071342	6622	Lee HJ	Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.	The Journal of biological chemistry	2010	170
20106983	6622	Doxakis E	Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153.	The Journal of biological chemistry	2010	104
20152114	6622	Nemani VM	Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.	Neuron	2010	247
20203178	6622	Paleologou KE	Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.	The Journal of neuroscience 	2010	68
20385841	6622	Bieschke J	EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2010	122
20392839	6622	Thayanidhi N	Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs.	Molecular biology of the cell	2010	73
20534649	6622	Garcia-Reitböck P	SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.	Brain 	2010	56
20696318	6622	Oueslati A	Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.	Progress in brain research	2010	67
21488084	6622	Lam HA	Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.	Journal of neuroscience research	2011	35
21489994	6622	Nakamura K	Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein.	The Journal of biological chemistry	2011	129
21559417	6622	Masliah E	Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease.	PloS one	2011	102
21700325	6622	Mazzulli JR	Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.	Cell	2011	216
21994367	6622	Ebrahimi-Fakhari D	Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.	The Journal of neuroscience 	2011	76
22110584	6622	Byers B	SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.	PloS one	2011	49
22315227	6622	Fauvet B	α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.	The Journal of biological chemistry	2012	118
22350713	6622	Chesselet MF	A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.	Neurotherapeutics 	2012	36
22399753	6622	Colla E	Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.	The Journal of neuroscience 	2012	66
22737239	6622	Angot E	Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.	PloS one	2012	46
23392688	6622	Boassa D	Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson's disease pathogenesis.	The Journal of neuroscience 	2013	35
23703938	6622	Ulusoy A	Caudo-rostral brain spreading of α-synuclein through vagal connections.	EMBO molecular medicine	2013	29
23739956	6622	Harms AS	MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.	The Journal of neuroscience 	2013	45
23925565	6622	Rey NL	Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.	Acta neuropathologica	2013	40
24158904	6622	Chung CY	Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.	Science	2013	76
24243558	6622	Recasens A	Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.	Annals of neurology	2014	73
24381286	6622	Guardia-Laguarta C	α-Synuclein is localized to mitochondria-associated ER membranes.	The Journal of neuroscience 	2014	48
24382629	6622	Reyes JF	Alpha-synuclein transfers from neurons to oligodendrocytes.	Glia	2014	44
26076669	6622	Dettmer U	Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation.	Nature communications	2015	27
26564470	6622	Deas E	Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.	Antioxidants and redox signaling	2016	16
27018801	6622	Tuttle MD	Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein.	Nature structural and molecular biology	2016	34
8209258	6647	Gurney ME	Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.	Science	1994	776
11331366	6647	Pramatarova A	Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.	The Journal of neuroscience 	2001	88
12050154	6647	Mattiazzi M	Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.	The Journal of biological chemistry	2002	133
12754496	6647	Elam JS	Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.	Nature structural biology	2003	87
15233913	6647	Liu J	Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.	Neuron	2004	132
15758154	6647	Vijayvergiya C	Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.	The Journal of neuroscience 	2005	67
15768029	6647	Ralph GS	Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.	Nature medicine	2005	111
15952898	6647	Valentine JS	Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.	Annual review of biochemistry	2005	174
16806844	6647	Van Den Bosch L	The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.	Biochimica et biophysica acta	2006	69
17038899	6647	Xu L	Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats.	Transplantation	2006	63
17435754	6647	Di Giorgio FP	Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.	Nature neuroscience	2007	244
18282652	6647	Turner BJ	Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.	Progress in neurobiology	2008	144
18945894	6647	van Zundert B	Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.	The Journal of neuroscience 	2008	53
19041780	6647	Di Giorgio FP	Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation.	Cell stem cell	2008	148
19041781	6647	Marchetto MC	Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.	Cell stem cell	2008	146
19271992	6647	Chattopadhyay M	Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.	Antioxidants and redox signaling	2009	45
19672969	6647	Zhao W	Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.	Glia	2010	59
19903735	6647	Walker AK	Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.	Brain 	2010	44
20223753	6647	Wong M	Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.	Human molecular genetics	2010	74
21411657	6647	Ozdinler PH	Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.	The Journal of neuroscience 	2011	49
21832997	6647	Haidet-Phillips AM	Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.	Nature biotechnology	2011	186
21908873	6647	Ferraiuolo L	Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.	Brain 	2011	37
21930926	6647	Grad LI	Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	76
21969586	6647	Papadeas ST	Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2011	55
22219285	6647	Magrané J	Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons.	The Journal of neuroscience 	2012	41
23026746	6647	Graffmo KS	Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis.	Human molecular genetics	2013	30
24008656	6647	Foust KD	Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.	Molecular therapy 	2013	39
24292713	6647	Glasauer A	Targeting SOD1 reduces experimental non–small-cell lung cancer.	The Journal of clinical investigation	2014	28
24508385	6647	Re DB	Necroptosis drives motor neuron death in models of both sporadic and familial ALS.	Neuron	2014	65
24550511	6647	Grad LI	Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms.	Proceedings of the National Academy of Sciences of the United States of America	2014	78
1323840	7157	Kuerbitz SJ	Wild-type p53 is a cell cycle checkpoint determinant following irradiation.	Proceedings of the National Academy of Sciences of the United States of America	1992	317
1423635	7157	Hupp TR	Regulation of the specific DNA binding function of p53.	Cell	1992	231
1533443	7157	Yew PR	Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.	Nature	1992	177
1905840	7157	Hollstein M	p53 mutations in human cancers.	Science	1991	1290
2143698	7157	Michalovitz D	Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.	Cell	1990	217
2531845	7157	Nigro JM	Mutations in the p53 gene occur in diverse human tumour types.	Nature	1989	402
8380895	7157	Huibregtse JM	Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.	Molecular and cellular biology	1993	143
9176490	7157	Heise C	ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.	Nature medicine	1997	127
9774969	7157	Yang A	p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.	Molecular cell	1998	516
10446993	7157	Chang BD	A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.	Cancer research	1999	107
10728684	7157	Barcellos-Hoff MH	Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.	Cancer research	2000	151
11859195	7157	Yu JL	Effect of p53 status on tumor response to antiangiogenic therapy.	Science	2002	86
11875500	7157	Bykov VJ	Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.	Nature medicine	2002	198
12077306	7157	Hoh J	The p53MH algorithm and its application in detecting p53-responsive genes.	Proceedings of the National Academy of Sciences of the United States of America	2002	103
12235210	7157	Zaika AI	DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.	The Journal of experimental medicine	2002	92
12941807	7157	Riley RR	Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.	Cancer research	2003	97
14634023	7157	Melino G	p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.	The Journal of biological chemistry	2004	107
15042092	7157	Berns K	A large-scale RNAi screen in human cells identifies new components of the p53 pathway.	Nature	2004	267
15054096	7157	Wang S	Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.	The Journal of biological chemistry	2004	88
15158709	7157	Kolberg M	Structure, function, and mechanism of ribonucleotide reductases.	Biochimica et biophysica acta	2004	85
15351967	7157	Dellaire G	PML nuclear bodies: dynamic sensors of DNA damage and cellular stress.	BioEssays 	2004	117
16170357	7157	Bossi G	Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.	Oncogene	2006	68
16601753	7157	Murray-Zmijewski F	p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.	Cell death and differentiation	2006	154
17179143	7157	Qin H	Regulation of apoptosis and differentiation by p53 in human embryonic stem cells.	The Journal of biological chemistry	2007	76
17401423	7157	Soussi T	p53 alterations in human cancer: more questions than answers.	Oncogene	2007	58
17401431	7157	Li Y	Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?	Oncogene	2007	57
17417627	7157	Song H	p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.	Nature cell biology	2007	112
17468756	7157	Theodorou V	MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.	Nature genetics	2007	69
17638885	7157	Buzzai M	Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.	Cancer research	2007	296
17942417	7157	Rodier F	Two faces of p53: aging and tumor suppression.	Nucleic acids research	2007	111
18454141	7157	Tasdemir E	Regulation of autophagy by cytoplasmic p53.	Nature cell biology	2008	313
18495520	7157	Ashkenazi A	Targeting the extrinsic apoptosis pathway in cancer.	Cytokine and growth factor reviews	2008	86
18663127	7157	Muñoz-Fontela C	Transcriptional role of p53 in interferon-mediated antiviral immunity.	The Journal of experimental medicine	2008	66
19225112	7157	Sur S	A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.	Proceedings of the National Academy of Sciences of the United States of America	2009	108
19308457	7157	Pfeifer GP	Mutational spectra of human cancer.	Human genetics	2009	69
19881536	7157	Liu DP	A common gain of function of p53 cancer mutants in inducing genetic instability.	Oncogene	2010	50
19887545	7157	Hirai H	Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents.	Molecular cancer therapeutics	2009	90
20038740	7157	De Angelis A	Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.	Circulation	2010	62
20066118	7157	Zilfou JT	Tumor suppressive functions of p53.	Cold Spring Harbor perspectives in biology	2009	96
20074536	7157	Song H	Modeling disease in human ESCs using an efficient BAC-based homologous recombination system.	Cell stem cell	2010	68
20107315	7157	Hirai H	MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.	Cancer biology and therapy	2010	55
20123995	7157	Thompson SL	Proliferation of aneuploid human cells is limited by a p53-dependent mechanism.	The Journal of cell biology	2010	142
20182602	7157	Olivier M	TP53 mutations in human cancers: origins, consequences, and clinical use.	Cold Spring Harbor perspectives in biology	2010	236
20182618	7157	Oren M	Mutant p53 gain-of-function in cancer.	Cold Spring Harbor perspectives in biology	2010	181
20336134	7157	Sahin E	Linking functional decline of telomeres, mitochondria and stem cells during ageing.	Nature	2010	191
20619763	7157	Milyavsky M	A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.	Cell stem cell	2010	69
20871609	7157	Swarbrick A	miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.	Nature medicine	2010	52
21205082	7157	Nakahara T	Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models.	Cancer science	2011	43
21389100	7157	Rajeshkumar NV	MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.	Clinical cancer research 	2011	63
21427767	7157	Levine AJ	The p53 family: guardians of maternal reproduction.	Nature reviews. Molecular cell biology	2011	87
21530747	7157	Ullman TA	Intestinal inflammation and cancer.	Gastroenterology	2011	197
21576821	7157	Rhee YH	Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.	The Journal of clinical investigation	2011	74
21764762	7157	Textor S	Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.	Cancer research	2011	39
21779517	7157	Rufini A	p73 in Cancer.	Genes and cancer	2011	39
21799033	7157	Bridges KA	MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.	Clinical cancer research 	2011	50
21941372	7157	Marcel V	Biological functions of p53 isoforms through evolution: lessons from animal and cellular models.	Cell death and differentiation	2011	65
21962518	7157	Liu J	Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.	Cell	2011	142
22090360	7157	Skinner HD	TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.	Clinical cancer research 	2012	58
22265402	7157	Rausch T	Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.	Cell	2012	175
22351930	7157	Scarlett UK	Ovarian cancer progression is controlled by phenotypic changes in dendritic cells.	The Journal of experimental medicine	2012	78
22579044	7157	Reijns MA	Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development.	Cell	2012	118
22698402	7157	Davoli T	Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells.	Cancer cell	2012	58
22789538	7157	Bywater MJ	Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.	Cancer cell	2012	107
22986101	7157	Zhang K	Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.	Experimental hematology	2013	45
23151455	7157	Rodriguez OC	Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.	Cell cycle	2012	33
23242140	7157	Maddocks OD	Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.	Nature	2013	145
23512991	7157	Batey MA	Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.	Molecular cancer therapeutics	2013	25
23514892	7157	Cheng J	Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities.	Journal of virology	2013	27
23644491	7157	Kadoch C	Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.	Nature genetics	2013	169
23749640	7157	Kimple RJ	Enhanced radiation sensitivity in HPV-positive head and neck cancer.	Cancer research	2013	64
23811687	7157	Du W	TAp73 enhances the pentose phosphate pathway and supports cell proliferation.	Nature cell biology	2013	55
24487586	7157	Arjonen A	Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.	The Journal of clinical investigation	2014	36
25362853	7157	Gao J	miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.	Oncogene	2015	24
25689248	7157	Boulter L	WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.	The Journal of clinical investigation	2015	23
25792665	7157	Ahmad T	Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease.	FASEB journal 	2015	19
25860607	7157	Lee DF	Modeling familial cancer with induced pluripotent stem cells.	Cell	2015	28
25883152	7157	Younger ST	Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage.	Nucleic acids research	2015	23
26024390	7157	Soussi T	TP53: an oncogene in disguise.	Cell death and differentiation	2015	26
26605532	7157	Jin W	Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples.	Nature	2015	31
26748848	7157	Soragni A	A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.	Cancer cell	2016	19
26751173	7157	Korkmaz G	Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.	Nature biotechnology	2016	36
26853913	7157	Niopek D	Optogenetic control of nuclear protein export.	Nature communications	2016	11
7673356	7422	Roberts WG	Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.	Journal of cell science	1995	170
7683111	7422	Kim KJ	Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.	Nature	1993	547
7759509	7422	Frank S	Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing.	The Journal of biological chemistry	1995	119
9377574	7422	Presta LG	Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.	Cancer research	1997	287
9916127	7422	Benjamin LE	Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.	The Journal of clinical investigation	1999	225
10406801	7422	Asahara T	VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.	The EMBO journal	1999	299
10655109	7422	Zhang M	Maspin is an angiogenesis inhibitor.	Nature medicine	2000	95
10662790	7422	Yang TY	Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.	The Journal of experimental medicine	2000	94
11005565	7422	Rubenstein JL	Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.	Neoplasia	2000	137
11549582	7422	Skobe M	Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.	The American journal of pathology	2001	99
12177445	7422	Holash J	VEGF-Trap: a VEGF blocker with potent antitumor effects.	Proceedings of the National Academy of Sciences of the United States of America	2002	331
12600822	7422	Tuder RM	Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.	American journal of respiratory cell and molecular biology	2003	106
14993122	7422	Rehman J	Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.	Circulation	2004	362
15161630	7422	Galiano RD	Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.	The American journal of pathology	2004	136
15351965	7422	Storkebaum E	VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection.	BioEssays 	2004	93
16172288	7422	Khurana R	Role of angiogenesis in cardiovascular disease: a critical appraisal.	Circulation	2005	79
16322226	7422	Mironchik Y	Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.	Cancer research	2005	84
16397235	7422	LaMontagne K	Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.	Cancer research	2006	74
16490250	7422	Leach JK	Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration.	Biomaterials	2006	67
16571143	7422	Demedts IK	Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.	Respiratory research	2006	101
16880208	7422	Coppé JP	Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence.	The Journal of biological chemistry	2006	104
16912155	7422	Bao S	Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.	Cancer research	2006	351
17533168	7422	Rigau V	Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.	Brain 	2007	69
17591953	7422	Nishijima K	Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.	The American journal of pathology	2007	170
17631557	7422	Nagengast WB	In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.	Journal of nuclear medicine 	2007	63
17636120	7422	Sayed N	Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.	Proceedings of the National Academy of Sciences of the United States of America	2007	68
18000042	7422	Rudge JS	VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade.	Proceedings of the National Academy of Sciences of the United States of America	2007	66
18349829	7422	Varey AH	VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.	British journal of cancer	2008	74
18608994	7422	Mac Gabhann F	Systems biology of vascular endothelial growth factors.	Microcirculation	2008	52
19305413	7422	Reynolds AR	Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.	Nature medicine	2009	111
19666581	7422	Thangarajah H	The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
19805054	7422	Yang F	Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles.	Proceedings of the National Academy of Sciences of the United States of America	2010	68
20501804	7422	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	49
20811159	7422	Bird AC	Therapeutic targets in age-related macular disease.	The Journal of clinical investigation	2010	58
21732485	7422	Horie N	Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.	Stem cells	2011	61
22222630	7422	Pastuskovas CV	Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model.	Molecular cancer therapeutics	2012	33
22229128	7422	Zhang Y	Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.	American journal of nuclear medicine and molecular imaging	2012	39
22399811	7422	dela Paz NG	Role of shear-stress-induced VEGF expression in endothelial cell survival.	Journal of cell science	2012	37
22495829	7422	Oki K	Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain.	Stem cells	2012	56
22498007	7422	McIntyre A	Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.	Clinical cancer research 	2012	44
23108136	7422	Terme M	VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.	Cancer research	2013	61
23283490	7422	Shin L	Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells.	Stem cells translational medicine	2013	26
23358650	7422	Tabernero J	First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.	Cancer discovery	2013	116
23512266	7422	Soda Y	Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.	Journal of molecular medicine	2013	35
23585288	7422	Maruotti J	A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.	Stem cells translational medicine	2013	26
24013197	7422	Zangi L	Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.	Nature biotechnology	2013	70
24097868	7422	Kienast Y	Ang-2-VEGF-A CrossMab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy.	Clinical cancer research 	2013	34
24949972	7422	Eswarappa SM	Programmed translational readthrough generates antiangiogenic VEGF-Ax.	Cell	2014	40
25117977	7422	Baker GJ	Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.	Neoplasia	2014	26
25402324	7422	Hiroshima Y	Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.	Oncotarget	2014	41
10725386	7442	Mezey E	Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.	Proceedings of the National Academy of Sciences of the United States of America	2000	143
11606325	7442	Bisogno T	Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.	British journal of pharmacology	2001	113
11992116	7442	Trevisani M	Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1.	Nature neuroscience	2002	85
12151520	7442	Güler AD	Heat-evoked activation of the ion channel, TRPV4.	The Journal of neuroscience 	2002	201
15124026	7442	Karai L	Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.	The Journal of clinical investigation	2004	87
15615864	7442	Gavva NR	AMG 9810 (E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzob1,4 dioxin-6-yl)acrylamide, a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.	The Journal of pharmacology and experimental therapeutics	2005	86
17590514	7442	Ruparel NB	Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors.	Pain	2008	53
18000030	7442	Taylor-Clark TE	Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1).	Molecular pharmacology	2008	83
18337008	7442	Gavva NR	Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.	Pain	2008	89
20351268	7442	Yang F	Thermosensitive TRP channel pore turret is part of the temperature activation pathway.	Proceedings of the National Academy of Sciences of the United States of America	2010	66
21315593	7442	Everaerts W	The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil.	Current biology 	2011	51
22387095	7442	Okun A	Afferent drive elicits ongoing pain in a model of advanced osteoarthritis.	Pain	2012	31
24152419	7442	Kelly S	Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain.	Annals of the rheumatic diseases	2015	19
24305160	7442	Liao M	Structure of the TRPV1 ion channel determined by electron cryo-microscopy.	Nature	2013	308
25420066	7442	Wainger BJ	Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts.	Nature neuroscience	2015	24
9389720	8842	Yin AH	AC133, a novel marker for human hematopoietic stem and progenitor cells.	Blood	1997	355
15226377	8842	Richardson GD	CD133, a novel marker for human prostatic epithelial stem cells.	Journal of cell science	2004	184
15254585	8842	Torrente Y	Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle.	The Journal of clinical investigation	2004	87
15378086	8842	Singh SK	Cancer stem cells in nervous system tumors.	Oncogene	2004	166
17122772	8842	O'Brien CA	A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.	Nature	2007	1048
17205516	8842	Yin S	CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.	International journal of cancer	2007	149
17570225	8842	Ma S	Identification and characterization of tumorigenic liver cancer stem/progenitor cells.	Gastroenterology	2007	294
18037961	8842	Günther HS	Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.	Oncogene	2008	113
18560366	8842	Joo KM	Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.	Laboratory investigation; a journal of technical methods and pathology	2008	108
18654668	8842	Yang Z	Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice.	The Journal of clinical investigation	2008	73
18836486	8842	Baba T	Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.	Oncogene	2009	117
19047148	8842	Vander Griend DJ	The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.	Cancer research	2008	78
19092120	8842	Ronconi E	Regeneration of glomerular podocytes by human renal progenitors.	Journal of the American Society of Nephrology 	2009	147
19156211	8842	Mahller YY	Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.	PloS one	2009	51
19342601	8842	Barcelos LS	Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.	Circulation research	2009	64
19676044	8842	Salnikov AV	CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.	International journal of cancer	2010	53
19748175	8842	Zhang Q	A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.	Cancer letters	2010	50
19805294	8842	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	234
19816957	8842	Curley MD	CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.	Stem cells	2009	123
19904829	8842	Fan X	NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.	Stem cells	2010	191
20375132	8842	El Hallani S	A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.	Brain 	2010	85
21385990	8842	Tirino V	Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.	FASEB journal 	2011	49
21451132	8842	Stewart JM	Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	65
21695188	8842	Kim MP	ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.	PloS one	2011	95
22079466	8842	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	49
22431923	8842	Jamal M	The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.	Neoplasia	2012	33
23293278	8842	Bach P	Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.	Cancer research	2013	33
23524583	8842	Zhang S	Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.	Oncogene	2014	50
24436149	8842	Sarvi S	CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.	Cancer research	2014	30
25262208	8842	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	30
25938772	8842	Hu Y	Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.	PloS one	2015	24
11948178	10013	Gao L	Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.	The Journal of biological chemistry	2002	134
12606581	10013	Zhang Y	HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo.	The EMBO journal	2003	173
12677000	10013	Haggarty SJ	Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.	Proceedings of the National Academy of Sciences of the United States of America	2003	263
19167333	10013	Kim AH	A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons.	Cell	2009	86
22262760	10013	Santo L	Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.	Blood	2012	93
22367781	10013	Rao R	Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.	Molecular cancer therapeutics	2012	39
23962722	10013	Cook C	Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.	Human molecular genetics	2014	35
24200693	10013	Lam HC	Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.	The Journal of clinical investigation	2013	52
25972179	10013	Sen A	ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation.	The Journal of neuroscience 	2015	16
17653091	10018	Anderton E	Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.	Oncogene	2008	66
17927446	10018	Gong Y	Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas.	PLoS medicine	2007	113
18381439	10018	Hann CL	Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.	Cancer research	2008	64
18725989	10018	Kinkade CW	Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.	The Journal of clinical investigation	2008	151
20647567	10018	Bachmann PS	Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.	Blood	2010	42
21984578	10018	Santin I	PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim.	Diabetes	2011	38
22622039	10018	LaBelle JL	A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.	The Journal of clinical investigation	2012	54
23243017	10018	Rahmani M	Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.	Cancer research	2013	38
23382048	10018	Nakagawa T	EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.	Cancer research	2013	36
25737542	10018	Faber AC	Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2015	21
26575167	10018	Li GQ	Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.	Oncotarget	2016	12
26579470	10018	Huang L	Mechanisms of resistance to EGFR tyrosine kinase inhibitors.	Acta pharmaceutica Sinica. B	2015	29
17301055	10059	Taguchi N	Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.	The Journal of biological chemistry	2007	271
19342591	10059	Cho DH	S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.	Science	2009	280
21459773	10059	Manczak M	Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.	Human molecular genetics	2011	113
22321727	10059	Rehman J	Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer.	FASEB journal 	2012	87
22511751	10059	Marsboom G	Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.	Circulation research	2012	88
23349293	10059	Korobova F	An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2.	Science	2013	114
24231356	10059	Guo X	Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.	The Journal of clinical investigation	2013	52
25658204	10059	Serasinghe MN	Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors.	Molecular cell	2015	37
26618722	10059	Wang W	Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes.	Nature medicine	2016	21
16814713	10413	Zender L	Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.	Cell	2006	374
16894141	10413	Overholtzer M	Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.	Proceedings of the National Academy of Sciences of the United States of America	2006	278
17437995	10413	Pan D	Hippo signaling in organ size control.	Genes and development	2007	204
17889654	10413	Dong J	Elucidation of a universal size-control mechanism in Drosophila and mammals.	Cell	2007	582
17974916	10413	Zhao B	Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.	Genes and development	2007	583
17980593	10413	Camargo FD	YAP1 increases organ size and expands undifferentiated progenitor cells.	Current biology 	2007	317
18413746	10413	Zhang J	Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.	Cancer research	2008	88
18640976	10413	Oka T	Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).	The Journal of biological chemistry	2008	102
19111660	10413	Lapi E	PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.	Molecular cell	2008	69
19234525	10413	Wang K	YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.	Biochemistry and cell biology = Biochimie et biologie cellulaire	2009	60
19424602	10413	Katoh M	Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades.	International journal of molecular medicine	2009	53
19551889	10413	Xu MZ	Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.	Cancer	2009	124
19878874	10413	Zhou D	Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.	Cancer cell	2009	261
19935651	10413	Zhang J	YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.	Nature cell biology	2009	131
19952108	10413	Fernandez-L A	YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.	Genes and development	2009	110
20516196	10413	Lian I	The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation.	Genes and development	2010	167
21076472	10413	Xu MZ	AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.	Oncogene	2011	46
21102585	10413	Avruch J	Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.	British journal of cancer	2011	41
21346147	10413	Kang W	Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.	Clinical cancer research 	2011	47
21610251	10413	Silvis MR	α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1.	Science signaling	2011	92
22042863	10413	Zhou D	Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.	Proceedings of the National Academy of Sciences of the United States of America	2011	99
22215811	10413	Zhao B	Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.	Genes and development	2012	165
22337891	10413	Konsavage WM Jr	Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.	The Journal of biological chemistry	2012	62
22609549	10413	Straßburger K	Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP.	Developmental biology	2012	32
22677547	10413	Liu-Chittenden Y	Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.	Genes and development	2012	210
22707013	10413	Zhang T	Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.	Hepatology	2012	42
22886419	10413	Bai H	Yes-associated protein regulates the hepatic response after bile duct ligation.	Hepatology	2012	32
22891335	10413	Lamar JM	The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.	Proceedings of the National Academy of Sciences of the United States of America	2012	105
23143395	10413	Tumaneng K	YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.	Nature cell biology	2012	87
23178811	10413	Barry ER	Restriction of intestinal stem cell expansion and the regenerative response by YAP.	Nature	2013	106
23419361	10413	Tschaharganeh DF	Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.	Gastroenterology	2013	57
23685250	10413	Tang Y	MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis.	Developmental cell	2013	50
24268772	10413	Anakk S	Bile acids activate YAP to promote liver carcinogenesis.	Cell reports	2013	25
24362629	10413	Mohseni M	A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway.	Nature cell biology	2014	59
24468535	10413	Wang J	Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.	Cellular signalling	2014	21
24622501	10413	Xia Y	YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.	PloS one	2014	30
24803537	10413	Zhang W	Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.	Science signaling	2014	58
24833660	10413	Lin Z	Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.	Circulation research	2014	42
24882516	10413	Yu FX	Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.	Cancer cell	2014	66
24884509	10413	Tu K	Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.	Molecular cancer	2014	25
24954536	10413	Shao DD	KRAS and YAP1 converge to regulate EMT and tumor survival.	Cell	2014	119
25010260	10413	Perra A	YAP activation is an early event and a potential therapeutic target in liver cancer development.	Journal of hepatology	2014	40
25087979	10413	Tremblay AM	The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.	Cancer cell	2014	28
25195862	10413	Liu G	Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway.	Oncogene	2015	18
25293527	10413	Yu FX	Hippo pathway regulation of gastrointestinal tissues.	Annual review of physiology	2015	15
25305307	10413	Li J	Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity.	Circulation research	2015	24
25438054	10413	Ma B	Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.	Nature cell biology	2015	30
25480985	10413	Lange AW	Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.	Journal of molecular cell biology	2015	25
25665005	10413	Lin L	The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.	Nature genetics	2015	62
25731159	10413	Taniguchi K	A gp130-Src-YAP module links inflammation to epithelial regeneration.	Nature	2015	61
25739674	10413	Song S	The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.	Clinical cancer research 	2015	23
25751140	10413	Mo JS	Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.	Nature cell biology	2015	53
25772357	10413	Fitamant J	YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.	Cell reports	2015	26
25893606	10413	Zhou X	Estrogen regulates Hippo signaling via GPER in breast cancer.	The Journal of clinical investigation	2015	18
25908270	10413	Mannaerts I	The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.	Journal of hepatology	2015	22
25915126	10413	Cebola I	TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.	Nature cell biology	2015	25
25943351	10413	Morikawa Y	Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice.	Science signaling	2015	20
25961504	10413	Iglesias-Bartolome R	Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis.	Nature cell biology	2015	18
26058078	10413	Nguyen LT	ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.	Cancer cell	2015	18
26109051	10413	Chen Q	Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.	Genes and development	2015	23
26193883	10413	Cai J	β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.	Genes and development	2015	20
26276632	10413	Park HW	Alternative Wnt Signaling Activates YAP/TAZ.	Cell	2015	43
26701088	10413	Wang G	Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.	Cancer discovery	2016	17
27851739	10413	Gjorevski N	Designer matrices for intestinal stem cell and organoid culture.	Nature	2016	15
17622797	10533	Chu CT	Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death.	Autophagy	2007	60
19270530	10533	Hung SY	Autophagy protects neuron from Abeta-induced cytotoxicity.	Autophagy	2009	46
19881538	10533	Zhu K	Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.	Oncogene	2010	91
20174468	10533	Crews L	Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.	PloS one	2010	84
20231086	10533	Li J	Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model.	European journal of cancer	2010	77
20543840	10533	Zhao Y	Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.	Nature cell biology	2010	138
21081844	10533	Saiki S	Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition.	Autophagy	2011	73
21858812	10533	Shimizu S	Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.	International journal of cancer	2012	49
22055344	10533	DeSelm CJ	Autophagy proteins regulate the secretory component of osteoclastic bone resorption.	Developmental cell	2011	87
22447568	10533	Hu YL	Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.	Cancer research	2012	93
22504094	10533	Chang Y	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.	Gastroenterology	2012	48
22580614	10533	Ciechomska IA	Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death.	Oncogene	2013	29
22975756	10533	Lin NY	Autophagy regulates TNFα-mediated joint destruction in experimental arthritis.	Annals of the rheumatic diseases	2013	40
23117929	10533	Jansen HJ	Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression.	Endocrinology	2012	33
24492484	10533	Thapaliya S	Alcohol-induced autophagy contributes to loss in skeletal muscle mass.	Autophagy	2014	21
25484094	10533	Mitter SK	Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD.	Autophagy	2014	37
26214133	10533	Lévy J	Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.	Nature cell biology	2015	20
27184077	10533	Park SM	U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.	Molecular cell	2016	13
11226311	10625	Basler CF	Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.	Proceedings of the National Academy of Sciences of the United States of America	2001	95
11825945	10625	Alcon S	Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.	Journal of clinical microbiology	2002	124
15956587	10625	Quinlivan M	Attenuation of equine influenza viruses through truncations of the NS1 protein.	Journal of virology	2005	102
15994826	10625	Lo MS	Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness.	Journal of virology	2005	94
18052531	10625	Avirutnan P	Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.	PLoS pathogens	2007	68
19073731	10625	Steel J	Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.	Journal of virology	2009	82
19939933	10625	de Wit E	Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.	Journal of virology	2010	55
20444891	10625	Hale BG	Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.	Journal of virology	2010	59
22202676	10625	Khaperskyy DA	Influenza A virus inhibits cytoplasmic stress granule formation.	FASEB journal 	2012	37
24965472	10625	Nogales A	Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.	Journal of virology	2014	24
26355030	10625	Beatty PR	Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.	Science translational medicine	2015	43
26355031	10625	Modhiran N	Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity.	Science translational medicine	2015	47
27417494	10625	Stettler K	Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.	Science	2016	71
27820802	10625	Spencer-Smith R	Inhibition of RAS function through targeting an allosteric regulatory site.	Nature chemical biology	2017	10
16815144	10631	Takayama G	Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.	The Journal of allergy and clinical immunology	2006	127
17632525	10631	Kühn B	Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.	Nature medicine	2007	176
22246863	10631	Uchida M	Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2012	31
22535894	10631	Frangogiannis NG	Matricellular proteins in cardiac adaptation and disease.	Physiological reviews	2012	102
24218511	10631	Cheon DJ	A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.	Clinical cancer research 	2014	47
25345775	10631	Underwood TJ	Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.	The Journal of pathology	2015	25
25477501	10631	O'Meara CC	Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration.	Circulation research	2015	24
25580734	10631	Zhou W	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.	Nature cell biology	2015	59
26747277	10631	McConnell JC	Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.	Breast cancer research 	2016	10
8649389	10664	Filippova GN	An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.	Molecular and cellular biology	1996	180
18235444	10664	Wendt KS	Cohesin mediates transcriptional insulation by CCCTC-binding factor.	Nature	2008	434
18237772	10664	Parelho V	Cohesins functionally associate with CTCF on mammalian chromosome arms.	Cell	2008	337
18682548	10664	Bourque G	Evolution of the mammalian transcription factor binding repertoire via transposable elements.	Genome research	2008	156
19008940	10664	Libby RT	CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination.	PLoS genetics	2008	52
19308701	10664	Wendt KS	How cohesin and CTCF cooperate in regulating gene expression.	Chromosome research 	2009	45
19818655	10664	Sekimata M	CCCTC-binding factor and the transcription factor T-bet orchestrate T helper 1 cell-specific structure and function at the interferon-gamma locus.	Immunity	2009	58
21044947	10664	López Castel A	Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.	Human molecular genetics	2011	44
21454523	10664	Chien R	Cohesin mediates chromatin interactions that regulate mammalian β-globin expression.	The Journal of biological chemistry	2011	39
21576252	10664	Bartolomei MS	Mammalian genomic imprinting.	Cold Spring Harbor perspectives in biology	2011	120
21602820	10664	Martin D	Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes.	Nature structural and molecular biology	2011	36
21964334	10664	Shukla S	CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing.	Nature	2011	302
22495300	10664	Dixon JR	Topological domains in mammalian genomes identified by analysis of chromatin interactions.	Nature	2012	917
22912568	10664	Guo Y	High resolution genome wide binding event finding and motif discovery reveals transcription factor spatial binding constraints.	PLoS computational biology	2012	57
23483581	10664	Xu D	Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-catenin signaling.	Hepatology	2013	40
25497547	10664	Rao SS	A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping.	Cell	2014	482
26034287	10664	Gómez-Marín C	Evolutionary comparison reveals that diverging CTCF sites are signatures of ancestral topological associating domains borders.	Proceedings of the National Academy of Sciences of the United States of America	2015	27
26276636	10664	Guo Y	CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function.	Cell	2015	100
10359578	10673	Schneider P	BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.	The Journal of experimental medicine	1999	252
10398604	10673	Moore PA	BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.	Science	1999	235
11123269	10673	Zhang J	Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.	Journal of immunology	2001	140
12427767	10673	Mackay F	BAFF AND APRIL: a tutorial on B cell survival.	Annual review of immunology	2003	198
15634903	10673	Gong Q	Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.	Journal of immunology	2005	107
15701725	10673	Sims GP	Identification and characterization of circulating human transitional B cells.	Blood	2005	133
16914324	10673	Bossen C	BAFF, APRIL and their receptors: structure, function and signaling.	Seminars in immunology	2006	82
16973390	10673	Enzler T	Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.	Immunity	2006	66
17942754	10673	Bossen C	TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.	Blood	2008	81
19521398	10673	Mackay F	Cracking the BAFF code.	Nature reviews. Immunology	2009	202
20360558	10673	Obata T	Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
20727041	10673	Townsend MJ	B-cell targeted therapies in human autoimmune diseases: an updated perspective.	Immunological reviews	2010	63
22124120	10673	Kreuzaler M	Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.	Journal of immunology	2012	43
22197976	10673	Puga I	B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.	Nature immunology	2011	138
11340167	10891	Andersson U	Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells.	Molecular and cellular biology	2001	98
11943463	10891	Scarpulla RC	Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells.	Gene	2002	82
12807871	10891	Tiraby C	Acquirement of brown fat cell features by human white adipocytes.	The Journal of biological chemistry	2003	97
12808457	10891	Mootha VK	PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.	Nature genetics	2003	1654
15087503	10891	Schreiber SN	The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2004	155
15100410	10891	Mootha VK	Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.	Proceedings of the National Academy of Sciences of the United States of America	2004	218
15716268	10891	Nemoto S	SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}.	The Journal of biological chemistry	2005	284
15914121	10891	Valle I	PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.	Cardiovascular research	2005	115
16079133	10891	Koves TR	Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency.	The Journal of biological chemistry	2005	163
17466956	10891	Murphy E	Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury.	Cardiovascular research	2007	56
17468099	10891	Feige JN	The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.	The Journal of biological chemistry	2007	75
18270681	10891	Ling C	Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.	Diabetologia	2008	98
18431490	10891	Fu X	Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation.	PloS one	2008	55
19273754	10891	Qin W	PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.	Archives of neurology	2009	71
19460884	10891	Chaturvedi RK	Impaired PGC-1alpha function in muscle in Huntington's disease.	Human molecular genetics	2009	72
19542216	10891	Wareski P	PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.	The Journal of biological chemistry	2009	78
19853062	10891	Spindler SR	Caloric restriction: from soup to nuts.	Ageing research reviews	2010	58
20371735	10891	Lira VA	PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.	American journal of physiology. Endocrinology and metabolism	2010	60
20585248	10891	Bournat JC	Mitochondrial dysfunction in obesity.	Current opinion in endocrinology, diabetes, and obesity	2010	48
20661474	10891	Kong X	Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis.	PloS one	2010	132
21376232	10891	Shin JH	PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.	Cell	2011	228
21508222	10891	Seibler P	Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells.	The Journal of neuroscience 	2011	86
21775390	10891	Bouitbir J	Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.	European heart journal	2012	34
22033933	10891	Hondares E	Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16.	The Journal of biological chemistry	2011	41
22318941	10891	Wang B	Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.	Hepatology	2012	54
22405075	10891	Barrès R	Acute exercise remodels promoter methylation in human skeletal muscle.	Cell metabolism	2012	129
22861165	10891	Aquilano K	p53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance.	Antioxidants and redox signaling	2013	28
22975021	10891	Russell AP	Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis.	Neurobiology of disease	2013	36
23175776	10891	Koves TR	PPARγ coactivator-1α contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans.	Journal of lipid research	2013	32
23416000	10891	Vazquez F	PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.	Cancer cell	2013	104
23449689	10891	Ryan JJ	PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2013	30
23949796	10891	Sharma K	Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.	Journal of the American Society of Nephrology 	2013	61
24161908	10891	Corazao-Rozas P	Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor.	Oncotarget	2013	29
24186207	10891	Tennakoon JB	Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.	Oncogene	2014	35
24411942	10891	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	64
24506866	10891	Sawada N	Endothelial PGC-1α mediates vascular dysfunction in diabetes.	Cell metabolism	2014	27
24606795	10891	Valero T	Mitochondrial biogenesis: pharmacological approaches.	Current pharmaceutical design	2014	24
24722248	10891	Kurtz CL	MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.	Diabetes	2014	24
25241037	10891	LeBleu VS	PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis.	Nature cell biology	2014	121
25516156	10891	Blednov YA	Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.	Alcoholism, clinical and experimental research	2015	19
25761413	10891	Wang S	Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) α1.	International journal of obesity	2015	16
25863249	10891	Diebold I	BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.	Cell metabolism	2015	18
26002865	10891	Karunakaran D	Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.	Circulation research	2015	19
27496732	10891	Scharping NE	The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.	Immunity	2016	19
20643923	11009	Bartosh TJ	Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.	Proceedings of the National Academy of Sciences of the United States of America	2010	118
21555592	11009	Dash R	Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
21052097	11035	Vanlangenakker N	cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production.	Cell death and differentiation	2011	90
23612963	11035	Chen W	Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.	The Journal of biological chemistry	2013	47
24535827	11035	Morioka S	TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation.	The Journal of cell biology	2014	25
24901049	11035	Li JX	The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.	Cell death and disease	2014	30
24963148	11035	Gautheron J	A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.	EMBO molecular medicine	2014	29
25083992	11035	Mizumura K	Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD.	The Journal of clinical investigation	2014	48
25316792	11035	Wang X	Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
25592536	11035	Pasparakis M	Necroptosis and its role in inflammation.	Nature	2015	141
25607459	11035	Duong BH	A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.	Immunity	2015	28
25674982	11035	Huang Z	RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice.	Cell host and microbe	2015	32
25801023	11035	Ofengeim D	Activation of necroptosis in multiple sclerosis.	Cell reports	2015	37
25939025	11035	Onizawa M	The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.	Nature immunology	2015	33
25952668	11035	Koo GB	Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.	Cell research	2015	25
26531064	11035	Desai J	PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling.	European journal of immunology	2016	15
26817517	11035	Mulay SR	Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.	Nature communications	2016	12
27321907	11035	Nogusa S	RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.	Cell host and microbe	2016	26
9070310	11315	Nagakubo D	DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.	Biochemical and biophysical research communications	1997	160
12446870	11315	Bonifati V	Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.	Science	2003	510
14662519	11315	Bandopadhyay R	The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.	Brain 	2004	84
15766664	11315	Kim RH	DJ-1, a novel regulator of the tumor suppressor PTEN.	Cancer cell	2005	125
15944198	11315	Zhang L	Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.	Human molecular genetics	2005	108
16227205	11315	Zhou W	DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.	The Journal of biological chemistry	2005	93
17015834	11315	Clements CM	DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.	Proceedings of the National Academy of Sciences of the United States of America	2006	187
18556627	11315	Malhotra D	Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.	American journal of respiratory and critical care medicine	2008	129
19124468	11315	Blackinton J	Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.	The Journal of biological chemistry	2009	72
19144925	11315	Vasseur S	DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
20186336	11315	Krebiehl G	Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.	PloS one	2010	81
20639397	11315	Irrcher I	Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.	Human molecular genetics	2010	108
20812780	11315	Wilson MA	The role of cysteine oxidation in DJ-1 function and dysfunction.	Antioxidants and redox signaling	2011	58
22492997	11315	Im JY	DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.	Human molecular genetics	2012	35
22523093	11315	Lee JY	Human DJ-1 and its homologs are novel glyoxalases.	Human molecular genetics	2012	36
11672522	23411	Luo J	Negative control of p53 by Sir2alpha promotes cell survival under stress.	Cell	2001	634
12006491	23411	Langley E	Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.	The EMBO journal	2002	233
14980222	23411	Motta MC	Mammalian SIRT1 represses forkhead transcription factors.	Cell	2004	385
15205477	23411	Cohen HY	Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.	Science	2004	531
15719057	23411	Pagans S	SIRT1 regulates HIV transcription via Tat deacetylation.	PLoS biology	2005	91
16012755	23411	Kobayashi Y	SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.	International journal of molecular medicine	2005	72
16335928	23411	Napper AD	Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.	Journal of medicinal chemistry	2005	91
16751189	23411	Qin W	Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.	The Journal of biological chemistry	2006	154
17213307	23411	Zhang Q	Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex.	Proceedings of the National Academy of Sciences of the United States of America	2007	77
17360536	23411	Timmons JA	Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages.	Proceedings of the National Academy of Sciences of the United States of America	2007	185
17581637	23411	Kim D	SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.	The EMBO journal	2007	272
17612497	23411	Yuan Z	SIRT1 regulates the function of the Nijmegen breakage syndrome protein.	Molecular cell	2007	101
17638871	23411	Huffman DM	SIRT1 is significantly elevated in mouse and human prostate cancer.	Cancer research	2007	131
18235502	23411	Zhao W	Negative regulation of the deacetylase SIRT1 by DBC1.	Nature	2008	186
18239056	23411	You M	Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.	American journal of physiology. Gastrointestinal and liver physiology	2008	75
18414679	23411	Firestein R	The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.	PloS one	2008	193
18805010	23411	Kwon HS	The ups and downs of SIRT1.	Trends in biochemical sciences	2008	75
18835033	23411	Wang RH	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.	Cancer cell	2008	247
19060927	23411	Lara E	Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.	Oncogene	2009	67
19071085	23411	Suchankova G	Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells.	Biochemical and biophysical research communications	2009	51
19104446	23411	Julien C	Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.	Journal of neuropathology and experimental neurology	2009	56
19107194	23411	Sasaki T	Phosphorylation regulates SIRT1 function.	PloS one	2008	98
19229036	23411	Westerheide SD	Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.	Science	2009	213
19286634	23411	Orimo M	Protective role of SIRT1 in diabetic vascular dysfunction.	Arteriosclerosis, thrombosis, and vascular biology	2009	47
19376817	23411	Nakamaru Y	A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9.	FASEB journal 	2009	52
19455179	23411	Liang F	SIRT1 and insulin resistance.	Nature reviews. Endocrinology	2009	69
19996091	23411	van Loosdregt J	Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.	Blood	2010	103
20027304	23411	Nasrin N	JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.	PloS one	2009	93
20042607	23411	Zhang R	SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages.	The Journal of biological chemistry	2010	47
20089851	23411	Tanno M	Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.	The Journal of biological chemistry	2010	79
20169165	23411	Ghosh HS	SIRT1 negatively regulates the mammalian target of rapamycin.	PloS one	2010	72
20448046	23411	Aquilano K	Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis.	The Journal of biological chemistry	2010	72
20627091	23411	Ito T	MicroRNA-34a regulation of endothelial senescence.	Biochemical and biophysical research communications	2010	69
20631301	23411	Calvanese V	Sirtuin 1 regulation of developmental genes during differentiation of stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	54
20644332	23411	Kao CL	Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation.	Journal of atherosclerosis and thrombosis	2010	52
20668205	23411	Satoh A	SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus.	The Journal of neuroscience 	2010	63
21149730	23411	Ming M	Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
21364612	23411	Morselli E	Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy.	Cell death and disease	2010	128
21746786	23411	Donato AJ	SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans.	The Journal of physiology	2011	40
21778425	23411	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	44
22207735	23411	Yuan H	Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis.	Blood	2012	49
22249256	23411	Byles V	SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.	Oncogene	2012	68
22331558	23411	Zhang Q	A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53.	EMBO molecular medicine	2012	33
22553202	23411	Nin V	Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.	The Journal of biological chemistry	2012	38
22700961	23411	Liu TF	NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response.	The Journal of biological chemistry	2012	48
22902550	23411	Castro RE	miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.	Journal of hepatology	2013	54
23696823	23411	Endo H	Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.	PloS one	2013	33
24184811	23411	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	33
24439680	23411	Hubbard BP	Small molecule SIRT1 activators for the treatment of aging and age-related diseases.	Trends in pharmacological sciences	2014	77
24449278	23411	Ou X	SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress.	Stem cells	2014	39
24567379	23411	Cai W	Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24931715	23411	Mercken EM	SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass.	Aging cell	2014	23
25538153	23411	Planavila A	Fibroblast growth factor 21 protects the heart from oxidative stress.	Cardiovascular research	2015	21
26768768	23411	Pan H	SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2.	Cell research	2016	19
10591213	23621	Yan R	Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.	Nature	1999	262
14507929	23621	Lichtenthaler SF	The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1.	The Journal of biological chemistry	2003	77
16407166	23621	Sastre M	Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.	Proceedings of the National Academy of Sciences of the United States of America	2006	92
16407538	23621	Spoelgen R	Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme.	The Journal of neuroscience 	2006	65
17121991	23621	Sun X	Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.	Proceedings of the National Academy of Sciences of the United States of America	2006	117
17576410	23621	Kim DY	BACE1 regulates voltage-gated sodium channels and neuronal activity.	Nature cell biology	2007	101
18434550	23621	Hébert SS	Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.	Proceedings of the National Academy of Sciences of the United States of America	2008	298
19006075	23621	Xie Z	The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo.	Annals of neurology	2008	89
19237574	23621	Chen Y	Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.	Proceedings of the National Academy of Sciences of the United States of America	2009	82
20041192	23621	Hemming ML	Identification of beta-secretase (BACE1) substrates using quantitative proteomics.	PloS one	2009	62
20507594	23621	Faghihi MA	Evidence for natural antisense transcript-mediated inhibition of microRNA function.	Genome biology	2010	101
22090477	23621	May PC	Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor.	The Journal of neuroscience 	2011	79
25621019	23621	Vassar R	BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.	Alzheimer's research and therapy	2014	34
12766759	114548	Inohara N	NODs: intracellular proteins involved in inflammation and apoptosis.	Nature reviews. Immunology	2003	200
16470011	114548	Dinarello CA	Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process.	The American journal of clinical nutrition	2006	77
18005730	114548	Willingham SB	Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.	Cell host and microbe	2007	105
19454352	114548	Hise AG	An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans.	Cell host and microbe	2009	163
19826485	114548	Craven RR	Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.	PloS one	2009	115
20008285	114548	Meixenberger K	Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.	Journal of immunology	2010	65
20383149	114548	Ichinohe T	Influenza virus activates inflammasomes via its intracellular M2 ion channel.	Nature immunology	2010	166
20688930	114548	Vilaysane A	The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.	Journal of the American Society of Nephrology 	2010	81
20835230	114548	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.	Nature immunology	2010	281
20962258	114548	Shigeoka AA	An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury.	Journal of immunology	2010	59
20980503	114548	Barlan AU	Adenovirus membrane penetration activates the NLRP3 inflammasome.	Journal of virology	2011	51
21349431	114548	Guarda G	Type I interferon inhibits interleukin-1 production and inflammasome activation.	Immunity	2011	203
21474346	114548	Kool M	An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma.	Immunity	2011	76
21508263	114548	Niemi K	Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.	Journal of immunology	2011	63
22461501	114548	Shenoy AR	GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals.	Science	2012	88
22541070	114548	Tarallo V	DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.	Cell	2012	149
22948162	114548	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	98
23264657	114548	Wang W	Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.	Journal of immunology	2013	32
23530046	114548	Rajamäki K	Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.	The Journal of biological chemistry	2013	40
23737748	114548	McAuley JL	Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.	PLoS pathogens	2013	45
23809162	114548	Yan Y	Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.	Immunity	2013	71
23937860	114548	Hillegass JM	Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells.	Particle and fibre toxicology	2013	27
23955712	114548	Jourdan T	Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.	Nature medicine	2013	63
24008734	114548	Fann DY	Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.	Cell death and disease	2013	38
24043885	114548	Snodgrass RG	Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.	Journal of immunology	2013	31
24054327	114548	Wen H	Mechanisms of NOD-like receptor-associated inflammasome activation.	Immunity	2013	91
24243015	114548	Kim HS	Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.	Cell	2013	54
24453977	114548	Ataide MA	Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection.	PLoS pathogens	2014	30
24630723	114548	Cai X	Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation.	Cell	2014	104
24861026	114548	Wree A	NLRP3 inflammasome activation is required for fibrosis development in NAFLD.	Journal of molecular medicine	2014	30
24952504	114548	Baroja-Mazo A	The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.	Nature immunology	2014	100
25686105	114548	Coll RC	A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.	Nature medicine	2015	119
25686106	114548	Youm YH	The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.	Nature medicine	2015	70
25744023	114548	Kaushal V	Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.	Cell death and differentiation	2015	17
25828455	114548	Macia L	Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.	Nature communications	2015	53
25993444	114548	Schaale K	Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.	Mucosal immunology	2016	11
26341399	114548	Bronner DN	Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage.	Immunity	2015	27
26553871	114548	Schmid-Burgk JL	A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.	The Journal of biological chemistry	2016	25
26611636	114548	He WT	Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.	Cell research	2015	55
26814970	114548	He Y	NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.	Nature	2016	24
26877061	114548	Karmakar M	Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP.	Nature communications	2016	23
26972847	114548	Iannitti RG	IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.	Nature communications	2016	11
27006445	114548	Xi H	Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells.	Circulation research	2016	11
27037191	114548	Gaidt MM	Human Monocytes Engage an Alternative Inflammasome Pathway.	Immunity	2016	25
27313051	114548	Arbore G	T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.	Science	2016	26
27669650	114548	He Y	Mechanism and Regulation of NLRP3 Inflammasome Activation.	Trends in biochemical sciences	2016	22
16437559	120892	Ross OA	Lrrk2 and Lewy body disease.	Annals of neurology	2006	64
16437584	120892	Giasson BI	Biochemical and pathological characterization of Lrrk2.	Annals of neurology	2006	67
17120249	120892	Biskup S	Localization of LRRK2 to membranous and vesicular structures in mammalian brain.	Annals of neurology	2006	178
17341485	120892	Hatano T	Leucine-rich repeat kinase 2 associates with lipid rafts.	Human molecular genetics	2007	59
18445495	120892	Shin N	LRRK2 regulates synaptic vesicle endocytosis.	Experimental cell research	2008	101
19302196	120892	Gloeckner CJ	The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.	Journal of neurochemistry	2009	64
19545277	120892	Gillardon F	Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?	Journal of neurochemistry	2009	76
19740074	120892	Nichols RJ	Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease.	The Biochemical journal	2009	67
20642453	120892	Nichols RJ	14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.	The Biochemical journal	2010	89
20659021	120892	Dzamko N	Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization.	The Biochemical journal	2010	97
20659558	120892	Melrose HL	Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.	Neurobiology of disease	2010	81
20876399	120892	Meixner A	A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.	Molecular and cellular proteomics 	2011	36
20921534	120892	Gardet A	LRRK2 is involved in the IFN-gamma response and host response to pathogens.	Journal of immunology	2010	79
21168496	120892	Winner B	Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.	Neurobiology of disease	2011	50
21248115	120892	Dusonchet J	A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2.	The Journal of neuroscience 	2011	44
21362567	120892	Nguyen HN	LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.	Cell stem cell	2011	178
21494637	120892	Ramonet D	Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.	PloS one	2011	96
21552986	120892	Hakimi M	Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.	Journal of neural transmission	2011	47
22342962	120892	Gillardon F	Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.	Neuroscience	2012	38
23075850	120892	Liu GH	Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.	Nature	2012	72
23125283	120892	Cho HJ	MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.	Human molecular genetics	2013	30
23455607	120892	Orenstein SJ	Interplay of LRRK2 with chaperone-mediated autophagy.	Nature neuroscience	2013	100
23916833	120892	Manzoni C	Inhibition of LRRK2 kinase activity stimulates macroautophagy.	Biochimica et biophysica acta	2013	27
24682598	120892	Schapansky J	Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy.	Human molecular genetics	2014	23
25501810	120892	Arranz AM	LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism.	Journal of cell science	2015	22
25653221	120892	Fuji RN	Effect of selective LRRK2 kinase inhibition on nonhuman primate lung.	Science translational medicine	2015	19
1719635	100133941	Stefanová I	GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.	Science	1991	202
11121071	100133941	Uchida N	Direct isolation of human central nervous system stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2000	361
12629218	100133941	Al-Hajj M	Prospective identification of tumorigenic breast cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2003	2582
16778178	100133941	Liu S	Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.	Cancer research	2006	360
16885410	100133941	Sagrinati C	Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys.	Journal of the American Society of Nephrology 	2006	163
17053208	100133941	Lian Q	Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs.	Stem cells	2007	75
17283135	100133941	Li C	Identification of pancreatic cancer stem cells.	Cancer research	2007	864
17700640	100133941	Keller S	CD24 is a marker of exosomes secreted into urine and amniotic fluid.	Kidney international	2007	70
17975224	100133941	Cho RW	Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.	Stem cells	2008	108
17978305	100133941	Lazzeri E	Regenerative potential of embryonic renal multipotent progenitors in acute renal failure.	Journal of the American Society of Nephrology 	2007	55
18241344	100133941	Wright MH	Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.	Breast cancer research 	2008	177
18268494	100133941	Hurt EM	CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.	British journal of cancer	2008	118
18366788	100133941	Fillmore CM	Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.	Breast cancer research 	2008	344
18539958	100133941	Lee CJ	Pancreatic cancer stem cells.	Journal of clinical oncology 	2008	112
18681906	100133941	Croker AK	High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.	Journal of cellular and molecular medicine	2009	125
19188015	100133941	Keller S	Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.	Cancer letters	2009	64
19264983	100133941	Chen GY	CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.	Science	2009	186
19414749	100133941	Palanichamy A	Novel human transitional B cell populations revealed by B cell depletion therapy.	Journal of immunology	2009	80
19582426	100133941	Li C	Identification of human pancreatic cancer stem cells.	Methods in molecular biology	2009	57
19725119	100133941	Pruszak J	CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells.	Stem cells	2009	55
20027313	100133941	Hwang-Verslues WW	Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.	PloS one	2009	70
20176987	100133941	Lian Q	Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.	Circulation	2010	117
20190812	100133941	Gao MQ	CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.	Oncogene	2010	83
20572012	100133941	Battula VL	Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.	Stem cells	2010	85
20937839	100133941	Wu K	Cell fate determination factor Dachshund reprograms breast cancer stem cell function.	The Journal of biological chemistry	2011	35
20962324	100133941	Iwata Y	Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.	Blood	2011	221
20964822	100133941	Keller PJ	Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.	Breast cancer research 	2010	65
21067584	100133941	Louie E	Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.	Breast cancer research 	2010	47
21392411	100133941	May CD	Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.	Breast cancer research 	2011	87
21394208	100133941	Song Z	Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer.	PloS one	2011	42
21407814	100133941	Yuan SH	Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells.	PloS one	2011	108
21480217	100133941	Kryczek I	Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.	International journal of cancer	2012	70
21633165	100133941	Marotta LL	The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.	The Journal of clinical investigation	2011	209
21726833	100133941	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	139
21835433	100133941	Idowu MO	CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.	Human pathology	2012	46
21882047	100133941	Zhang C	Identification of CD44+CD24+ gastric cancer stem cells.	Journal of cancer research and clinical oncology	2011	35
21996751	100133941	Buijs JT	The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.	Oncogene	2012	37
22308459	100133941	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22496457	100133941	Palafox M	RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.	Cancer research	2012	40
22565037	100133941	Cufi S	Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.	Oncotarget	2012	61
22692575	100133941	Leth-Larsen R	Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.	Molecular medicine	2012	34
23124355	100133941	Smeets B	Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration.	The Journal of pathology	2013	36
23318426	100133941	Nishi M	Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.	Oncogene	2014	25
23340294	100133941	Schott AF	Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.	Clinical cancer research 	2013	41
23644405	100133941	Wang F	Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay.	Gastroenterology	2013	49
23943797	100133941	Cieply B	Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.	Cancer research	2013	32
24127583	100133941	Kusaba T	Differentiated kidney epithelial cells repair injured proximal tubule.	Proceedings of the National Academy of Sciences of the United States of America	2014	62
24497554	100133941	Lau AN	Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.	The EMBO journal	2014	38
24945524	100133941	Chen W	Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration.	Journal of tissue engineering and regenerative medicine	2017	5
24955581	100133941	Yang CH	Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma.	PloS one	2014	21
25051962	100133941	Khoder A	Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.	Blood	2014	41
25605369	100133941	de Masson A	CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.	Blood	2015	24
25823923	100133941	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	19
26421710	100133941	Farnie G	High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.	Oncotarget	2015	22
9836530	100506658	Antonetti DA	Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.	Diabetes	1998	115
11914275	100506658	Gudjonsson T	Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.	Genes and development	2002	97
15761153	100506658	Barrios-Rodiles M	High-throughput mapping of a dynamic signaling network in mammalian cells.	Science	2005	212
16635908	100506658	Drago S	Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.	Scandinavian journal of gastroenterology	2006	62
19017651	100506658	Elias BC	Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions.	The Journal of biological chemistry	2009	55
19182773	100506658	Ploss A	Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.	Nature	2009	327
19470647	100506658	Siu ER	Focal adhesion kinase is a blood-testis barrier regulator.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
20617177	100506658	Bitzegeio J	Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.	PLoS pathogens	2010	45
21654804	100506658	Dorner M	A genetically humanized mouse model for hepatitis C virus infection.	Nature	2011	131
21909359	100506658	Biron KE	Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.	PloS one	2011	49
